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Abstract
Charles WINTERHALTER
A unified platform for experimental and computational biology
In natural sciences, the correct engineering of a system’s chemical, biological and phys-
ical properties may allow it to sustain life. Bioengineering cells is probably one of the
most complex challenges of biological research; yet, the little we do know about the na-
ture of life is sufficient to guide scientific research, and to explore the elements beyond
the apparent simple proliferation of living cells. Although Mendel first characterised
the concept of genetic heredity over 150 years ago, we only recently became able to
perform tailored genetic modification of living organisms. The development of digital
technologies, in particular, has positively influenced the quality and reproducibility of
experimental results emerging from biological assays. However, the use of any equip-
ment may require the need for a specific expertise in order to perform a given experi-
mental procedure. Therefore, multidisciplinary research can bring benefits to all fields
of science by helping the development of analytical methods that cross the boundaries
of individual disciplines. This emerges as a systematic view of scientific problems, and
relies on the adequation and integration of results from different research areas. Nev-
ertheless, there is a complex interface between hard sciences that often creates a gap
between experimental and theoretical models.
In this thesis, we explored synthetic biology approaches and created a unified plat-
form to fill this gap. We propose the first barcoding platform (Bac2code) that allows
the identification and the tracking of bacterial strains. In order to facilitate communi-
cation between researchers, we developed a barcode system in DNA that physically
links bacteria to their genetic description. We designed DNA barcodes as bioorthog-
onal elements, elaborated a universal cloning strategy to integrate these sequences in
Gram-negative and Gram-positive bacteria, and demonstrated their stability over time.
Through a generic protocol, any barcoded strain can later be identified via a single se-
quencing read. With the engineering of a synthetic circuit library, we built a biorepos-
itory of genetic constructs for our barcoding platform. These biological devices were
optimised based on the closest achievable interface between experimental biology and
viii
computational results. Following their characterisation, and in the context of intercel-
lular communication, we studied the behaviour of small cohorts of bioengineered cells
at the microscale in microfluidics. We pushed the biological and physical boundaries
of engineering techniques to the maximum, in order to observe physiological changes
between bacteria separated by distances down to 20µm. However, we also showed that
we reached a technological barrier, where even the use of nanoscale features was found
insufficient to maintain cells isolated under high cellular density. Yet, microfluidics re-
mains a remarkable technology, and we propose the expansion of barcoding methods
to automated systems, which would allow serial barcode integration and documenta-
tion retrieval at any one time.
Here, we developed and tested a barcoding method to ensure the cohesion of ex-
perimental and computational biology resources. We demonstrated its use by the in
vitro assembly and the in vivo or in silico characterisation of a series of genetic circuits
via different techniques. The research output of this thesis is realised as a step forward
in interdisciplinary studies, and is now being adapted to reach a larger community of
users as a startup company.
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Introduction
This thesis is focussed on the unseen majority that evolves in our environment: bacte-
ria. The huge number of these unicellular organisms surrounding us, invisible to the
naked eye, is essential for the proliferation of life on Earth. Bacteria may affect other
species and either be beneficial, detrimental, or both, depending on a specific biologi-
cal context[229]. Regardless of their effect, all bacteria follow the same basic biological
rules; they display a certain behaviour based on the molecular processes that are di-
rected by the central dogma of biology (conversion of deoxyribonucleic acid (DNA)
to ribonucleic acid (RNA) and proteins, described in Chapter 2)[39]. For instance, in
common bacterial cells such as Escherichia coli, there are over 4,000 proteins that form
a complex interaction network, based on information encoded from a genome of ∼ 4.6
million nucleotides (individual bases of DNA). For a single cell, that is a lot to han-
dle. Yet, a long time before humans even populated the Earth, bacterial strains have
evolved and developed techniques to adapt their growth to an enormous range of envi-
ronments[184]. Humans, in turn, later started developing techniques to engineer bac-
teria for specific applications. Although we have been using bacteria for centuries, we
did not appreciate until recently the complexity that lies behind their various, seem-
ingly simple processes. For instance, the maturation of milk is coordinated with the
growth of a set of bacterial species, and these bacteria are now of major importance for
dairy industries[64]. Over time, scientists have developed a thorough understanding
of the cellular mechanisms that happen at the microscale, and it is nowadays possi-
ble to program cells with a specific cellular behaviour, based on the engineering of the
genetic code and environmental factors.
In 1953, Watson and Crick published the structure of DNA, but there was still at
the time a tremendous amount of biological processes to be understood[236]. How-
ever, scientists had already started thinking about cells as small devices that carry out
specific functions. For instance, the physicist Feynman postulated in 1960 that cells
are analogous to machines and that they are, at a small scale, capable of an impressive
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amount of operations[66, 159, 221]. This vision suggested that cells may act as molec-
ular machines, which undertake a certain set of actions in response to different stimuli
in order to produce a variable output. It was noneless 30 years later, with the devel-
opment of sequencing technologies, that synthetic biology emerged as a discipline of
real interest in the field of biological research. Synthetic biology aims to create robust
biological circuits, with a well-known function and predictable behaviour[27, 28]. It
includes the development of computational tools that help the understanding of ex-
perimental processes, and the optimisation of biological device functions. In fact, most
synthetic biology studies are driven by the creation of tools to solve variable prob-
lems[33, 168]. Many applications are aimed towards the production of therapeutics to
cure various conditions or diseases affecting humankind, but some other studies, for
instance the terraformation project led by the National Aeronautics and Space Admin-
istration (NASA), use bacteria to transform the outer space into potential Earth-like
habitats. There are thus a plethora of experimental techniques available for genetic
modification, which may be used to engineer bacteria for completely different kinds of
objectives. Altogether, the engineering of novel synthetic devices is generally directed
towards getting a better understanding of life, or to have a specific use in a production
process such as pharmaceuticals, or biofuel companies. However, there are a number
of restrictions that emerge from the nature of living cells[24, 218]. Therefore, as shown
in Figure 1.1, the engineering of a biological device is often a cyclic process, where
several cycle iterations need repeating before obtaining well-behaved circuits.
In the context of synthetic biology, the development of description and analysis
tools should aid the rapid engineering of novel synthetic devices. However, this type
of multidisciplinary research involves a profound understanding of the elementary ge-
netic elements of bacteria, and often requires circuit optimisation to obtain robust con-
structs in vivo. On one side, computational studies should help the modelling and pre-
diction of physiological changes; these are hidden behind stochastic noise represented
by living microorganisms and their associated subcellular processes. On the other side,
biologically engineered constructs should be portable and also provide replicable be-
haviour in various genomic context. Throughout this thesis, we adopted these prin-
ciples and developed a series of genetic devices and screening platforms, in order to
to facilitate the connection between experimental and computational biology. In the
following section, we provide more details about the context of this study: the design
of artificial circuits in synthetic biology.
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FIGURE 1.1: The model starts with a theory over the circuit design and
mathematical rules dictating its behaviour. Theoretical models can be
tested in the wet lab: first, parts necessary for the circuit are functionally
assembled, then the circuit behaviour is followed in living cells. Fitting
between experimental data and theoretical model helps re-evaluating the
circuit and improving it in other iterations of this engineering process.
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1.1 Design in synthetic biology
Synthetic biology and computer science are two intertwined disciplines. This is be-
cause bioengineered cells can display the same characteristics as micro-/nanocomputers.
Specific algorithms are associated with different cellular mechanisms, and genetic pro-
gramming becomes feasible by changing modular subunits within molecular devices[218,
185, 123, 6]. To exemplify this approach, we use the analogy between a simple electri-
cal circuit and a light production device in bacteria (Figure 1.2). On the electric board,
if the switch is turned on, the light bulb should receive current generated by the bat-
tery and start emitting light. If no light is observed, then it is easy to either change
the light bulb or the battery, which are the most likely causes of fault. In synthetic
biology, we build modular devices that can be adapted to reproduce similar systems.
There should thus be known components and methodological controls that allow the
troubleshooting of any uprising issue (no light emission protein observed for instance).
Since individual cells are the tiny batteries powering genetic devices, it is important to
grow them in optimal conditions in order to provide these circuits reliable environmen-
tal conditions. Genetic modification of specific circuit transcription or translation units
can then be compared to replacing a light bulb, but at the molecular level. Therefore,
there are key parameters that allow for the construction of stable biological devices,
and optimising one element is analogous to one or multiple cycles through the devel-
opment of synthetic circuits presented in Figure 1.1. By the end of this optimisation
process, biological devices should be thoroughly tested, well-characterised and show
a good response to changes in the environment.
1.1.1 Cellular stochasticity
When studying genetic circuits in a cellular context, there are a lot of processes oper-
ating at the same time as the specific device functions. Therefore, there are constant
perturbations within cells that restrict our ability to obtain precise parameters over
synthetic circuit behaviour[167]. Without the use of external methods of analysis, bi-
ological research would be like looking for a needle in a haystack. Fortunately, the
development of characterisation methods for single cell or population scale measure-
ments facilitated our understanding of biological processes. As displayed in Figure
1.2B, one can use intrinsic biological system properties to activate light emission in
bacteria. Actually, this is a common approach in synthetic biology, where a reporter
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FIGURE 1.2: (A) A simple classic electrical system lightling up a bulb upon
activation of a switch if wired through a power supply (battery). (B) A
generic biological circuit, or plasmid, replicating itself with a replicon and
selected for with a specific marker. This plasmid drives the expression of a
protein of interest (fluorescent reporter F) through transcription (from the
promoter to the terminator) and translation (via ribosomes recognising a
ribosome binding site, or rbs).
provides variable illumination given different cellular states. Since bacteria are in-
dividual microscopic organisms, cellular signals often need amplification to be per-
ceived, and the use of fluorescent reporters allows an easy detection of physiological
changes via a range of qualitative and quantitative methods[112]. External tools thus
enable us to analyse and to interpret changes invisible to the naked eye, but resulting
from significant biological activity performed at the microscale. These physiological
changes later need to be compared to the proposed theoretical model. Nevertheless,
the background noise behind experimental data may sometimes impair with the use
of automated analysis methods, and it makes the matching of experimental data to
computational models a trickier process.
Bacteria represent a stochastic environment: cellular responses may vary from ex-
periment to experiment, and sometimes lead to false-positive and false-negative re-
sults. This highlights the importance of performing biological replicates in order to
obtain meaningful data. However, the complementation of biological studies with in
silico resources usually facilitates the identification of true-positives. For instance, fluo-
rescence measurements derived from in vivo experiments can be analysed, modelled by
mathematical models and compared to theoretical results in order to improve genetic
devices[176, 128]. Generally, this is achieved with a low modelling level of abstraction,
better to model biological processes, that is based on simulating the main features of
the central dogma of biology for a specific function (cf. Chapter 2). In practice, this
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allows us to overcome the noise imposed by millions of surrounding molecules, and to
truly characterise a device function. Yet, the modelling process of synthetic constructs
is sometimes context specific, and may not provide an exact prediction of the observed
physiological changes in different conditions. Thus, the documentation of in silico re-
sources linked to biological devices should account for specific features, which allow
the easier characterisation of novel circuits.
1.1.2 Host/circuit compatibility
In the microscopic world, any individual that does not fit the environment is quickly
eliminated by natural selection. In all biological assays, cells can sustain a specific
metabolic load, which is directly connected to their growth profile. Therefore, in syn-
thetic biology, any defect in bacterial growth is usually synonym of an increased metabolic
load, resulting from the functionality of a genetic circuit creating crosstalk between
host and specifically encoded elements[79, 185]. Back to the analogy between genetic
and eletrical circuits presented in Figure 1.2, leaving the light on at all times would
likely reduce the life time of a light bulb, besides leaving a salty bill. To avoid this sit-
uation at the molecular level, we thus try to limit the impact that genetic devices may
display on cellular metabolism, since it is the same metabolism that is also responsible
for the functionality of a given construct. Hence, in the development of any biological
circuit, it is of upmost importance to be aware of its potential metabolic load, and to
control the impact it may create on other specific cellular processes.
So far, we have provided an overview of biological circuit design in synthetic bi-
ology, and explained how cells may be programmed to perform different kinds of
actions. Differential behaviour is obtained by the setup of an ordered nucleotide se-
quence that contains regulatory regions, required for a specific biochemical phenomenon
to take place in vitro/in vivo. However, many genome and DNA sequences are of un-
known function, and some may be deleted without altering the bacterial fitness. In
contrast, attempting to remove other unknown regions may also be detrimental to the
overall metabolism. Although, per se, the succession of individual nucleotides may not
provide direct information about its function, it still follows generic patterns that are
recognised and used by the cellular machinery. Therefore, a possibility to minimise the
potential for interactions between synthetic circuits and host metabolism is to design
bioorthogonal circuits[129]. This consists of engineering a nucleic acid sequence that
displays minimal homology with the elements of nature, making it biologically inert.
In this area of synthetic biology called DNA programming, nanoengineering methods
must account for context specificity (where a circuit evolves), and circuit functionality
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(what a circuit does). It is usually only after a rigorous optimisation of these features
that bioengineered devices may provide robust behaviour in different cellular contexts.
Synthetic biology is a unique discipline in biological research that has numerous
advantages resulting from its systematic engineering principles. Novel synthetic de-
vices are constructed by assembling and inserting specific modules into larger systems,
which are in turn connected into a complex biochemical network within cells. This in-
credible complexity implies that nearly all applications in synthetic biology require the
optimisation of biological devices. By doing so, it increases the chances of getting a
theoretical model and equivalent experimental data providing the same results. Ulti-
mately, genetic devices rely on a specific sequence of nucleotides. This DNA sequence
may encode functional or biologically inert features, but should, in all cases, provide
stable information. In a bacterial context, this involves considering a stochastic sys-
tem where multiple molecules and underlying processes may interact with a circuit
functionality. Therefore, in order to achieve specific goals in synthetic biology, it is es-
sential to control and to protect the integrity of the bioengineered devices, and to fully
document their variable behaviour.
1.2 Thesis problem statement and objectives
Synthetic biology represents the combination of engineering, computer science and
biology. Multidisciplinary studies bring together the expertise of various disciplines,
and this implies the use of standards for a better coordination. However, the interface
between individual research areas needs to be crystal clear for a smooth orchestration
of multiple project strands. For most fields of science, the communication between
experts in different domains is not trivial because it requires the abstraction of precise
mechanisms into formal entities and concepts. For instance, DNA modelling tools such
as the Synthetic Biology Open Language (SBOL) greatly help the in silico characterisa-
tion of genetic circuits, and their virtual description[202, 194, 37]. These resources are
tailored to simplify the communication between molecular biologists and computer
scientists, and allow the investigation of further computational studies associated with
a synthetic device[23, 128]. Due to the noise and the stochastic environment imposed
by living cells, manipulating microogranisms themselves makes biology arguably the
messiest of all hard sciences. Therefore, there is a multitude of platforms designed to
help the understanding of specific biological processes. Nevertheless, such a number
of resources produces large amounts of data, which may become difficult to track in
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order to derive meaningful conclusions. Although these tools are connected to biolog-
ical devices, there is no physical link between them, and only this could guarantee the
perfect adequation of computational and experimental data. Hence, there is a gap be-
tween the in silico data and experimental studies that often delays the overall progress
of research projects.
In this thesis, we focussed our interest on unifying wet laboratory and computa-
tional resources. The first research statement we tried to answer was the following:
(i) Is it possible to engineer a robust physical link between bacteria and
external resources?
In order to answer this question, we designed a barcoding platform (Bac2code) that
uses artificial and unique DNA sequences for the identification/documentation of bac-
terial strains, which is summarised in Figure 1.3. Throughout this work, we first
endeavored the development of bioorthogonal DNA barcodes and their associated
cloning protocols, and then verified artificial sequences stability in vivo. For the de-
velopment of a barcode biorepository, we used a case study with a library of genetic
devices; our second research question was thus stated as:
(ii) How to optimise and to integrate the documentation of bioengineered
devices on a unified platform?
For the contruction of the biorepository shown in Figure 1.3, we developed a series of
biological circuits displaying intercellular communication features. For specific cellu-
lar process optimisation, we characterised bioengineered cells in different settings and
iterated through the engineering cycle of synthetic biology multiple times via different
techniques. In particular, we restricted our field of study to the microscopic scale and
investigated microfluidics solutions for bacterial screening, which led us to our last
scientific question:
(iii) How to design microfluidics platforms for microscale bacterial stud-
ies?
For this matter, we used the synthetic devices created for the biorepository, and pre-
sented a few microfluidic design examples that can be used for microscale communica-
tion of bacterial species. Finally, we also discuss the potential use of high-throughput
platforms for the automation of barcoding processes. In a nutshell, we reviewed and
adapted in this thesis the engineering of synthetic biology methods for the creation of
a unified bacterial barcoding platform, in an attempt to bridge the gap between in silico
and in vitro/in vivo biology.
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FIGURE 1.3: Main features of the Bac2code platform. Each coloured circle
represents an area of optimisation in the development of the barcoding
platform. The overlap between circles represents the interface that needed
consideration for the integration of individual concepts.
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1.3 Plan
We structured this thesis as follows:
• In Chapter 2 we review the fundamental processes of bacterial bioengineering.
We used molecular biology methods detailed in Appendix A to produce a series
of genetic variants, and provide a list of these constructs later characterised in
Chapter 4.
• In Chapter 3 we describe the technical methods that were used to create the bar-
coding platform. In particular, we explain the concepts of the DNA barcode algo-
rithm that translated biological rules into a computer program, which generates
unique bioorthogonal DNA sequences. Secondly, we provide a thorough descrip-
tion of biological protocols that were elaborated to accommodate the propagation
and retrieval of these artificial sequences. We present the properties of DNA bar-
codes and their study in two large scale assays. In order to demonstrate barcode
stability, we grew barcoded strains over an extended number of replication cy-
cles in multiple conditions, and provide their characterisation via chemostat and
high-throughput systems. Here, we show the efficiency of the barcode integra-
tion method - available as a barcoding kit (cf. Appendix C) - and discuss the
accuracy of DNA barcode retrieval.
• In Chapter 4 we review the optimisation of genetic circuits for signalling studies
in bacteria. This chapter examplifies the type of data hosted by our barcoding
platform, representing our first biorepository parts (cf. Figure 1.3). We guide
the characterisation of synthetic circuits via a case-study using a quorum sensing
system allowing intercellular communication.
• In Chapter 5 we describe the technical methods that were used to fabricate mi-
crofluidics devices. We review microfluidics design and properties for bacterial
studies, and provide optimised fabrication protocols (cf. Appendix D) for the
setup of micron or submicron size circuits. We describe the results obtained for
the fabrication and testing of high-throughput microfluidics devices: first, we
provide an overview of the microfluidics chips manufacturing process; then, us-
ing the genetic circuits presented in Chapter 4, we discuss the observation of cel-
lular communication at the microscale, taking place between distal microcolonies
of bacteria.
• In Chapter 6 we expand on current and further developments of our barcoding
platform. In particular, we discuss the online barcoding platform, and potential
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applications to adapt barcoding techniques to large scale screening applications
via microfluidics.
• In Chapter 7, we close this dissertation with a few concluding remarks and fur-
ther prospects of this research.
1.4 Contributions to this thesis
The work on DNA barcodes was carried out in collaboration with Dr. Jurek Kozyra.
He wrote the algorithm to encode bio-orthogonal sequences and to recognise barcode
sequences from sequencing reads, and is also developing the online barcoding plat-
form.
In the microfluidics chapter, the channel-type biochips were designed by Dr. Sunny
Park and their silicon wafer was kindly provided by Dr. Lucy Eland. The silicon
wafer for diffusion-type biochips was manufactured by INEX, a company specialised
in photolithography based in Newcastle-upon-tyne.
The rest of this thesis, including experimental and computational approaches, was
research I conducted by myself.
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Chapter 2
Background and genetic library
engineering
"A grain in the balance will determine which individual shall live and which shall
die - which variety or species shall increase in number, and which shall decrease, or
finally become extinct" – Charles Darwin (1859)
These words were written by the father of the theory of evolution, and explain the
basis of natural selection. Although Darwin postulated and presented his theory over
150 years ago[42], it was not until the 1950s that the molecular structure of living cells
was elucidated. Based on preliminary work from Franklin and Wilkins, Watson and
Crick published in 1953 the crystal structure of DNA and later earned the Nobel price
for Physiology and Medicine in 1962 for their discoveries[236, 39, 181]. After decades
of labour to decipher the nature of life, scientists are yet to comprehend all the intricate
mechanisms that are involved in the regulation of biological systems. In this thesis, we
explored the prokaryotic kingdom[245] and bestowed our efforts to streamline its use
for bioengineering studies. In this chapter, we provide the biological background re-
quired to understand the engineering of biological circuits in bacteria, and we explain
the different notions that were used to build a library of genetic constructs, listed in
the last section.
2.1 Engineering the genetic code
Genetic circuits evolve in living organisms and obey general biological rules that are
driven by the flow of information from DNA to proteins. Often documented as a three-
component system, the central dogma of biology relies on the transcription of DNA
to RNA molecules, and the translation of certain types of RNA (messenger RNA or
mRNA) to proteins (Figure 2.1)[38]. This highly connected network of DNA, RNA
and proteins forms the essence of biological function. In the following subsections, we
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FIGURE 2.1: The central dogma of biology and its components. DNA is
transcribed to RNA, that can be in turn reverse transcribed to DNA or
translated to proteins. Both DNA and RNA can replicate through specific
polymerases, and proteins can assemble into complexes to perform trans-
regulation of DNA.
introduce the basic notions that need understanding in order to undertake biological
studies.
2.1.1 DNA
The key to understanding life relies on genetic information encoded in DNA[236, 237].
Through this chemical machinery, cellular organisms can replicate and adapt their re-
sponse to change in the environment. Four nucleotides form the core of DNA: adenine,
guanine, thymine and cytosine, commonly abbreviated to A, G, T and C respectively.
These nucleotides, or bases, are polymerised on sugar phosphate backbones, generally
referred to as DNA strands (Figure 2.2). Strand polymerisation relies on the presence
of a 5’-phosphate on individual nucleotides to be incorporated into a growing chain of
nucleic acid. By convention, every strand has a 5’-3’ orientation depending on the end
containing the 5’-phosphate. The 3’-end displays a deoxyribose hydroxyl group, and
is thus available to bond a phosphate group, thereby extending the DNA strand. This
model depicts our chemical understanding of DNA primary structure.
Individual DNA strands form a duplex structure depending on sequence comple-
mentarity between A and T, and G and C, and naturally adopt a helical conformation as
shown in Figure 2.3. In nature, the most common form of DNA is found as the B-form
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FIGURE 2.2: Two complementary strands of DNA consisting of DNA
bases sitting on sugar phosphate backbones. Two or three hydrogen bonds
are formed between individual bases depending on the AT or GC base
pairing.
double-helix (Figure 2.3). Figure 2.2 outlines that AT and GC base pairing differ in the
number of hydrogen bonds formed between individual nucleotides. While AT pairs
account for two hydrogen bonds and allow for flexibility in DNA helices, GC pairs
form three hydrogen bonds that are harder to break, and add stiffness to helices. There-
fore, even if DNA structure is prone to form a double-helix, it can in fact adopt multiple
conformations; these are dictated by specific nucleotide sequences. For instance, a sin-
gle strand of DNA may display hairpin-like secondary structures, where complemen-
tary regions form short double helices (or stems), separated by single-stranded DNA
loops of non-complementary bases. In the following chapters, we used these features
as cofactors to coordinate biological behaviour.
2.1.2 RNA
RNA molecules follow the same principles as DNA, but represent its altered copy
where uracyl (U) bases replace DNA-specific thymine nucleotides. The three other
bases A, G and C remain unchanged. In cells, RNAs play major roles in the conversion
of DNA to proteins, and are a means of regulation for the overall metabolism. Our
current understanding of biology allows the division of the RNA world into different
categories, dependent on molecule structure and associated functions. RNA is com-
parable to DNA in many aspects but usually evolves in single-stranded conditions.
Since it shares the same basic properties as DNA, stable secondary structures can also
emerge to stabilise RNA intermediates. The simplest form of them all is the hairpin
model that was aforementioned for DNA. Using a series of these stem loops, a special
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FIGURE 2.3: The three-dimensional double helix structure of DNA, cor-
rectly elucidated by James Watson and Francis Crick. Complementary
bases are held together as a pair by hydrogen bonds and stacking inter-
actions. Image from Pray (2008)[181]
type of RNA is the transfer-RNA (tRNA), known to incorporate individual amino acids
into nascent proteins (or polypeptides) during translation (Figure 2.4). Its structure is
complex but very conserved among species as it allows polymerisation of polypeptide
chains from mRNA molecules, one of the many essential features for cellular prolif-
eration[35]. Messenger-RNA is the only RNA used for protein translation, and yet, it
only represents 1% to 5% of the total RNA in cells. Therefore, only a small percentage
of total RNA is recognised by ribosomes and available as a valid template for protein
synthesis.
2.1.3 Proteins
Proteins are the third type of polymer present in the central dogma of biology. As
aforementioned, only mRNA molecules are used in the translation of RNA to pro-
teins. Ribosomes sliding on mRNA sequences allow the polymerisation of polypep-
tides encoding protein sequence information. By triplets of nucleotides (or codons),
ribosomes read mRNA sequences and recruit individual tRNAs to incorporate spe-
cific amino acids to nascent polypeptides[39]. All amino acids are based on a chemical
backbone formed of three groups: the N-terminal amine (NH2), the central carbon and
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FIGURE 2.4: Alanine tRNA sequence conformation. Dotted lines between
complementary bases denote hydrogen bonds between DNA strands. Dif-
ferent hairpin loops are used to stabilise the tRNA on the ribosome ma-
chinery. A specific anticodon matching an alanine codon (bottom loop) is
used for the specific recognition of adequate tRNAs during translation.
the C-terminal carboxyl (COOH) groups. One of 20 available side chains can be inte-
grated on the central carbon (or Cα), and each side chain is typically associated with
specific physico-chemical properties[26]. During translation, tRNAs are specialised to
recruit amino acids and to present them to sliding ribosome complexes for elongation
of polypeptide chains. When an amino acid is added to a nascent polypeptide, its N-
terminal region is fused to the peptide at its C-terminal end. In this process, a molecule
of water is lost, and we thereby refer to individual amino acids in proteins as residues.
In translation, when protein sequences are first produced, they only form a lin-
ear sequence of residues, and are catalytically inactive. In order to gain functionality,
proteins need to undergo a number of maturation processes that are associated with
the formation of secondary, tertiary and quaternary structures. This sequential post-
translational process starts by the arrangement of linear peptide chains into α-helices
and pleated sheets (or β-sheets). These secondary structures can then be combined to
display higher level tertiary structures, also known as folds. Several folds can be as-
sembled into functional protein domains, with multiple domains interacting with one
another (quaternary structure), eventually leading to protein multimerisation[213]. In
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FIGURE 2.5: Protein maturation process. (I) Nascent popypeptides are
synthesised and found as a chain of amino acid residues in a primary
structure. (II) These are then assembled into α-helices and β-pleated
sheets known as the secondary structure. Finally, several secondary struc-
ture motifs can be assembled into more complex tertiary (III) and quater-
nary structure complexes (IV). Adapted from [205].
Figure 2.5, we streamline the maturation process of proteins that leads to the activation
of their catalytic activity. Under the right environmental conditions, a protein may dis-
play one or several active sites processing different regulatory functions. These func-
tions are usually reached upon binding of ligands on proteins, which triggers specific
enzymatic activity. These ligands may be DNA, RNA, proteins or other small metabo-
lites. This regulatory process has further implications for protein function, and may in
particular allow the activation or repression of various cellular responses.
The central dogma of biology drives our understanding of biological processes.
Transcription and translation are essential for life to replicate, and bacteria are par-
ticularly good chassis organisms to study these processes. For instance, cloning cir-
cuits in E. coli only takes a couple of days, which eases the testing of genetic de-
vices. In most applications in synthetic biology, modification of transcription (promot-
ers/terminators) and translation (ribosome binding site (RBS) and small RNA (sRNA))
regulatory units allows the programming and optimisation of defined cellular func-
tions behaviour[95, 153, 135, 156, 41, 188, 186]. In the next section, we review the key
regulatory elements that were accounted for in the construction of a series of genetic
devices.
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2.2 Circuit replication
In order to modify living organisms, a given genetic circuit needs to account for its
replication within the host it evolves in. The world of bacteria is competitive and non-
replicative circuits cannot survive in such conditions. Any synthetic circuit must then
account for a method to multiply along its host[113]. One method is to integrate ge-
netic devices directly onto the host chromosome, which ensures a stable replication.
By definition, cells need to maintain the chromosome (their genetic material) to sur-
vive[165]. However, chromosomes usually consist of a single copy per cell, and even
if the use of rich media may form concatemers (duplicated fused copies of the chro-
mosome[132]), the overall amount of DNA to be expressed remains very little[34]. To
reach higher genetic circuit expression levels, we used vectors that carried biological
sequences along a self-replicating high copy backbone.
2.2.1 Replicative plasmids
The backbone normally contains an origin of replication and an antibiotic marker to
be selected for in bacterial replication[44]. Plasmid vectors are automatically recog-
nised by their host cellular metabolism. On their own, plasmids are only inert pieces
of DNA but some DNA sequences may become active in a biological context where
cellular machinery recognises replication elements. Plasmids’ origin of replication are
usually characterised by an average number of DNA copies per cell. Low copy num-
ber plasmids may contain from one to 20 copies of the genetic material per cell whilst
high copy number plasmids may reach up to 1000 copies per cell[30, 25, 253, 215]. In
practice, one can design genetic devices and ensure they contain replicative elements
that allow for in vivo propagation. However, this was not the only requirement for a
plasmid to survive in bacterial populations: it also needed to be specifically selected
for by the use of antibiotics.
2.2.2 Selective pressure
When a plasmid is inserted (or transformed) in bacteria, its replicative elements are
detected by the cellular machinery. As all there is is genetic information, transformed
DNA is yet another piece of material to be propagated within the host. Therefore, even
if a genetic circuit can replicate on its own, it will not be kept in the long term if it
does not provide a selective advantage. We usually use antibiotics to solve this issue.
There are two types of antibiotics, that either target the cellular membrane or perturb
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the central metabolism[127, 59]. Similar to the toxin/antitoxin concept, antibiotics are
toxic to bacteria unless they harbor a specific "antitoxin" (the resistance gene product)
that inactives the antibiotic. Two of the most commonly used antibiotics are ampicillin
and chloramphenicol[55, 2]. If two genetic circuits were to be combined, these may be
used in conjunction with each other in order to select for the replication of each device.
Although there are possibilities to combine several vectors in a single host, a major
issue may arise if they use the same replication mechanism[172]. A number of origins
of replication have been discovered over the years and all share the same problem: if
two circuits using an identical replication unit are combined, the cellular metabolism
would not be able to differentiate between the circuits and copy-numbers would con-
stantly fluctuate. This scenario could result in losing one of the circuits. There are
a number of compatible E. coli origins, however, relatively few are used in laborato-
ries[100, 192]. In this study, we focussed on the use of the plasmid-derived pUC[253]
and p15A[207] origins of replication when needed to select for two vectors simultane-
ously.
Plasmids ease of use and limitations Plasmids are very easy to propagate in bacte-
ria and can be harvested from lysed cells to be used for further genetic manipulation.
This is possible due to their independent origins of replication from the chromosome,
which allows maintenance of a stable DNA copy number in cells. From an engineer-
ing point of view, it is important to be able to change different parameters, such as
how much genetic material we want as an input to a system. High copy number plas-
mids are good to reach substantial levels of expression and, therefore, a better signal
of the circuit in the experiment. However, it is common to find some circuits to be
toxic in live cells, and that either do not allow for bacterial growth, or that evolved
through mutations within the circuit itself and/or the host. In order to avoid this kind
of situation, an alternative to lighten cytotoxicity effects is to reduce the plasmid copy
number[138]. Another issue may arise from plasmid size[141]. For instance, pUC19 is
a plasmid commonly used as backbone, is found in high copy number in E. coli and
consists of less than 2.5kb of DNA. If the cloning reaction only adds a few kilobases of
synthetic circuit to the plasmid, it is unlikely to cost much more to the cells to repli-
cate than the original version (based on the DNA size). However, a 30kb plasmid in
high copy would probably not be very easy for bacteria to replicate. First, it would
need to be transformed[93, 49, 8] and somehow permeated through the bacterial mem-
brane and then, use the cellular metabolism to replicate its entire sequence. In high
copy number settings, this would be > 20Mb of additional DNA to replicate per cell,
while the E. coli chromosome varies from 4.5 to 5.5Mb; cells would have to replicate
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five times as much DNA as they normally do. To avoid this kind of scenario, it is al-
ways important to think how we want to propagate a circuit in cells, whether that is
the main effector of the system, if it needs to be complemented with other units or if
it is cytotoxic. With careful planning, plasmids are a real advantage to test combina-
torial libraries of genetic parts. However, in the case of DNA barcodes that were not
meant to be expressed in cells, we placed artifical circuits directly on the chromosome
via recombination.
2.2.3 Chromosomal recombination
In biology, strands of DNA can be exchanged by the action of specific enzymes called
recombinases. These enzymes carry out recombination where a region of homology
is detected in DNA, which recruits one or several proteins that cleave and modify
pieces of genetic material[234]. A recombination mechanism can be either site-specific
or not. This means that certain recombinases are only active when they identify specific
recognition sequences (site-specific recombination, e.g. lambda-red[180, 102], Cre[252]
or CrispR[134] systems). However, other enzymes are solely based on DNA strand
homology recognition and exchange, and are often found as a native means of recom-
bination in bacterial species (for instance, the recA system[122]). We discuss in Chapter
3 further aspects of recombination for the insertion and update of barcode sequences.
2.3 Transcription machinery
In DNA, gene coding sequences display functional features on one strand only, and are
subject to a specific orientation on the genome. In bacteria, the codirectionality of gene
coding sequences allows the transcription of large operons, which generally encode
biologically related components.
2.3.1 Promoters
The first key element in transcription is the recruitment of the RNA polymerase (RNAp)
at a promoter sequence. In E. coli, these sequences are relatively simple and are respon-
sible for the melting of double-stranded DNA (dsDNA) to allow RNA polymerisation
on the non-coding strand. The driving force of transcription, the RNA polymerase, is
a highly processive protein complex that slides on the DNA coding strand and poly-
merises an RNA molecule. The sigma (σ) factor is a functional domain of the RNAp
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with the objective of finding a relatively stable site on DNA where RNA polymerisa-
tion can start[87, 257, 256]. In bacteria, these sites are often characterised with their
associated -35/-10 sequences (or boxes), which refers to the relative positioning of se-
quences with respect to the transcription start site, referred to as +1. With regards to
the +1, the further -35 site is the main effector to reach open-complex conformation of
the RNAp. Closer -10 sites usually define the rate of dsDNA opening (melting). As
a rule of thumb, there are usually 17bp between the -35 and -10 boxes, and 7bp from
the end of the -10 to the +1[105]. However, promoter engineering is a tedious task and
combining supposedly ideal sequences does not always produce a functioning device.
Besides, promoters can be subject to operator sites that attract activators or repressors
of DNA transcription by modifying the contact between DNA and RNAp.
2.3.1.1 Constitutive promoters
Promoters have different affinity with the RNAp due to the sequence combinations
they may display. In E. coli, the -35 ’TTGACA’ and -10 ’TATAAT’ sequences form
the consensus for the maximum level of open-complex formation and DNA melting
respectively[212]. Constitutive promoters are usually very conserved within a same
species and only vary from one or two nucleotides per -35/-10 box. These polymor-
phisms, however, may have a direct impact on a promoters capacity to recruit RNAp
molecules, which creates a range of promoter activities (or strengths)[45]. In this study,
we used Anderson’s library of E. coli promoters[10]. Although constitutive promoters
hardly differ from their characteristic basal transcription start rate, some other promot-
ers can have more complex structures and involve cofactors to change their relative
activity.
2.3.1.2 Arabinose-dependent promoter
The arabinose promoter (PBAD) is an example of a highly responsive inducible pro-
moters where a regulatory protein (AraC) activates its expression state when bound
to specific DNA boxes. AraC is constitutively expressed upstream of PBAD in the
antisense direction and recognises several sites, one partly overlapping with the -35
box[90, 204]. As shown in figure 2.6, AraC can bind to proximal (I1, I2 half sites) and
distal (O1, O2) sequences. Any combination other than binding I1 and I2 abolishes the
transcription rate by not leaving enough room for the RNAp to sit on -35/-10 boxes.
Only an allosteric change in AraC (provided by arabinose) allows binding to I2 and
activation of transcription.
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FIGURE 2.6: In the absence of arabinose (left panel), AraC binds to I1 and
a distal operator site O2 and forms an inactive dimer. In the presence
of arabinose (right panel), arabinose binds to AraC proteins and changes
AraC conformational state to I1 and I2 sites, which facilitates RNAp load-
ing onto DNA. Adapted from[90]
2.3.1.3 Quorum-sensing promoter
Bacterial populations growth can be regulated by certain metabolites called quorum
sensing signals[51, 240]. Quorum molecules synchronise a number of biological path-
ways and regulate bacteria at the population level. Acyl-homoserine lactones (acyl-
HSL) production is controlled by a bipartite promoter resembling PBAD in a number
of ways. As for the role of AraC in PBAD, LuxR acts as a cofactor in order to modulate
the promoter activity depending on the presence of acyl-HSL[209]. The PL−lux pro-
moter controls LuxR levels and has a weak activity. The leaky PR−lux promoter encodes
LuxI, an autoinducer synthase catalising formation of acyl-HSL which, in turn, forms
an active complex with LuxR and increases its binding activity to PR−lux, and thereby
production of inducer. This type of circuit is often referred to as a positive feedback
loop, where induction of the system tends to increasingly amplify the inducer signal
production. On a population scale, it is only over a certain environmental concentra-
tion of acyl-HSL that bacteria become synchronous. For our studies, we focussed on
the 3-oxo-C6-HSL: the main quorum molecule in V. fischeri.
2.3.2 Terminators
We have previously described how DNA can form secondary structures such as stem
loops and vary from a standard double-helix conformation. These structures are se-
quence dependent and generally harbor long GC stretches that allow stable structures
to emerge. Hairpin loops form as physically stable secondary structures and are a sys-
tem to stop sliding RNAp complexes in their elongation phase[139]. When processing
RNAp complexes encounter such secondary structures, it looks like a building block
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FIGURE 2.7: Structure of the lux operon in V. fischeri. A bipartite promoter
drives the expression of LuxR (via PL, or PL − lux) and activates the ex-
pression of autoinducer and bioluminescence genes via PR, or PR − lux,
in the presence of the quorum signal AHL.
too stable to open and they simply fall off of DNA and terminate mRNA transcription.
These so called terminator structures are a check-point ensuring that only certain oper-
ons are transcribed and overall genetic regulation is observed. In genetic circuits with
consecutive promoters, each controlling some protein expression, terminators are the
only way to ensure minimal crosstalk between genetic elements. Without terminators,
the RNAp complexes would carry on transcription and be likely to interfere with fur-
ther regulatory units. In this study, we used a fusion of the E. coli rrnB T1[174] and
bacteriophage T7[246] terminators. Figure 2.8 shows the predicted fold of this termi-
nator fusion, which appears to be very stable in vivo and achieves consistantly good
transcription termination.
2.4 Translation machinery
There are three types of molecules involved in the central dogma of biology: DNA,
RNA and proteins. We have introduced so far which components are used to engineer
transcription, and how nascent RNA molecules can be produced from DNA.
2.4.1 Ribosomes
The cellular machinery relies on a big family of ribosomal proteins involved in a pro-
cess called translation. Ribosomes are large RNA/protein complexes that recognise
some specific RNA sequences and initiate biosynthesis of proteins from mRNA molecules[117].
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FIGURE 2.8: Predicted DNA fold with three predominant conformations
at 37◦C (a)∆G = −33.31, (b)∆G = −32.00 and (c)∆G = −31.69 kcal/mol.
Plots generated by mFold[263].
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FIGURE 2.9: (A) Simplified small and big subunits and their assembly. (B)
Subunits assemble on a mRNA during translation to incorporate amino
acids to a native polypeptide chain chain via specialised tRNA. Adapted
from [61]
When they find a binding site on a mRNA sequence, two subunits are assembled into a
sliding complex that reads ribonucleotides three at a time (codons) from a start consen-
sus ’AUG’ sequence. This start codon initiates peptide synthesis and tRNA molecules
bring individual amino acids to the ribosome, depending on a specific anticodon to in-
corporate the right residue in the native polypeptide chain (Figure 2.9)[61]. The role of
ribosomes is to recognise specific sequences upstream of protein coding sequences, to
translate the coding regions and to achieve translation. Ribosomes sliding on mRNAs
stop translation when they encounter a stop codon (’UAG’, ’UAA’ or ’UGA’). However,
there is not necessarily a system as in DNA, where secondary structures would make
ribosomes fall off from RNA molecules. This said, bacteria have made very good use
of this feature. In bacterial genomes, most genes are encoded in operons where a single
promoter drives the expression of several downstream genes. In operons, intergenic
regions that separate the different proteins are usually small and coding sequences
sometimes overlap. Having little to no spacer on mRNA intergenic regions ensures
that ribosomes currently translating one gene of an operon are likely to recognise the
next start sequence and translate the entire operon. Nevertheless, ribosomes are sensi-
tive to the presence of small RNAs (sRNA) that cover some of the mRNA regions, and
may create roadblocks for the assembly and/or sliding of ribosomes.
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2.4.2 Ribosome binding sites
In synthetic biology, one can modulate protein expression on the transcriptional and
translational levels. While promoter engineering is not trivial (transcription regula-
tion), changing ribosome recognition sequences (RBSs) is sometimes an easier way to
regulate protein levels[200]. As RNAp complexes recognise DNA sequences to start
transcription, ribosomes assemble sequentially on mRNA molecules at a RBS. Ribo-
somes are ribonucleoproteins, which means they are made of a mixture of RNA (ribo-
somal RNA, or rRNA) and proteins. In E. coli, the small RNA subunit 16S recognises
a consensus sequence ’AGGAGG/A’ located about 8bp upstream of a protein start
codon. The formation of a complex between the ribosome small subunit and RNA in
turn recruits the bigger ribosomal subunit to initiate the search for a start codon[117].
We generally represent a RBS by a core 6bp combination, but combinatorial libraries
of RBSs have showed that RBS neighbouring sequences are also important in the reg-
ulation of translation. In this study, we mainly tested four RBS sequences of different
strengths (or affinity to start translation) and adapted the circuits with weaker RBSs in
order to accommodate the translation of multiple proteins simultaneously.
2.4.3 Transcription factors
In bacterial genomes, a lot of operons express proteins that may in turn regulate their
own promoter activity. These are transcription factors that affect the rate at which the
RNAp may recognise and process intracellular mRNA molecules. Transcription inhi-
bition is often achieved by hybridisation of regulatory proteins to DNA near or within
promoters and by loop formation due to transcription factor multimerisation[90, 209,
164]. In general, transcription factors dimerise in order to activate or repress the ac-
tivity of certain promoters. In the example given in Figure 2.6, AraC strongly binds to
different operator sites located around the promoter and only facilitates the access to
the RNAp when bound to L-arabinose[204]. In the context of synthetic biology where
genetic circuits should be remotely controlled, the activity of such transcription factors
together with promoter engineering allows different regulatory units to turn on and
off, given certain environmental cofactors. Circuits built in this study involved the use
of AraC, TetR, LuxR, and cI transcription factors.
2.4.4 Protein degradation tags
In bacterial cells, there are no intracellular compartments that split DNA from RNA
and proteins, as opposed to eukaryotes. Hence, all cellular products are mixed and
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held together by a membrane in what is called the cytosol[228]. It is easy to see how
the space within the cytosol can become crowded: if a lot of proteins are produced from
an exogenous genetic circuit, then translation spends a lot of resources on expressing
target proteins but the cell has less energy to replicate its own metabolism. Therefore,
in genetic circuits, it is necessary to minimise the long term impact protein overexpres-
sion may have over the cellular background[56]. In order to reduce the metabolic load
of protein overproduction, some tags can be attached to proteins in order to attract
intracellular protein degradation complexes[81, 9, 86]. The E. coli system is widely
used in microbiology and based on the ClpXP and ClpAP proteases. In this study,
we tagged proteins with the peptide ’AANDENYALVA’ C-terminal regions for rapid
degradation of protein products. Proteins tagged with this peptide achieve a half-life
of T 1
2
= 40 − 45min, which allows for degradation of proteins that could be stable for
days otherwise, and is essential for reliable and precise time-lapse measurements.
2.5 Fluorescence integration
In synthetic biology, a lot of methods make use of reporter systems to visualise bio-
logical responses to changes. Within cells, fluorescence emission is a way to report
the activity of some regulatory units potentially localised at certain loci[21]. Mod-
ern technologies provide multiple types of fluorescence detection methods that allow
for taking measurements from single cell to population level over a discrete or con-
tinuous time scale. From an engineering point of view, the coupling of fluorescence
emission with metabolic processes helps to track progression of the behaviour of ge-
netic circuits[200]. It makes invisible processes quantifiable, which is essential for the
modelling of biological devices.
2.5.1 Fluorescent reporter proteins
To study bacteria, we often coexpress fluorescent reporters with regulatory units that
aim to express specific signals. If fluorescence can be observed, then it means that
target signals should be expressed too. In a functional genetic design, fluorescence
measurements are a good indicator of the state of biological processes. For instance,
automated equipment such as plate readers now usually integrate several filters to
process absorbance, fluorescence and other types of light emission in an incubator over
long periods of time. In this system, 96 or 384 samples are usually loaded onto a mi-
croplate (Figure 2.10) and growth characteristics can be assessed simultaneously[222].
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FIGURE 2.10: Automated plate readers for in vitro/in vivo characterisation.
On the left, a BMG plate reader that integrates absorbance and fluores-
cence measurements to follow bacterial cultures over time. On the right,
a Biotek plate reader that is specialised in the making of precise growth
curves.
This method is particularly efficient for screening of libraries and allows a large num-
ber of replicas in characterisation studies. However, it does not capture single-cell
resolution details that can be achievable with microscopes[80]. In this study, we used
different fluorescent reporters to follow genetic circuit activation upon external sig-
nal reception, and characterised constructs from the single cell to the population scale
(data presented in Chapter 4).
The choice of fluorescent protein needs to account for the fact that several signals
associated with different cellular processes may need to be detected at the same time.
If so, reporters should be distinguishable from one another to observe interpretable
metabolic signals. This is possible because the wavelength at which a fluorescent pro-
tein is excited is often a narrow window within ultra violet light (UV). However, as
shown in Figure 2.11, excitation and emission spectra of different fluorophores may
sometimes overlap. For instance, green and yellow fluorescent proteins have overlap-
ping spectra, and would be a poor combination in order to differentiate fluorescence
from disparate cellular processes. Nevertheless, coupling one of these with red flu-
orescence would ensure that detected signals would come from a single fluorescent
protein. In this study, we mainly used green and red fluorescent proteins and opti-
mised genetic constructs for a better signal to noise ratio based on fluorescence output.
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FIGURE 2.11: The excitation spectrum (left panel) represent what light
should be shined at a protein to observe a quantum response. This re-
sponse is characterised by the emission of a slightly different type of light
(right panel). A few common proteins are represented by areas of the plot
with specific peaks of fluorescence excitation/emission[53].
2.5.2 Photostability
In synthetic biology, genetic circuits can be represented as interconnected regulatory
networks and fluorescence is a way to report differential biological states, linked to
the activity of a circuit. While target proteins can be fused with fluorescent proteins
at their N- or C-terminal fragment, protein fusions sometimes affect the activity of the
target protein. In the context of this thesis, we kept fluorescent proteins as coexpressed
reporters in order to keep other enzymes in their native form. Fluorescent proteins are
photostable molecules that can be excited when exposed to UV light and emit fluo-
rescence as a response[118]. The first isolated fluorescent protein originated from the
jellyfish A. victoria, and it encodes the green fluorescence protein (GFP). Now, a num-
ber of fluorescent proteins are available for use and proteins mainly differ in terms
of maturation time, photostability and brightness[210]. For practical reasons, brighter
proteins are better for long-term fluorescence detection since the signal they emit does
not need a long UV exposure time to produce a detectable response[108, 19]. At the
same time, this limits physical damage that UV light can impose on living cells. Fluo-
rescent proteins are an easy reporter system to use to study living cells and the choice
of specific proteins should be made carefully.
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2.6 Genetic circuits built in this study
2.6.1 Microbiology techniques
For the construction of genetic circuits and nanodevices, we used standard microbi-
ology techniques as described in Appendix A. DNA isolation was usually performed
using miniprep kits supplied by Qiagen and enzymatic reactions based on the New
England Biolabs (NEB) catalogue. When possible, basic microbiological protocols were
derived from the Green and Sambrook manual[83].
2.6.2 Plasmids
For E. coli and B. subtilis studies, we used or built the plasmids listed in Table 2.1.
Plasmids were always propagated in E. coli DH5α at 37◦C unless stated otherwise in
the plasmid notes (for instance, temperature sensitive replicons). The R6k origin of
replication plasmids were propagated in an E. coli DH5α λpir strain to allow them to
replicate[133]. Plasmids were usually constructed in DH5α and characterised in E. coli
MG1655 or BW25113 strains[12].
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TABLE 2.1: Plasmids used in this thesis
Source Label Template Modification Marker Note
[195] pACYC184 Cam, Tet Cloning template
[253] pUC19 Amp Cloning template
[238] pBR322 Amp Cloning template
[187] pSB1A2 Amp Cloning template
[187] pSB1C3 Cloning
template
[187] pSB1AK3 Amp, Kan mCherry LuxR with LVA degradation
tail
[90] pBad33 Cam Cloning template for low-copy num-
ber circuits with inducible Pbad sys-
tem
[43] pKD46 Amp thermosensitive plasmid with 30deg
growth and propagation
Demuris pIJ790 Cam thermosensitive plasmid with 30deg
growth and propagation
[32] pCP20 Amp Frt-site recombinase, temperature
sensitive
This study pCWqs01 pACYC184 B0015 Cam Cloning template for low-copy num-
ber circuits
This study pCWqs02 pSB1AK3-B0015 B0015 x3 Amp Cloning template for high-copy num-
ber circuits
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This study pCWqs03 pACYC184-B0015 Cam sender-CI without TetR constitutive
expression
This study pCWqs04 pSB1AK3-B0015x2 Prlux-B0034-
mCherry
Amp mCherry under control of Prlux
This study pCWqs05 pSB1AK3-B0015x2 J23119-B0034-
LuxR
Amp LuxR under the control of strong con-
stitutive promoter
This study pCWqs06 pSB1AK3-B0015x2 J23119-B0034-
LuxR-Prlux-
B0034-mCherry
Amp, Kan mCherry LuxR with LVA degradation
tail
This study pCWqs07 pSB1C3 PltetO1-B0034-
LuxI
Cam LuxI with LVA degradation tail
This study pCWqs08 pSB1C3 B0034-GFPlva-
B0015
Cam GFP with lva degradation tail
This study pCWqs09 pACYCB15 J23119-B34-TetR Cam TetR with LVA degradation tail
This study pCWqs10 pSB1C3 Plteto1-B34-LuxI-
B34-GFP-B15
Cam inducible signal of C6-HSL couple
with GFP, LuxI and GFP both with
LVA degradation tail
This study pCWqs11 pACYCB15 Plteto1-B34-LuxI-
B34-GFP-B15-
J23119-TetR
Cam LuxI GFP and TetR witrh LVA degra-
dation tail
This study pCWqs12 PACYCB15 and
pSB1AK3
Cm, Amp,
Kan
cotransformation of s-3oc6hsl and r-
3oc6hsl
This study pCWqs13 pSB1A2 B34-
luxI.B34.GFP.B15
Amp LuxI and GFP with LVA degradation
tags
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This study pCWqs14 pACYCB15 Ptet.B34-
luxI.B34.GFP.B15
Cam LuxI GFP with LVA
This study pCWqs15 pACYCB15 Ptet.B34-
luxI.B34.GFP.B15-
J23119.TetR
Cam LuxI GFP and TetR with LVA
This study pCWqs16 pSB1C3 Ptet.B34-
luxI.B34.GFP.B15
Cam LuxI and GFP with LVA
This study pCWqs17 pBad33 B34-
luxI.B34.GFP.B15
Cam LuxI and GFP with LVA
This study pCWqs18 J23100 B34-GFPlva-B15-
pSB1C3
Cam GFP with LVA degradation tag;
This study pCWqs19 J23104 B34-GFPlva-B15-
pSB1C3
Cam GFP with LVA degradation tag
This study pCWqs20 J23117 B34-GFPlva-B15-
pSB1C3
Cam GFP with LVA degradation tag;
This study pCWqs21 J23107 B34-GFPlva-B15-
pSB1C3
Cam GFP with LVA degradation tag;
This study pCWqs22 pBad33 B30-sfGFP Cam sfGFP; col2
This study pCWqs23 pBad-sfGFP b30-luxI Cam LuxI with LVA tag
This study pCWqs24 B30-mCherry-
pUC19
luxR.b30 Amp coding parts of 3oc6hsl receiver
This study pCWqs25 B30-mCherry-
pUC19
J23104 Amp mCherry reporter
This study pCWqs26 LuxR.b30.b30-
mCherry-pUC19
pLuxRI Amp assembled receiver for 3oc6hsl
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This study pCWqs27 luxR-pluxRI-
mCherry
b30-sfGFPlva Amp sfGFP with LVA degradation tag
This study pCWqs28 pBad-luxI-sfGFP b30-mCherrylva Cam luxI and mCherry with LVA tags;
colony 2
This study pCWqs29 pBad-luxI-sfGFP b30-sfGFPlva Cam luxI and sfGFP with LVA degradation
tags; isolated col3
This study pCWqs30 pUC18r6k-Tn7T-
Kan
b30-luxI Amp, Kan insertion of luxI sender device under
Pbad control into ApaI sites
This study pCWqs31 luxR-PluxRI-
sfGFP
pUC18r6k-Tn7T-
Kan
Amp, Kan insertion of luxR receiver device un-
der Plux-R/L control into ApaI sites
This study pCWqs32 AraC-pBad-luxI-
mCherry
pUC19 Amp luxI and mCherry with LVA degrada-
tion tag; col5
This study pCWqs33 AraC-pBad-luxI-
sfGFP
pUC19 Amp luxI and sfGFP with LVA degradation
tag; col2
This study pCWqs34 AraC-Pbad-luxI-
sfGFP
pUC18r6k-Tn7T-
Kan
Amp, Kan insertion of luxI sender device under
Pbad control into ApaI sites; col23
This study pCWqs35 luxR-PluxRI-
sfGFP
pACYC184 Cam sfGFP with LVA degradation tag
This study pCWqs36 luxR-pluxRI-
sfGFP
pBR322 Amp sfGFP with LVA degradation tag
This study pCWqs37 pUC19-luxR-
pLpR-sfGFP
luxI Amp luxI and sfGFP with LVA degradation
tag
This study pCWqs38 pUC19 pRlux-sfGFP Amp sfGFP with LVA degradation tag
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This study pCWqs39 luxR-J23104-
pRlux-sfGFP
pUC19 Amp luxR and sfGFP with LVA degrada-
tion tag; synthetic receiver with luxR
strong constitutive expression; col 5
This study pCWqs40 luxI pUC19-luxR-
J23104-pRlux-
sfGFP
Amp luxR, luxI and sfGFP with LVA degra-
dation tag; synthetic receiver with
strong luxR expression and luxI am-
plification; col3
This study pCWqs41 luxR-pLpR-sfGFP pUC19 Amp luxR and sfGFP with LVA degrada-
tion tag; original synthetic receiver
with LVA-tagged cofactor; col 3
This study pCWqs42 luxI pUC19-luxR-
pLpR-sfGFP
Amp luxR, luxI and sfGFP with LVA degra-
dation tag; original synthetic receiver
with LVA-tagged cofactor and luxI
amplifier; col 4
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2.6.3 Strains
For in vivo studies, we used Escherichia coli and Bacillus subtilis species. As part of
the Portabolomics project (portabolomics.ico2s.org), our basic strains of Escherichia coli
MG1655 and Bacillus subtilis 168CA were fully sequenced by MiSeq shotgun genome
sequencing. Table 2.2 lists the strains used and created in this thesis. As detailed for
plasmids, strains were grown at 37◦C unless stated otherwise. This table does not
include all E. coli plasmid propagation and expression strains. For the study of genetic
devices in microfluidics, we expressed plasmids in E. coli BW25113 (Chapter 4) and
fabricated 33 models of biochips (Chapter 5).
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TABLE 2.2: Strains used in this thesis
Source Label Species Name/description Phenotype Marker Note
Portabolomics E. coli MG1655 MG1655 Wild-type E. coli;
strain sequenced
for Portabolomics
project
Portabolomics E. coli BW25113 BW25113 Wild-type E. coli;
strain sequenced
for Portabolomics
project
Portabolomics B. subtilis 168 CA 168CA trpC2 Wild-type B. subtilis;
strain sequenced
for Portabolomics
project
[260] B. subtilis ZPM6 ZPM6 trpC2 amyE::(zeo-
Pxyl-mazF)
Zeo20 derived from B. sub-
tilis 1A751; contains
miniMazF cassette
with Pxyl promoter
This study sCPW01 E. coli MG1655 pKD46 Amp thermosensitive
plasmid with 30deg
growth and propaga-
tion; col4
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This study sCPW02 E. coli MG1655 pIJ790 Cam thermosensitive
plasmid with 30deg
growth and propaga-
tion; col8
This study sCPW03 E. coli MG1655 Barcode selection
E. coli
::(barcode-cat) Cam better propaga-
tion with Cam17
(portabolomics strain
4);
This study sCPW04 B. subtilis 168 CA Barcode selection
B. subtilis
trpC2 ::(barcode-zeo-
Pxyl-mazF)
Zeo portabolomics strain
5
This study sCPW05 B. subtilis 168 CA Barcode loopout B.
subtilis
trpC2 ::(barcode) sCPW04 barcoded
strain without se-
lection cassette
(portabolomics strain
6);
This study sCPW06 E. coli MG1655 Barcode loopout E.
coli
::(barcode) sCPW03 barcoded
strain without se-
lection cassette
(portabolomics strain
7)
This study sCPW07 E. coli BW25113 chromosome
sender GFP
tn7-AraC-pBad-luxI-
sfGFP-tn7
Kan insertion in BW25113
chromosome; col 8
This study sCPW08 E. coli BW25113 chromosome
sender mCherry
tn7-AraC-pBad-luxI-
mCherry-tn7
Kan insertion in BW25113
chromosome; col 3
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This study sCPW09 E. coli BW25113 chromosome
receiver GFP
tn7-luxR-pluxRI-
sfGFP-tn7
Kan insertion in BW25113
chromosome; col 11
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Here, we presented the basis of biological processes and a simplified version of the
factors that affect the cellular metabolism. There are many ways to optimise genetic
circuits, but the best way is to build them rationally, and to keep them simple. Bio-
logical functionality depends on a number of factors, and while different circuits may
produce the same output, the simplest one will often be easier to propagate in cells. In
the context of bacterial signalling by fluorescence, we characterised a set of genetic de-
vices and describe their optimisation and use in Chapters 4 and 5. In the next chapter,
we provide a walkthrough the development of DNA barcodes.
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Chapter 3
DNA barcoding in bacteria
The work presented in this chapter was performed in collaboration with Dr. Jurek
Kozyra, who developed the in-silico encoding method of DNA barcodes.
3.1 Filling the gap between in silico and in vitro/in vivo
biology
There is a vast amount of techniques that are used to characterise biological devices.
These include computational studies, or in silico methods, that produce biological mod-
els that aim to describe experimental data. However, there is sometimes a narrow link
between models and precise in vitro/in vivo data. Consequently, this makes the match-
ing of theoretical and experimental measurements more challenging, and may result in
results irreproducibility. In particular for the field of biomedical research, data repro-
ducibility is a major issue for scientific progress[250, 13]. Currently, the authentication
of biological strains is based on a set of sparse documentation (protocols, simulations,
sequences...) and a relatively well-labelled test tube[69]. This usually results in a gap
between wet lab and computational biology.
In this chapter, we detail the creation of DNA barcodes as bacterial identifiers, their
associated cloning method for barcode insertion/update, and their stability in-vivo. We
focussed on the prokaryotic kingdom and studied chromosomally-encoded barcodes
in the context of two distinct types of bacteria: E. coli and B. subtilis. In order to assess
the integrity of DNA barcodes, we used two types of assays - hereinafter referred to
as chemostat and high-throughput studies - followed by the targeted sequencing of
barcode sequences.
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FIGURE 3.1: Barcoding cells: a specific genetic circuit can be tagged
and saved along computational/experimental resources on the bac2code
server. These tags, known as DNA barcodes, allow retrieval of full docu-
mentation for any barcoded strain via a single sequencing reaction.
3.1.1 Sequencing technologies
Over the last 40 years, the development of DNA sequencing methods - from Sanger to
Next Generation Sequencing (NGS) approaches - has greatly helped the understanding
of biological sciences[201, 104]. For instance, bacterial species identification can be
streamlined by rRNA sequencing, which can provide information about the class of
microorganism a sample may belong to. These rRNA sequences are highly conserved
among species but display different polymorphisms, often characteristic of diverging
species[115, 189]. However, precise strain identification remains difficult, and apart
from wide-scale whole genome sequencing, there is not a single, short and inert DNA
fragment that could be used as a standard identifier for individual species. As an
advance towards the grouping of in silico resources to relevant strains, we created a
barcoding platform that, via a single Sanger sequencing read, can provide thorough
documentation about the studied microorganism.
3.1.2 A biological version control system
The Bac2code system aims at standardising the storage of information about biological
circuits. A barcoded strain on its own is associated with a a set of key characteri-
sation features, and making the link between strains allows to recreate the structure
of a version control repository. In the field of computer science, version control soft-
ware eases the organisation of files and allows a better coordination between multiple
project strands. This is because to produce reliable results, pieces of code need to be
embedded in specific files and organised in a defined manner to be compiled. It works
the same way in the development of biological devices for synthetic biology. Design
modularity helps to create several genetic constructs, and to combine these in an organ-
ised fashion for higher level assembly. On the software side, version control systems
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streamline the error-tracking mechanism and allow for "roll-back" solutions, where un-
functional code can be reverted to a previous working state. However, in biology, the
tracking of a parental strains information in complex genetic backgrounds can become
a tedious process. By the use of a standard DNA barcode identifier, we recreated the
architecture of a version control software where barcoded strains are automatically
linked to one another; these are used to reconstruct a strains lineage and facilitate the
retrieval of parental sequences. Figure 3.1 displays an overview of our unified barcod-
ing platform (bac2code). A dedicated server stores resources about bacterial strains
(in silico and in vitro/in vivo protocols) and links them to a specific DNA tag (barcode)
anchored in the bacterial chromosome. These tags are synthetically engineered DNA
identifiers and provide the missing link between biological samples and all types of
external documentation.
3.1.3 Online documentation platform: Bac2code
We are currently developing the web-platform called Bac2code that hosts all barcoded
strain documentation. The construction of the barcode database and online platform
are led by Dr Jerzy Kozyra. When users retrieve new strain information on the Bac2code
server, a targeted sequencing read, or a barcode sequence only, allow access to a spe-
cific barcoded strain profile. On the online server (http://bac2code.com), a set of key
strain features are highlighted to provide an easy access to computational and wet lab
data. A basic strain is characterised by its genetic information (the DNA sequences of
the chromosome and eventual genetic circuits) and different types of assays that pro-
vide supporting information. We aim to design a modular system that could be used as
a laboratory notebook and also integrate external tools such as SBOL and other in silico
resources, as outlined in Figure 3.2. Practically, a biologist in possession of a barcoded
strain should be able to access all of its in silico, in vitro and in vivo information and
browse the strains lineage in a single Bac2code profile. Further aspects of the online
Bac2code platform are discussed in Chapter 6.
3.1.4 Barcode minimal identifiers
In this study, we focussed on the biological interface of synthetic DNA barcodes en-
gineering. As shown in Figure 3.3, the design of DNA barcodes had to comply with
many considerations from both computational and biological points of view. In the
following sections, we describe methods that were used to design DNA barcodes and
their integration in the biological context of two model bacterial species: E. coli and B.
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FIGURE 3.2: Retrieval of barcoded strain information and lineage from the
Bac2code server. A single barcoded strain can provide access to a range of
relevant computational and wet lab data.
subtilis. DNA barcodes were enabled to replicate within their host in a set of different
conditions and were tested for stability over an increasing number of bacterial gener-
ations (e.g. chromosome replication cycles[165]), and used as a key to a tailored strain
documentation profile.
3.2 Bacterial referencing via DNA barcodes
We devised a DNA barcoding system to anchor barcodes in the bacterial chromosome
as synthetic references. In this section, we focus on the molecular structure and cloning
of DNA barcodes. These references needed to be propagated within bacteria at every
cycle of DNA replication in order to persist in the environment as reliable identifiers.
Stable genetic circuits generally need to provide an advantage to their host to be cor-
rectly propagated (for instance, some antibiotic resistance[59]). However, instead of
adding to the pre-existing cellular complexity, we rather aimed at adding to the cells a
short kinetically stable label, not interfering with any cellular components[129]. We de-
veloped a stable DNA encoding method using random identifiers in order to produce
uniquely addressable nucleotide sequences, free of biological features.
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FIGURE 3.3: Design of a barcoding platform. The design of DNA barcodes
was split in three parts: the software stage, the biological stage and the in-
terface between the two. The software stage (left) assures a stable encod-
ing of DNA barcodes and the easy storage of links to computational data.
The biological stage (right) is represented by the setup of an unobstru-
sive cloning method. The interface (middle panel) is a set of parameters
required to define the structure of DNA barcodes.
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FIGURE 3.4: Different types of barcodes. (A) EAN barcode, (B) QR-code
and (C) universally unique identifier (UUID).
3.2.1 DNA encoding
3.2.1.1 Barcode sequences
In order to build DNA barcodes, it was necessary to choose an appropriate DNA en-
coding method. Barcodes are found everywhere in everyday life: from train tickets
to products packaging. For instance, european article number (EAN) and universal
product code (UPC) barcodes are used worldwide - in particular in Europe - and aim
to reference all sorts of consumer goods (EAN and UPC barcodes). All barcodes are,
per se, a visual and/or alphanumerical sequence that references some item (Figure 3.4).
The encoding method behind our DNA barcodes relies on universally unique identi-
fiers (UUIDs)[1]. Initially used by Microsoft to create encoded object identifiers, we
used the UUID version 4 algorithm to generate random 32-hexadecimal character se-
quences. Because these are randomly generated, there are about 5.3 ∗ 1036 different
possibilities of UUIDs of this type[244]. Version 1 and 2 are connected to the date/time
and MAC addresses of the machine generating UUIDs, which would have been un-
necessary for our purpose. Version 3 and 5 are related to namespace identifier and
name, and are encoded by hashing algorithms MD5 and SHA1. These would only
make sense if all strains had a unique name, which cannot be guaranteed at the scale
of multiple laboratories. Therefore, we chose the random UUID version 4 to help us set
a potentially large-scale system for the identification and encoding of bacterial species
profile.
Based on the redundancy of the genetic code, we encoded each UUID hexadecimal
character as a chain of three nucleotides, which resulted in constructing 96bp DNA
barcodes (Figure 3.5). We were inspired by the way cells naturally perform translation
from 64 codons to encode 20 amino-acids, but we set an equal distribution of DNA
triplets per hexadecimal character to obtain four codons per character (Table 3.1). To
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FIGURE 3.5: DNA barcodes genetic structure. DNA barcodes can be read
through targeted sequencing at a universal primer binding site. Their
structure is divided in subsequences that correspond to a specific UUID
(96bp), a recognition synchronisation sequence (9bp) and a checksum for
UUID read inaccuracies (18bp).
apprehend sequencing result variability, we also integrated an error-correction mech-
anism to account for truncated or partially incorrect reads. This was done via a 9bp
recognition sequence that our decoding algorithm searches for, in order to to align se-
quencing reads of variable lengths. Once this sequence is found, its upstream region
maps a UUID reference encoded as 96 nucleotides, while downstream 18 bases cor-
respond to the checksum for errors handling (details in Additional barcode features
paragraph). Barcodes generated with our platform are kept in a secure database and
mapped to sequencing reads in order to retrieve strain profile content. Should there be
any misalignment between a sequencing read and a UUID, the checksum is used as a
secondary encoding method to provide better chance of retrieving strain documenta-
tion in poor sequencing conditions.
3.2.1.2 Bio-orthogonality
We introduced in chapter 1 how biological elements may interfere with DNA, and how
abiological sequences may be designed to minimise the impact of the introduction of
synthetic DNA in cells. In the design process of DNA barcodes, we reduced the possi-
bility of biological interaction between synthetic DNA and cellular molecular machin-
ery as much as possible. While our encoding method created pseudorandom DNA
barcodes, most sequences would still display biological features to some extent. As
a standard tool for cloning, restriction enzymes are molecular subunits that generally
recognise sequences of 4 to 8 nucleotides and cleave these sequences. In the prospect
of DNA barcodes, these were exactly the type of features that needed removal. During
barcode generation, we removed over 180 recognition sequences from barcodes, which
covered a vast majority of known restriction sites (Figure 3.6B). However, we omitted
to remove one non-specific enzyme site, as it would appear in most sequences. If it
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TABLE 3.1: Mapping between hexadecimal characters and nucleotide
triplets for the encoding of DNA barcodes
Character Triplet 1 Triplet 2 Triplet 3 Triplet 4
0 AGC GTA CCG CGT
1 ACC TAT GAC GGC
2 ATT GGT TAG TCT
3 AGA GAT GTG TAC
4 GTT TAA TCA CTG
5 GGG ATC CTC TCC
6 AAC CGG GCC GCG
7 AAG AGT CCT GCT
8 GAG GTC TGC TTC
9 CCC AGG CAA CGA
a ATG GAA GGA TGA
b CCA GCA AAT TCG
c ACT CTA TTA TTG
d CAG CAT CTT TGT
e ATA CGC TGG ACA
f AAA ACG TTT CAC
were to be removed, it would have detrimental effects on the DNA encoding algo-
rithm. These would cause a greedy convergence towards solutions where a single
nucleotide would be repeated over the entire barcode sequence. Since this enzyme
restriction site was promiscuous along E. coli and B. subtilis chromosomes, we thus
considered that it would not be an issue if it were present on barcode sequences too.
Figure 3.6 shows a conflicting case of DNA sequence containing a restriction enzyme
site, and how it could be removed by using redundancy of the DNA encoding method.
For each UUID hexadecimal character, there were 4 possibilities of nucleotide triplets
(Figure 3.6A, note that the final encoding map shown in Table 3.1 was updated). There-
fore, our algorithm allowed use of an alternative triplet in conflicting cases, where a
sequence had to be changed to alleviate any potential biological interaction. In a sim-
ilar fashion, and for sequencing needs this time, we limited the appearance of single-
or di-nucleotide repetitions in barcode sequences. These tend to decrease the quality
of sequencing reads, especially in Sanger sequencing[98]. Besides practical considera-
tion for sequence retrieval, removing repetitive features also minimised the chances of
mutations appearing due to DNA polymerases sliding over long DNA stretches of the
same nucleotide. Finally, a transcriptional/translational units screen was performed
by removing any sequences that would locate a protein start codon in the proxim-
ity of potential ribosome binding sites. After all the biological information removal
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FIGURE 3.6: DNA barcode redundancy. (A) Each UUID hexadecimal char-
acter corresponds to four possible DNA nucleotide triplets (or codons),
while each codon can only match one hexadecimal character. When UUID
hexadecimal characters are converted to nucleotide triplets, undesirable
sequences (for example, the MnII enzyme restriction site in (B)) are di-
rectly removed by choosing one of three alternative triplet possibilities
that would comply with all the barcode design concepts.
layer of our algorithm, DNA barcode sequences often resulted in an average of < 50%
GC-content. As it is known that AT base pairing contributes to destabilising DNA he-
lices[251], a lower than average GC content favorises DNA unstability. Unstable DNA
sequences would not naturally be expected to encode biological information, and fol-
lowing biological orthogonality concepts, the development of abiological DNA bar-
codes allowed us to build inert sequences that should not interact with the metabolism
of bacteria.
3.2.1.3 Additional barcode features
Universal primer All barcoded strains present a DNA barcode preceeded by a primer
binding site. This universal primer allows the targeted sequencing of any barcoded
strain after polymerase chain reaction amplification (PCR) of the neighbouring species-
specific genes. Our DNA encoding algorithm was mainly used for the production of
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DNA barcodes from individual UUIDs and to minimise potential interactions with
cellular components. However, we submitted the primer binding sequence to the
same process too, in order to produce a primer that would be unlikely to be linked
to the molecular machinery. Best primer sequences were analysed by GC-content
(50% − 55%), dissimilarity to bacterial genomes and GC-clamp. A consensus of ad-
equate GC content featuring a GC-clamp and the highest dissimilarity to genomic
content was chosen as the universal primer. Finally, as a complementary verifica-
tion method of barcodes integrity, we designed a second species-specific primer. This
sequence is located downstream of barcodes and targeted by a reverse primer to se-
quence DNA antisense strand. Together, this set of primers allows for full recovery of
barcode sequences in two sequencing reactions.
Synchronisation sequence Synchronisation sequences, located directly downstream
of barcode UUIDs, are invariant sequences that are used to align sequencing reads
and to retrieve barcode and checksum information. These sequences were subjected to
the same rules as the primer design (without a GC-clamp constraint), but consisted of
much smaller synthetic DNA fragments (9bp).
Checksum There are three checksum elements appended to barcode sequences. These
checksums allow to verify that barcode sequences match a record in our database, and
to retrieve their associated information. An individual checksum is a number encoded
by the MD5 hashing algorithm and represented by the combination of six nucleotides.
Three checksums are concatenated one to another to validate the identity of DNA bar-
codes. Two of them respectively represent the sum over the elements of first and sec-
ond part of DNA barcodes, while the last checksum element is computed for the entire
barcode sequence. Any conflicting result between a given sequence and the expected
checksum would detect inacurrate or incomplete sequences. In which case, checksums
are compared to barcode entries and blasted against the barcode database to find an
associated profile.
3.2.2 Cloning of DNA barcodes
3.2.2.1 Considerations related to the design and use of DNA barcodes
In synthetic biology, the two most commonly used microorganisms for bacterial stud-
ies are E. coli and B. subtilis. To use barcodes as universal identifiers, we demonstrated
barcode stability in these two model organisms. Although E. coli (Gram-negative) and
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B. subtilis (Gram-positive) are two common strains of bacteria in laboratories, perform-
ing the same experiment in each microorganism often requires substantially different
protocols. One of the main differences between these species is explained by the struc-
ture of their cell walls[54]; they have different thicknesses, and therefore processes that
allow transport of DNA through the cell wall are different too. In order to create a
generic cloning method, we gathered information about common cellular mechanisms
for DNA uptake in Gram-negative/-positive species and formulated a consensus pro-
tocol to clone barcodes in these species.
Due to their different cellular structures, DNA uptake mechanisms differ between
bacterial species, but still converge in the use of analogous genetic concepts. Although
the manipulation of E. coli and B. subtilis may be distinct, both species rely on similar
kinds of events for the remodelling of their genetic structure. In order to ensure sta-
ble replication of DNA barcodes, we cloned synthetic products on the bacterial chro-
mosome. Although barcoding methods may be adapted to barcoding plasmids and
other kind of DNA vectors, barcoding a strain directly onto its chromosome would
ensure the natural propagation of artificial sequences. For these means, we devised
a generic method to first, assemble barcodes in vitro, then to clone them in different
species through an analogous system of homologous recombination. This approach
provided several advantages: (i) there is no need for selective pressure to propagate
the chromosome, (ii) it avoids barcode loss if it was placed on an unstable plasmid
and (iii) this places DNA barcodes away from eventual genetic circuits propagated
in bacterial strains, reducing the risk of unexpected proximity interactions. In E. coli,
and to a further extent in B. subtilis, different cloning sites have been characterised
and are known as points of insertion of genetic circuits. Therefore, it made sense to
find new cloning sites located away from any such points of insertion or important
genome regions. Altogether, we developed a strategy suitable for cloning in E. coli and
B. subtilis, but this generic method could in theory be applied to a wider a range of
Gram-negative/-positive organisms and yeast species. Last but not least, cloning via
homologous recombination allows seamless insertion of barcode sequences and their
update through the exact same procedure.
3.2.2.2 Overview of the cloning method
Cloning of DNA barcodes is a two step process: recombinant barcode in vitro assembly
and in vivo bacterial chromosome propagation. Figure 3.7 streamlines the process of
barcoding bacteria. We chose homologous recombination as the consensus mechanism
for the best flexibility and ease of use to clone DNA barcodes[173]. Other approaches,
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FIGURE 3.7: Method to barcoding bacteria. The barcode server (bac2code)
supplies DNA barcodes provided with the necessary samples to to assem-
ble a recombinant barcode fragment by SOE-PCR (top panel). Recombi-
nant DNA is integrated by homologous recombination at specific E. coli
and B. subtilis loci and is curated from selective markers by site-specific
recombination (bottom panel).
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FIGURE 3.8: Single and double crossover events. (A) Single crossover:
within a singular double strand of DNA, repeated or homologous regions
(red) can be found separating different regions of DNA (blue). These ho-
mologous regions can hybridise and loop out DNA fragments, thereby
losing an intermediary piece of genetic information. (B) Double crossover:
when two double-strands of DNA share some homology (represented by
the crossing points), pieces of DNA strands can be exchanged.
including CrispR amongst others, were also considered but using the most basic mech-
anism for DNA strand exchange appeared to be more scalable on a large scale[22, 146,
11, 58, 239, 252, 259, 102, 134, 160]. To promote this type of recombination, the easiest
method was to place flanking regions of the chromosome upstream and downstream
of specific circuits to propagate[191, 178]. When DNA is added to the cells, the chro-
mosome replication machinery recognises homologous DNA arms and crosses them
with parental DNA (Figure 3.8B). In this process, regions of the genome that separate
homology arms are lost and replaced by recombinant DNA. The chromosome then
harbors a synthetic DNA circuit, but there is a need for selective pressure to keep this
modification as a dominant feature in an entire bacterial population. Therefore, within
recombinant DNA fragments, we placed a selective marker downstream of barcode
sequences and aimed at: (i) integrating DNA barcodes in the presence of a selection
marker and (ii) removing the selection marker after isolation of barcoded strains. The
latter alleviated the risk of incompatibility between potential selection markers, and re-
duced the amount of biological features to a minimal bioorthogonal barcode sequence.
Functional recombinant DNA fragments were obtained by a first in vitro step: this
was achieved by splicing overlap with extension PCR (SOE-PCR, cf. Figure 3.9). In
PCR, DNA mixed in different proportions with reagents is amplified and provides a
good starting material for cloning experiments[241, 163]. Cloning via homologous re-
gions required amplification of a homologous region with the host genetic material,
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FIGURE 3.9: (A) Two DNA fragments are amplified individually. The ge-
netic primer design allows two fragments to overlap at one end. (B) As-
sembly by splicing overlap extension of individual fragments. Fragments
anneal at the overlap region whilst the polymerase fills in missing 3’-ends
of fused products. (C) Purification of the fused product via a standard
PCR with primers corresponding to 5’- and 3’-ends of the final product.
Adapted from [106]
and to introduce a disruption in native DNA sequences. In SOE-PCR[106], barcodes
were assembled and selected by the fusion of homology arms to synthetic barcodes
linked to a selection marker. After purification of recombinant DNA barcode frag-
ments, bacterial cells were transformed and selected for the integration of barcode se-
quences via the expression of a selection cassette. By default, we used chloramphenicol
in E. coli and zeocin in B. subtilis. However, alternative selection cassettes may be cho-
sen instead, if these were to be incompatible with strain specific features. A counter-
selection step follows the isolation of positive transformants (barcoded bacteria) and
allows removal of selection markers by site specific recombination. This second step
permits "looping-out" of selection cassettes. This mechanism is natural in B. subtilis;
bacteria recognise genome fragments of homology and can undergo chromosomal re-
configuration via single-crossover events (Figure 3.8A)[258, 161]. Although E. coli is
usually not capable of such reconfiguration, genetic tools can replace this process by
expressing specific recombinase proteins. For both species, this resulted in the removal
of selection markers and left a final piece of recombinant DNA as marker-free synthetic
DNA barcodes.
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TABLE 3.2: Barcodes cloning sites in E. coli and B. subtilis
Species Upstream gene Downstream gene Genome location
Escherichia coli MG1655 pspG qorA 331◦
Bacillus subtilis 168CA dusA/ybxH ybxI 19◦
3.2.2.3 Finding new cloning sites
We adopted a well-defined method to integrate biological concepts, and to find new
suitable cloning sites in E. coli and B. subtilis species. First, we gathered data about
known chromosomal insertion sites in each species[183]. We then postulated that DNA
barcodes would have fewer chances to interact with cellular machinery if they were to
be located in "dead-end" regions. Here, we mean an integration at converging ends
of operons. As detailed in chapter 1, bacterial genomes are organised in operons that
drive transcription of several genes on a single mRNA. Translation then takes place
on these mRNA molecules, almost immediately. Therefore, placing barcode sequences
at the 3’-end of oppositely orientated operons - together with filtering out biological
sequences - would ensure that barcodes would not be actively transcribed in cells. This
reasoning tackled the issue of a relative location for a cloning site, but did not account
for specific biological context.
On the chromosome, interacting regulatory units are often found in neighbouring
locations. Not all genes in the genome are essential, and studies have looked at reduc-
ing genomes to minimal working living organisms[77, 111, 121, 224, 180]. Therefore,
for each species, we gathered and curated data about essential genes from the literature
and ruled out locations in the genome that were neighbouring any essential units[125,
116, 43]. In a similar logic, we avoided locations near elements that were known to
belong to important families of metabolism/membrane/transcription and translation
proteins. Finally, in order to get a higher average of barcode copy number per cell, we
searched for sequences that comply with the aforementioned considerations from the
origin of replication (oriC) and picked sites within a 1Mbp window around oriC. This
way, barcodes could be placed in safely replicable zones in a favourable biological con-
text, where they would be unlikely to interact with proximal elements or to interfere
with strain specific genetic circuits. Table 3.2 provides more precise information about
integration sites location in E. coli and B. subtilis, while Figure 3.10 provides a visual of
the different genomic features.
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3.2.2.4 In vitro assembly of recombinant DNA
Barcodes need to be logically assembled into cloning products in order to lead to vi-
able replication in bacteria. All steps that were involved in PCR amplification of DNA
fragments were performed using primers listed in Table 3.3. To minimise the risk of
nucleotide misincorporation in PCR, one should use high-fidelity DNA polymerases
at all times. Two homology arms were chosen and amplified from each recipient strain
of E. coli MG1655 and B. subtilis 168CA. For homologous recombination, barcodes were
flanked by DNA fragments - about 500bp in length - that corresponded to regions up-
stream and downstream of the species-specific insertion sites (Figure 3.10). A low melt-
ing temperature overlap between homology fragments and DNA barcode/selection
cassette sequences allow a first PCR reaction (splicing-overlap) to anneal specific over-
laps in an ordered fashion. This PCR was set with equimolar amounts of left-/right-
homology arms, individual DNA barcodes and selection marker sequences (75fmol
each), but without primers. At the melting temperature, individual fragments would
anneal to one another. In the following extension cycle, the DNA polymerase would fill
gaps and regenerate complementary strands. Individual fragments were thus sequen-
tially assembled into longer ones, up to the correct recombinant DNA arrangement. A
second PCR was then used in order to "clean" the assembly, and specifically amplify
recombinant products (Figure 3.9). This was done with a pair of primers annealing
at a higher temperature corresponding to the targeted amplification from the ends of
the recombinant DNA. Because this method allowed intermediary products to form,
for instance homology fragments with selection cassette but without barcode, a gel
purification was recommended to isolate the exact DNA fragment that represented re-
combinant products. Recombinant DNA was obtained with this purification step and
500ng at least should be extracted for successful bacterial transformation.
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TABLE 3.3: Individual PCR fragments generated to clone barcodes. Fragments that were amplified represented either
left-/right-homology (respectively Left-H and Right-H), selection cassette (Selection) or Barcode sequences. Gram
represents the species primers are designed for: E. coli (Gram-negative, -) and B. subtilis (Gram-positive, +).
Fragment Gram Template Forward primer Reverse primer TA Size
Left-H - gDNA GTAGTCAAATTCACCACGC CGCAATAGTGACAGATTTGA-
TTATC
62 443
Right-H - gDNA GTTCCTATTCTCTAGAAAGT-
ATAGGAACTTCGTGCTGTAC-
CCTACATACAGC
GATCACCGGCGGTAAGAAAG 66 474
Selection - pACYC184 TTACGCCCCGCCCTG GTTCCTATACTTTCTAGAGA-
ATAGGAACTTCGAGACGTTG-
ATCGGCACGTAAGAG
67 801
Barcode - Gblocks TCAAATCTGTCACTATTGCG-
TGGACATACATAGTATACTC-
TGGTG
GGCGGGGCGTAATAAG 63 287
Left-H + gDNA AGCAGAAGGAAAGGTGTTC GGCTCTAAATCTCATGCTCA-
AAAC
63 485
Right-H + gDNA TATACCCAGGGAGACCCGGC-
GACACTAACCATTTAGGATG-
TAATCAGGCCATAC
GTCAAGCGTGAATTCGAATC 62 527
Selection + gDNA TTATCAGTCCTGCTCCTCGG CGGGTCTCCCTGGGTATACG-
AGTAGGTATTACTACCCAAT-
CAGTACGTTAATTTTGGC
67 941
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Barcode + Gblocks GAGCATGAGATTTAGAGCCT-
GGACATACATAGTATACTCT-
GGTG
CCGAGGAGCAGGACTGATAAG 64 296
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3.2.2.5 In vivo integration protocols
The linear recombinant DNA obtained from the in vitro assembly was used to promote
barcode double recombination on the bacterial chromosome. We developed two proto-
cols that allowed the integration of recombinant barcode DNA in E. coli and B. subtilis
strains, and provide these experimental procedures in Appendix B. These methods
were used as a consensus and are applicable for any barcode that needs to be propa-
gated.
3.2.3 Retrieval of DNA barcodes
As synthetic identifiers, DNA barcodes needed to offer the possibility of being address-
able and retrieved. In the context of this study, this was achieved by Sanger sequenc-
ing. A number of sequencing techniques exist and work in different ways, but Sanger
sequencing is probably the most used technique for sequencing small cloning products
in laboratories[98]. To sequence a DNA fragment, Sanger sequencing adds fluores-
cently labelled dideoxynucleotides from a targeted locus defined via a single primer.
This reaction is achieved with the DNA polymerase and means that nucleotides are
incorporated in the 5’-3’ direction. The directionality of the sequencing primer is there-
fore important in the targeting of sequencing products. In our approach, a uniquely
addressable sequence is located upstream of all DNA barcodes and targeting this re-
gion allowed us to retrieve any DNA barcode on demand.
In this section, we have explained the methods that were set up in order to integrate
DNA barcodes in bacteria. We designed DNA barcodes to fulfil a set of requirements
including bio-orthogonality, a minimal size, in vivo stability and versatility of cloning
methods. DNA assembly and transformation protocols were tested by four individual
scientists who demonstrated positive integration of barcodes in different E. coli and
B. subtilis species. The following sections provide a better understanding of barcode
retrieval and their in vivo stability studies.
3.3 Large-scale screening setup
Barcode identifiers should be stable and their sequence should be able to be retrieved
and intact after many cycles of DNA replication (e.g. cellular growth). Automated
growth equipment allows serial growth of bacterial cultures at a high-throughput rate,
and to take measurements of the biological fitness at regular intervals. A basic method
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to observe whether cells behave normally is to grow them in favourable conditions and
to observe their resultant growth curve[165, 68]. Bacteria are small and divide rapidly:
about every 20min for classic laboratory E. coli and B. subtilis strains. Therefore, any
abnormal replication due to the insertion of a genetic device should be recognisable
by affecting specific growth rates. We opted for high-throughput techniques to screen
for a large number of genetic isolates and followed them over unusually prolonged
periods of growth to identify any barcode sequence instability.
The idea of integrating DNA barcodes in bacteria is only viable if barcode sequences
can be retrieved, and still provide the encoded information they are meant to carry.
In order to demonstrate barcodes stability, we employed two different methods: (i)
imitating a "lab-like" situation, where strains would be grown and subcultured many
times, and (ii) a more accurate approach to evaluate an exact number of replication
events (e.g. barcodes replication), and subsequently drawing a link between barcodes
replicability and eventual mutations appearing over time.
3.3.1 Continuous flow systems
As we detailed above, bacteria grow quickly and the need for fresh nutrient is a lim-
iting factor in most biological applications. If the right molecules do not surround
cells or if these molecules are in insufficient quantities, then bacteria slow down their
growth in what is called a stationary phase (cf. Figure 3.11)[233]. Although it is always
possible to redilute stationary cultures into fresh medium, bacterial growth is physi-
ologically affected by periods of starvation (maximal cell density in the medium, no
more growth)[158, 264]. One solution to this problem is to cultivate cells in continuous
growth conditions via bioreactors. Bioreactors can be assembled in order to provide
a constant supply of fresh nutrients to growing cultures and, therefore, allow a better
tracking of growth experiments.
Bioreactors require a deeper understanding of cell growth as represented in Fig-
ure 3.11[262, 107]. In Figure 3.11, phase 3 shows the steepest increment in cell density
over time. Derived by plotting optical density measures at λ = 600nm over time, the
exponential growth phase can be used to approximate cellular division rate[158, 147].
Knowledge of the frequency of cellular division (coupled with replication of one copy
of the chromosome) is essential for the work with bioreactors. Chemostats, a specific
type of bioreactor, are designed to have a continuous flow system which constantly
provides fresh medium to an ongoing bacterial culture. To run this system, a manifold
ensures that excess medium is extracted from growing cultures, and this volume must
be equivalent to the fresh nutrient input rate[208, 226]. As a whole, chemostats allow
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FIGURE 3.11: Bacteria undergo 6 consecutive phases during growth:
(1) the lag phase (null growth), (2) growth acceleration, (3) exponential
growth, (4) late-exponential growth (or retardation phase), (5) stationary
phase (or no more growth) and (6) biological decay. Error bars show stan-
dard deviation based on 12 individual samples.
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cultures to be grown at a constant rate that can be controlled via a pump settings, where
the best rate is equivalent to bacteria growth rate measured in exponential phase. With
the approximation of a culture growth rate, it is relatively straightforward to test and
derive an appropriate chemostat dilution rate to maintain constant growth with a suf-
ficient nutrient input, and to sustain near-optimal growth conditions for long periods
of time.
Although mechanistic aspects of chemostats are well-defined, a thorough calibra-
tion process is necessary to obtain relevant data. As shown in Figure 3.12 (assembly),
tubing first needs to be cut and assembled with connectors in order to build the man-
ifold[3, 216]. In our setup, four 50ml vessels could be followed simultaneously and
it was important to match all tubing dimensions in order to get an identical flow rate
across multiple samples. Calibration could be carried out with water, since LB is water-
based and both substances share similar viscosity, and was repeated after instruments
sterilisation at least twice to make sure culture dilution rates remained stable. Once the
chemostat calibration was verified and validated, all autoclavable units were sterilised
and prepared for assembly immediately after autoclaving, as shown in Figure 3.12.
For this study, the benefit of using a chemostat was to obtain accurate predictions
of the number of bacterial replication events and thus information regarding barcode
replication cycles. Given a bacterium growth rate, it is easy to program a calibrated
chemostat with settings that would comply with these specific growth requirements.
Therefore, the number of replication cycles can be precisely obtained by actively dilut-
ing growing cultures at a specific rate. However, cells first need to reach exponential
growth, and the number of generations between a culture inoculation and exponen-
tial growth is usually a rough estimate. As a standard method in microbiology, one
can estimate the number of viable bacteria inoculated onto a plate via the number of
colony forming units (CFUs) obtained after overnight growth. For the purpose of this
study, we performed CFU growth curves and serially diluted cultures over time to
obtain ideal dilution rates at which a minimal number of cells could be used to inoc-
ulate a chemostat. Given this minimum amount of cells, it was possible to evaluate,
given a specific growth rate, the time needed for cultures to attain exponential phase
(e.g. when the chemostat continuous flow should be turned on). Although chemostat
calibration defined the exact dilution rate of growing cultures, it always took between
3 and 5 vessel volumes of fresh medium for bacteria to reach steady-state growth.
Therefore, along all chemostat experiments, we recorded optical density (OD) mea-
surements while sampling cells for barcode sequencing to ensure estimated dilution
rates were accurate and cultures could reach steady-state growth.
Figure 3.13 displays an overview of the chemostat we built in this study. Panel
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FIGURE 3.12: The setup panel (top left) outlines the tubing necessary to
connect the multiple components of a chemostat with their associated
plugs (male/female luers and syringes), without forgetting a magnetic
stirrer to keep continuous cultures well-mixed. Autoclaving (top right
panel) must be performed on all sterilisable equipment in an organised
manner, since chemostats should be started as soon as their equipment has
been autoclaved. Calibration (bottom panel) can be performed with water
and should be timed and measured to match bacteria optimal growth rate.
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A details schematics of the continuous flow system: under a constant vacuum, fresh
medium is pumped from a reservoir via a peristaltic pump to provide nutrients to an
ongoing bacterial culture. Air pressure allows to keep the cultures dilution with fresh
nutrients balanced with waste removal. This is done via a custom fusion of an Akta
head to a Duran bottle cap, photographed in Figure 3.13B on the right. This picture
allows to see three 14G serological needles set at different levels to adjust the bacterial
culture volume with input, output and pressure ports. These caps were used to seal
culture vessels in combination with a circular piece of silicon to act as a joint. We also
coated silicon with vaseline to keep vessels sealed after autoclaving and to ease setup
of the chemostat manifold. Pressure problems often come as the main issue in the setup
of chemostats and setting up four individual vessels per experiment always allowed
us to keep at least three of them under appropriate experimental conditions.
Here, we detailed the system through which we studied the replication of DNA
barcodes over an exact, large number of bacterial generations. However, the experi-
mental conditions of these assays do not represent general growth methods that are
usually undertaken when growing bacteria. Therefore, we also studied DNA barcodes
via a "laboratory-like" fashion, where cells would be grown and rediluted for an ex-
tensive number of times between freeze/thaw cycles. The next paragraph details the
setup of this assay.
3.3.2 High-throughput screening
In large scale combinatorial or screening studies, many biological replicas or mutants
can be observed simultaneously[97, 230]. Following a series of individual cultures
allows eventual growth defects to be detected. These defects are unlikely to be ob-
served on a small scale, as they may emerge in one over a hundred or more cases[14].
Extended periods of slow growth or starvation (such as stationary or decay phase con-
ditions, for instance - Figure 3.11 phases 5 and 6) naturally appear to be stressful to
bacterial cells. Therefore, redilutions from overnight cultures can propagate cells that
acquired suppressor mutations to get a better fitness to stress conditions.
Automated plate handling systems now provide a strong advantage to screen large
populations of bacteria. Experimental procedures such as incubation periods, growth
measures and redilutions can be relatively automated to minimise human-induced er-
rors and measurement imprecision[96]. Our high-throughput studies allowed the com-
parison of 384 subcultures of barcoded and control cells over a number of stationary
phase redilutions, and to observe any changes represented in growth defects. Besides
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FIGURE 3.14: B. subtilis growth curves in LB supplemented with 0.4% glu-
cose at 37◦C with different shaking parameters: 200rpm (A), 600rpm (B)
or 1200rpm (C).
growth characterisation, all barcoded samples were sequenced to uncover any poten-
tial mutations in DNA barcode sequences. These experiments were organised jointly
with Dr. Peter Banks at the High Throughput Screening Facility (HTSF) at Newcastle
University.
At the facility, we used a liquid handling robot (Beckman Coulter Biomek FX) and
an automated plate reader to handle 8 individual 96-well plates simultaneously. Bacte-
rial cultures needed to be conditioned for the plate reader assay via the liquid handling
robot. An integrated graphical user interface on a computer set next to the equipment
allows the programming of liquid handling steps one-by-one. A moving head hovers
around specific locations (corresponding to media, plates and tips) and follows instruc-
tions to aspirate, dispense and mix different liquids. Before starting a growth experi-
ment, plates were also sealed by an oxygen permeable membrane. Once all plates were
ready to use, they could be placed on a rotating and shaking platform and connected
to a plate reader for absorbance readings, and a growth assay could start.
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Classical plate readers are generally designed to handle one plate at a time. For bac-
terial culture, different bacteria may require different shaking settings and handling a
single plate at a time allows to shake cells continuously while the machine is not busy
taking measurements. However, the equipment at the HTSF could only shake two
plates in parallel while other samples would have to sit in the incubator. Realistically,
this meant that plates would be shaken for 1min, absorbance readings would be taken
and they would stand still for about 10min before the next shaking/measurement cy-
cle. Although that was not a problem for E. coli cells, B. subtilis needs a thorough
shaking to provide bacteria enough oxygen in order to proliferate. Therefore, grow-
ing all bacteria simultaneously needed adjustments to accomodate the growth of both
model organisms. Figure 3.14 shows how higher shaking parameters could comply
with a good and replicable B. subtilis growth. Such high-speed shaking settings would
probably be detrimental if sustained for prolonged periods of time, but 1min shak-
ing at 1200rpm every 10min appeared to fit both E. coli and B. subtilis species growth
conditions.
In this assay, we followed barcoded and control strains over 10 subculture exper-
iments. Initially, a single colony from each strain was picked from a fresh plate and
grown in LB supplemented with 0.4% (w/v) glucose overnight at 37◦C with regu-
lar shaking parameters (about 150rpm). In the morning, saturated cultures were spun
down, resuspended in fresh LB medium, diluted 100 times and 200µl were loaded onto
ThermoFischer clear 96-well microplates. For all subculture experiments, two condi-
tions were tested: an early stop of bacterial cultures after 6h (in late exponential/start
of stationary phase) and a prolonged culture in stationary phase (12h) before snap-
freezing. For the first subculture, 100µl were harvested after 6h for the early sampling
point, and the remaining bacterial culture was further incubated up to 12h. All sub-
sequent cultures were diluted 100 times from frozen stocks and cultivated in a 100µl
total volume for both early and late sampling points. By the end of the 10 subcultures,
genomic DNA (gDNA) was extracted and screened for potential variations in barcode
sequences.
3.4 DNA barcodes in vivo characterisation
3.4.1 Cloning method
In this study, we created a cloning method to barcode bacteria with a synthetic se-
quence. We applied this method to either barcode strains for the first time, or to up-
date a strain already barcoded. As shown in Figure 3.7, the in vivo step firstly involves
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FIGURE 3.15: Process to retrieve a barcoded strain barcode information.
Bacteria to be identified are grown for genome extraction and a PCR reac-
tion is carried out to target barcode sequences.
the insertion of a barcode alongside a selection cassette. This selection marker is then
removed to leave only the barcoded sequence on the genome. For biological valida-
tion, we carried out PCR screening of transformant colonies and sequencing of PCR
products (Figure 3.15). In E. coli MG1655, 47 colonies were screened for insertion of the
barcode cassette/removal of the antibiotics marker and all transformants were found
to be positive by PCR and sequencing data. The cloning method in E. coli is based on
helper plasmids that are selected at 30◦C in the presence of ampicillin (100µg/ml). In
all cases, plating on NA/Ampicillin plates did not allow any bacterial growth, as ex-
pected to prove the loss of helper plasmid after recombination. In the Gram-positive
species B. subtilis 168CA, we obtained a 93% success rate for integration of the barcode
cassette with a zeocin antibiotic marker (20µg/ml). The PCR screening revealed 31/32
products of the right band size, and all of the 31 expected positive clones were con-
firmed by sequencing. The second step of antibiotic marker removal, associated with
the expression of the MazF toxin, was successful for 35 of 46 screened colonies (76%).
While 35 transformants revealed the expected sequence, negative results always ap-
peared to have developed mutations within a xylose-inducible promoter, resulting in
negligeable amounts of MazF toxin being produced. This frequency of suppressor mu-
tations was observed over a range of xylose concentrations from 0.2% to 1%. The pro-
cedure detailed in Figure 3.15 approximately represents 10 replication cycles of DNA
barcode sequences. After these initial 10 generations, we were able to confirm barcode
sequences by Sanger sequencing for all positive PCR products. As a final validation
step to prove the feasibility of our cloning method, three additional research scientists
performed the cloning of DNA barcodes in two other strains of E. coli and B. subtilis,
and managed to retrieve expected barcode sequences in E. coli BW25113 and B. subtilis
PY79.
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3.4.2 Growth characteristics
Primarily as a control to verify barcoded strain fitness compared to their wild-type, we
performed a plate spotting assay to detect any replication defects visible on plates. For
the preparation of chemostat experiments, we evaluated the minimal number of colony
forming units (CFUs) and assessed growth rates from CFU-based growth curves.
3.4.2.1 Spot-plating assay
If bacteria show defective DNA replication, it directly affects division time and bacte-
rial colonies grow at abnormal rates. After spotting 5µl of 10-fold dilutions of control
and barcoded strains in exponential phase, we did not observe any significant changes
in either bacterial strains ability to replicate (Figure 3.16). For the Bacillus strain, the
ability to produce spores was unaffected. Spores are detectable to the naked eye as
they block more light, due to their thicker cell wall, and appear as darker colonies than
E. coli for instance.
3.4.2.2 CFUs counts
Initial plate spotting assays were followed by colony forming unit (CFU) growth curves.
Over bacterial growth, we plated serial dilutions of cultures on nutrient agar (usually
10−6, 10−7 and 10−8) and captured images after 24h growth via an Epson scanner (48-
bit colour and 400dpi). All images were processed via a custom protocol made with
ImageJ to extract background information and detect reliable CFUs (away from edges
and under a certain density). The appropriate number of CFUs detectable per plate
was set from 30 to 500 CFUs/plate. Images were first transformed in 8-bit greyscale
and thresholded to erase the agar background. A restricted selection, excluding petri
dish edges, was further used to detect particles (individual CFUs). CFUs were detected
on the basis of their sizes (from 3 to 300 pixels) and their circularity index (elliptic vs.
circular structures). Table 3.4 shows barcoded and control strains estimated growth
rates. These specific growth parameters were used to tweak continuous flow culture
parameters and allow optimal growth in chemostats.
3.4.3 Barcodes stability over long periods of continuous flow culture
We assessed DNA barcodes integrity over a number of DNA replication cycles by se-
quencing samples from a chemostat. For the best approximation of barcode replication
cycles, we inoculated the continuous flow culture apparatus with the minimal known
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FIGURE 3.16: The photograph was taken after 24h growth and remained
as such up to 72h. sCPW05 denotes the barcoded B. subtilis strain while
sCPW06 is barcoded E. coli MG1655.
TABLE 3.4: Barcoded strains growth rate in E. coli and B. subtilis compared
to wild-type strains.
Species Strain Growth rate (h−1) Generation time (min/sec+−sec)
Escherichia coli MG1655 control 3.00 20m00s+− 47s
Escherichia coli barcoded MG1655 2.86 21m00s+− 32s
Bacillus subtilis 168CA control 3.53 16m59s+− 34s
Bacillus subtilis barcoded 168CA 3.45 17m22s+− 28s
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FIGURE 3.17: E. coli (left) and B. subtilis (right) strains were serially diluted
from overnight cultures to assess their minimal achievable CFU dilution
factor.
amount of cells that could lead to viable colonies. According to Figure 3.17, we ap-
proximated minimal achievable CFUs for each studied species (E. coli and B. subtilis)
and started chemostat experiments from 1 to 3 CFUs (50-150 cells, 3.10−10 dilution) in
triplicates. We turned the continuous flow on when bacterial strains reached expo-
nential phase (OD600 = 0.4 after about 10h). This allowed us to provide fresh sterile
medium and to remove excess culture at the right time not to overdilute bacterial cul-
tures nor to let them slow down growth in stationary phase. As shown in Figure 3.18,
bacterial populations undergo two phases of higher/lower OD before stabilising in a
long-term steady state growth. We followed bacteria over 200 generations (about 4
days of culture) and retrieved barcode information at regular time points (every 15-25
generations). For E. coli the same cultures were followed over 200 consecutive genera-
tions, while in B. subtilis, cells were followed for 100 generations, induced to stress and
sporulation by ethanol treatment and regrown from spores for a further 100 genera-
tions. Barcode DNA sequences were obtained by Sanger sequencing of barcode PCR
products of specific genomic DNA (gDNA) amplification. We analysed 128 sequenc-
ing reactions, including 24 controls to compare the evolution of barcoded vs. wild-
type strains. We confirmed that control wild-type sequences remained unchanged and
found no variation in barcode sequences over 200 generations.
3.4.4 Barcodes stability in high-throughput subcultures
We evaluated the potential for spontaneous mutations in DNA barcodes in a high-
throughput assay, where barcoded and control strains were subcultured in 96-well
3.4. DNA barcodes in vivo characterisation 75
FIGURE 3.18: Optical density (OD600) measurements initially vary in con-
tinuous flow bacterial cultures. Cultures adjust their growth to nutrients
limitation and rapidly reach steady state, where same optical densities can
be observed up to hundred hours (or more). OD measurements were av-
eraged from 4 individual experiments, each performed in triplicate. Error
bars show standard deviation across samples.
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plates. Over 10 subcultures, we estimated from 100 fold dilutions of previous sub-
cultures that final samples reached about 100 generations. Figures 3.19 and 3.20 shows
the overview of the high-throughput method. From an initial subculture sampled at
early and late time points for 2x96 (E. coli/B. subtilis) barcoded strains, serial subcul-
tures were performed before sampling for sequencing. We extracted gDNA, amplified
the genome region of interest (barcode integration locus) by PCR and sequenced all
reactions. In our assay, sequencing of 384 barcoded strains tested in a normal vs. stress
conditions revealed intact DNA barcode sequences. As shown in Figures 3.19 and 3.20,
no major difference in growth rates was observed for different samples. The majority
of sequencing reads left a 26-27 nucleotide gap downstream of the universal primer
binding site and then showed a perfect match with the expected alignment. In less
than 5% of cases, sequencing data quality was noisy but a second complementary read
would always manage to recover the integrity of a barcode sequence. This, in partic-
ular, is the reason why we developed DNA barcodes with an algorithm including an
error correction feature.
3.4.5 Barcodes readability
Due to the technicalities of Sanger sequencing, it would not be expected to obtain fully
complementary sequences from the first nucleotide after barcodes universal primer
binding site. As detailed above, most sequencing reads show a gap in their 5’-end that
is formed at the start of the sequencing reaction. Sequences obtained from Sanger se-
quencing and chromatogram data (Figure 3.21) generally show a perfect match with
barcode sequencing after 20-30 nucleotides. This was important to retrieve DNA bar-
codes 3’-ends containing checksum elements. In order to map retrieved DNA bar-
codes, our server recognise an encoded synchronisation sequence and looks for up-
stream (barcode UUID) and downstream (checksum) DNA. The checksum accounts
for mismatches in the 96bp encoding a barcode UUID, and always allowed us to re-
trieve the correct barcoded strain information, even with gaps of variable length in
sequencing reads. To verify that missing 5’-ends would indeed match the expected
barcode, we repeated a sequencing reaction with an alternative universal primer (E.
coli and B. subtilis specific). A second read always allowed us to retrieve the integrity
of correct barcode sequences.
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FIGURE 3.19: Top and bottom panels describe the high-throughput assay
for B. subtilis. Top panel shows growth of the initial 96-well plate that
was used throughout this assay, sampled after a 6h incubation period or
a prolonged 12h period where cells are left in stationary phase. Nine sub-
sequent cultures – following early/late samples separately – were carried
out before extracting DNA for sequencing. In the bottom panel, growth
curves are averaged for the 96 samples of the same plate after the ninth
subculture experiment, and error bars show standard deviation.
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FIGURE 3.20: Top and bottom panels describe the high-throughput as-
say for E. coli. Top panel shows growth of the initial 96-well plate that
was used throughout this assay, sampled after a 6h incubation period or
a prolonged 12h period where cells are left in stationary phase. Nine sub-
sequent cultures – following early/late samples separately – were carried
out before extracting DNA for sequencing. In the bottom panel, growth
curves are averaged for the 96 samples of the same plate after the ninth
subculture experiment, and error bars show standard deviation.
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3.5 Considerations in the study of DNA barcodes
Living cells rely on DNA replication to proliferate in a given environment. In E. coli
and B. subtilis, DNA polymerase enzymes initiate bidirectional replication of the chro-
mosome at the oriC region[166, 192, 130]. In normal growth conditions, both halves
of the chromosome are simultaneously replicated and a second copy of the chromo-
some is segregated to a daughter cell, subsequently created by cellular division[21].
DNA polymerases are high-fidelity enzymes that misincorporate or skip nucleotides
at a 10−6 to 10−8 error rate[130]. In bacteria, they are connected to other families of
repair proteins and DNA replication exhibits an overall error rate of 10−9 to 10−10 per
nucleotide. In practice, one may observe up to 10 mutations at every cycle of DNA
replication in a ∼ 5Mb genome. We have developed a method to tag bacterial strains
with DNA barcodes and had to ensure that these sequences would remain stable over
time. To test this, we followed the proliferation of barcoded cells over hundreds of
replication cycles and sequenced barcode nucleotide sequences. In the following, we
discuss different aspects of the setup of DNA barcoding protocols and their optimisa-
tion for the study of barcode stability.
3.5.1 Barcode integration
3.5.1.1 Setup of a universal cloning method
We presented evidence for successful integration of DNA barcodes in E. coli and B. sub-
tilis strains, at two respective loci. Although many cloning techniques may have been
applicable to barcode insertion, homologous recombination was the best compromise
to obtain a consensus protocol between bacterial species. The main advantage of using
homologous fragments was that the procedure to barcode strains would remain the
same, regardless of inserting a new barcode sequence or replacing an existing one by
a updated version. Moreover, the adjustment of standard homology arm length pro-
vided the ability to control recombination specificity in both species. We started from
1kb homology arms upstream and downstream of barcode sequences, and observed
identical cloning results with the use of smaller homology fragments (∼ 500bp). As a
rule of thumb, 300bp or more are generally used for cloning via homologous recombi-
nation. Therefore, we could reduce barcode flanking homology regions even further,
but this may also result in a decrease in the efficiency of the cloning method (e.g. total
number of colonies obtained).
During cloning verification steps, we always identified correct transformant colonies
and obtained an optimal ratio of true vs. false positives (≥ 90%). However, we report
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that the mini-MazF cassette is susceptible to develop mutations rendering the PXY L
promoter obsolete. This issue could be tackled by substituting the xylose-inducible
system for a more stringent device, such as the PSPAC or PHY PERSPANK IPTG-regulated
promoters. Nevertheless, screening for the loopout of antibiotic resistance marker in
B. subtilis still displayed a 76% success rate, and given the easiness of the cloning vali-
dation technique (plating transformants on +/− antibiotic plate), it remained trivial to
find positive transformants. Altogether, we demonstrated the setup of a robust cloning
method, analogous for Gram-negative/-positive species, and showed its applicability
via multiple barcoding procedures that were proof-tested by three additional scientists.
3.5.1.2 Extending the barcoding technique
The current methodology to integrate barcodes in the bacterial chromosome uses an-
tibiotic selection markers. By default, we used chloramphenicol and zeocin for Gram-
negative and Gram-positive species respectively. Since a given design may already
use one of these antibiotics, we provided the possibility for recombinant DNA assem-
bly to be performed with alternative selection cassettes (kanamycin, tetracycline, ery-
thromycin, etcetera). Although the barcoding method remains a two-step process with
(i) insertion of barcode sequence and (ii) curation of selection marker, it accommodates
both species and displays good efficiency at barcoding strains.
In order to streamline our initial cloning method, Jonathan Tellechea is now work-
ing on adapting this technique to the CrispR/Cas system. With this type of genome-
editing tool, there is no need for a selection marker to be propagated along with insert
DNA[134]. Therefore, this reduces the integration process to a single transformation
step and alleviates the need for selection marker curation. However, this approach is
slightly less flexible for the replacement of existing DNA barcodes. This is because to
promote its activity, the CrispR/Cas system recognises specific DNA motifs flanking a
genome region to be edited. For the updating of barcode sequences, this would require
two different sites to be used, thereby the development of two genome editing tools.
Yet, the CrispR/Cas system is a very powerful tool and an increasing number of appli-
cations use this method for genome editing. With complementary cloning approaches,
we aim to expand the range of techniques that could be used to barcode strains and to
facilitate a high-throughput identification of bacterial species.
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3.5.2 Large scale characterisation studies
We demonstrated in the chemostat and high-throughput assays the stability of barcode
DNA sequences over a large number of bacterial generations. While we successfully
derived that DNA barcodes were stable over time, we also encountered specific equip-
ment challenges during these experiments. In the following subsections, we present
the main limitations of chemostat and high-throughput assays for the study of bar-
coded strain stability.
3.5.2.1 Continuous flow system
Chemostats are a type of continuous flow system that allow constant growth of bac-
terial species in a well-controlled environment. Their setup and calibration process is
of great importance; a thorough characterisation of flow rates, for a given device as-
sembly, is necessary in order to exert an adequate control over the studied strains.
Although this process should be repeated between autoclave cycles, it is relatively
straightforward to obtain stable parameters for bacterial growth. The main limitations
of chemostats are the amount of medium consumed and the waste produced by grow-
ing cultures. Per se, preparing large volumes of medium is not an issue. The trickier
step was to procure this fresh medium to the chemostat input reservoir, and to keep
sterile conditions over several iterations of this process. Since the chemostat appara-
tus was placed in a walk-in incubator set at 37◦C, the chances for contamination due
to other people’s nearby cultures were higher. In order to limit the likeliness of this
scenario, we always worked in proximity of a bunsen burner to create a sterile envi-
ronment nearby the input reservoir whilst topping it up with fresh medium. However,
a strong air-flow needed to maintain ambiant temperature in the incubator may some-
times have impaired with the use of bunsen burners. As one would expect, we report
that sample contamination was more likely to take place after prolonged period of cul-
ture for the same experiment (≥ 100h). If this situation were to occur, we would end
the assay and reiterate it.
As we have detailed earlier, cultures were followed over hundreds of hours. The
continuous flow of the chemostat was based on a peristaltic pump that could be pro-
grammed to run at different speeds. The tubing used with this pump had to be of
thinner diameter than normal wiring of the manifold. In general, after 100h of experi-
ment, we started observing silicon tubing degradation due to repeated pressure of the
peristaltic pump (cf. Figure 3.22). In a couple of instances, chemostat assays failed
because of silicon wire bursting. Such situations would normally only affect a single
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FIGURE 3.22: Schematics of a peristaltic pump. Tubing passing by the
pump is compressed at specific locations, which creates a flow movement
from input to output ports. The pump rotation speed is usually digitally
controlled and is expressed in number of rotations per minute.
bioreactor, but this would impede on the number of biological replicates used per as-
say. In order to prevent this type of occurence, we preferred using new tubing for the
peristaltic pump for each experiment. The rest of the manifold would otherwise be
cleaned with 2L of 70% ethanol and 5L of water before being sent for autoclave in-
strument sterilisation. In order to preserve chemostats in a sterile working state, we
recommend taking most care in the storage and handling of manifold pieces, and to
perform a thorough examination of individual parts prior to the start of an assay.
3.5.2.2 High-throughput assays
Although we showed the successful retrieval of DNA barcode sequences in high-throughput
settings at the HTSF (Newcastle University), we first needed to adjust growth parame-
ters to accommodate both E. coli and B. subtilis strains growth profile. This procedure,
as outlined in Figure 3.14, consisted of increasing shaking parameters to observe a
good B. subtilis growth fitness. For both bacterial strains, we harvested cells from sub-
cultures at early and late stationary phases, and snap-froze them in 50% glycerol. These
two sampling points represented normal vs. stress conditions, where cells harvested at
a later time would have more potential to have developed mutations. Nevertheless, we
did not observe any difference for any of the screened barcode sequences. As a com-
plementary approach to test the viability of barcoded cells, we also exposed bacterial
strains to other stress conditions such as ethanol treatment or UV-exposure, and could
nonetheless retrieve correct DNA barcodes after subgrowth of bacteria. The screen of a
large amount of biological replicates helped us to assess the robustness of barcode se-
quence insertion in the bacterial genome and demonstrated artificial sequence stability
over time.
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3.5.3 Barcode design and sequencing data
The design of DNA barcodes was driven by the creation of bio-orthogonal artificial
sequences that could be used as bacterial identifiers. During the development of this
project, we set up a minimal architecture of barcodes that would allow for their re-
trieval via universal primers. Nevertheless, it is typical for Sanger sequencing to leave
gaps at the 5’-end of sequencing reads. Figure 3.21 exemplifies this instance, where
barcode DNA located directly downstream of the primer binding site could not be
retrieved in a single reaction. Although a second sequencing read from the primer lo-
cated downstream of the barcode insertion site could always help recover the entire
barcode sequence, an alternative would have been to include a 30bp spacer between
universal primer and start of barcode sequences. This method would have ensured the
entire coverage of DNA barcodes in a single sequencing reaction, and would not have
impaired with any of the cloning features of the barcoding protocol. Finally, it is worth
noting that sequencing results from barcode stability studies were consistant with the
expectations one could have prior to the assays. Since bacterial DNA polymerases are
high-fidelity enzymes and only misincorporate a few - if any - nucleotides at every
replication cycle[67], DNA barcode sequences would not be expected to be mutated
even after 200 bacterial generations.
3.6 Summary
Here, we propose a unified platform for microbial tracking and bacterial strain iden-
tification through the use inert synthetic DNA barcodes. The system works on the
gathering of a strain experimental data together with in silico resources, and the stor-
age of this information as short DNA links within barcoded strains. We discussed in
this chapter the considerations involved in barcode design to efficiently tag two model
microorganisms, and how to retrieve strain documentation by a simple sequencing re-
action. Then, we demonstrated the efficiency of our barcode DNA cloning method.
For the development of our barcoding platform, we adapted the experimental pro-
tocols that were used to manipulate barcoded cells to a barcoding kit, presented in
Appendix C. Finally, we showed the stability of DNA barcodes in vivo over a large
number of bacterial generations with the use of continuous flow and high-throughput
culture equipment. Altogether, we set the foreground for the development of DNA
barcoding technologies. To open towards barcodes scalability, we discuss in the next
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chapter combinatorial genetic libraries that were characterised to populate our plat-
form with bacterial signaling example resources, and discuss further aspects of this
work in Chapter 6.
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Chapter 4
Genetic circuits engineering
In Chapter 3, we introduced the Bac2code platform with the creation and character-
isation of DNA barcode sequences. These sequences are used as identifiers to docu-
ment the information about specific bacterial strains. After setting up the barcoding
framework, we moved on to building a biorepository of genetic circuits to populate
our platform with documented examples of barcoded strains. This chapter provides
an overview of the construction and characterisation of genetic circuits that could be
found on the Bac2code server.
4.1 Bacterial communication via quorum sensing
Cell-to-cell signaling requires the intervention of specific metabolites that act as acti-
vators/repressors over genetic subunits[40, 140]. Widely spread amongst the bacte-
rial kingdom, quorum sensing is a universal way for bacteria to synchronise differen-
tial growth behaviour. Quorum compounds are signaling molecules that accumulate
within a bacterial population and trigger a coordinated response over a certain thresh-
old, dependent on cell density. Initially discovered in Vibrio fischeri by the emission
of bioluminescence in the dark[120], quorum sensing has now been characterised in
many Gram-negative and Gram-positive organisms as a mean of bacterial communi-
cation[155, 75, 206, 232]. For instance, Vibrio fischeri swims freely in seawater at con-
centrations of 10 cells for liter and does not produce any light in these conditions.
However, bacteria can stick and develop with a variety of sea organisms in a symbi-
otic relationship. In such environments, bacteria can grow to concentrations of 1010
cells per liter and coordinate cellular responses, coupled to a process of luminescence
emission[198, 197]. As an example, the Hawaiian squid Euprymna scolopes uses Vibrio
fischeri as a light organ, where fluctuating bacterial cell densities allow it to be prac-
tically invisible, or to hunt in deep sea water whilst using bacteria as a light source.
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In this chapter, we deconvoluted a quorum sensing system into sender and receiver
components in order to characterise signal transduction in bacteria.
4.1.1 Quorum signaling molecules: the lux model
Over the years, bacterial behaviour changes based on the detection of specific cell
densities has been referred to as quorum sensing[71, 31]. Quorum compounds are
very specific signaling molecules mediating intercellular communication via autoin-
duction[99, 94, 143, 78]. In simple terms, a chemical species is produced by a pro-
tein that positively regulates its own expression. This mechanism, called a positive
feedback loop, allows the amplification of signals as cellular density increases. There
are two known types of quorum molecules in bacteria: Gram-negative species use N-
acetylated homoserine lactones while Gram-positives use processed oligo-peptides[148,
254, 74]. We focussed on the engineering of E. coli species and thus specialised in a spe-
cific type of homoserine lactone (AHL).
We based this work on the use of Vibrio fischeri lux system. In this organism, the
quorum sensing machinery is controlled by the bipartite LuxR/LuxI operon[217]. As
shown in Figure 2.7, the left part of the operon drives the expression of the LuxR pro-
tein regulator, while the right part produces the LuxICDABEG transcript. The latter
encodes the AHL autoinducer (LuxI) and a cassette containing bioluminescence genes
(LuxCDABEG). In combination with AHL, LuxR activates transcription of LuxI and
more of the quorum molecule is produced. In the absence of the autoinducer, LuxR
represses the production of quorum sensing molecules.
4.1.1.1 LuxR regulator
Low constitutive expression of LuxR via the promoter PL−lux produces dimer proteins
that bind to the -35 unit of PR−lux. The PR−lux promoter uses a lux box as its -35 element.
This box is a 20bp inverted palindromic repeat (’ACCTGTAGGATCGTACAGGT’) and
allows dimerisation of active LuxR proteins[84]. However, in the absence of AHL
(quorum compound), LuxR is inactive and does not allow the RNAp to initiate tran-
scription at this site. Binding of AHL to the N-terminal domain of LuxR allows its
C-terminal DNA binding domain to become active. Therefore, the RNAp holoenzyme
can only initiate its activity in the presence of AHL, which facilitates LuxR dimerisation
on the PR−lux -35 to act as an activator of the RNAp open-complex formation. There
is a nonlinear relationship between concentration and response behaviour in quorum
sensing processes[124, 242]. The response exhibited by LuxR on the PR−lux promoter is
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typical of DNA binding proteins, and is essential for signal recording in in vivo expres-
sion studies.
4.1.1.2 LuxI autoinducer
In Vibrio fischeri, the AHL autoinducer (3-oxo-C6 HSL) is the product of the LuxI pro-
tein catalytic activity[52, 70, 82]. Precursors that are found within the cytosol (acyl-
ACP and S-adenosylmethionine or SAM) are converted by LuxI into AHL and become
available to ease LuxR binding to PR−lux. This, in turn, activates transcription of more
LuxI protein resulting in higher autoinducer levels[219]. As we described ealier, LuxI
is followed by the LuxCDABEG proteins in its native host and these are responsible
for the emission of luminescence. Nevertheless, for the sake of this study, we replaced
this large operon by a single fluorescent protein, offering better capabilities for in vivo
characterisation. This positive feedback loop is very important for hysteresis of trans-
fer curves in modelling studies. Here, hysteresis is shown as a lag in fluorescence
emission created by a change in inducer concentration. This phenomenon is further
described in the next sections.
4.1.2 Inducible quorum devices
As we detailed above, quorum sensing systems are found in a range of bacteria, and
the V. fischeri Lux operon was cloned in E. coli and shown to display similar functions as
in its native host[57]. In this Chapter, we describe the deconvolution of the lux operon
into sender and receiver genetic circuits in E. coli[152]. Figure 4.1 describes the rationale
behind building these circuits. Using generic methods for bioengineering described in
Chapter 2 and the next section, we constructed a series of bacterial devices (plasmids)
and characterised their behaviour in vivo. We replaced the lux emission of the lumines-
cence system by the emission of fluorescence, and followed signalling molecules over
a range of conditions using characterisation techniques providing single-cell to popu-
lation scale resolution. The following sections describe the genetic assemblies built in
this study to re-orchestrate quorum behaviour in E. coli. Bacterial systems were cre-
ated, characterised, modelled and re-evaluated in order to provide the most efficient
parameters for signal emission, detection and amplification in genetic circuits.
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FIGURE 4.1: Assembly of genetic circuits in synthetic biology. (A) de-
scribes the different genetic parts that were combined to build genetic
circuits. (B) shows a standard visual representation of these parts. (C)
displays an example of genetic circuit functional assembly producing a
protein of interest along a fluorescent reporter.
4.2 Construction of genetic circuits
As suggested in Figure 1.1, the construction of genetic circuits is an incremental pro-
cess in which devices of similar function are optimised based on previously obtained
characterisation results. In this section, we walk through the process of engineering
quorum devices in E. coli for the study of intercellular communication. In particular,
we explain the key features that allowed for the conversion of the LuxRI unit into a
tightly controlled sender/receiver system.
4.2.1 Engineering the lux operon
In this study, we isolated the two main components of the LuxR/LuxI system. As
shown in Figure 4.2, the V. fischeri Lux operon was divided into: (i) sender bacterial
units controlling production of the quorum molecule and (ii) receiver cells detecting
environmental quorum elements that would diffuse through their membrane. A third
type of device was also created where detection of AHL allowed PR autoinduction and
formation of a feed forward loop. Experiments were performed in four strains of E.
coli: DH5α, DH5α λpir, MG1655 and BW25113. We used E. coli DH5α or DH5α λpir
for cloning and MG1655 and BW25113 for expression of genetic constructs. Plasmids
that were built in this study are detailed in Table 2.1 and followed two main design
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principles: (i) optimisation of the inducible promoter to produce quorum sensing com-
pounds and (ii) reduction of the background noise/response maximisation in receiver
cells. This process involved basic modifications of genetic structures regulation. In
further subsections, we describe genetic circuit variants that were created for in vivo
characterisation.
4.2.2 Genetic circuits library
All plasmids were isolated and confirmed for correct insertion by colony PCR or re-
striction enzymes digestion. Positive isolates were then sequenced by Sanger sequenc-
ing to obtain exact sequence information. In cases of unexpected sequence mutations,
plasmids were corrected by amplification from overlapping primers and selected by
product recircularisation via in vitro mutagenesis.
4.2.2.1 Setup of bacterial terminators
The LuxR/LuxI system is natively controlled by a bipartite promoter. In order to sep-
arate the different biological entities for specification in sender/receiver circuits, we
placed terminators in template plasmids to isolate target products from cofactor regu-
lation. As detailed in Chapter 2, we used a fusion of the rrnB T1 and bacteriophage TE
terminators to disrupt transcription of mRNA molecules between regulatory subunits.
If short product PCR amplification fails due to secondary structures, we recommend
using a custom synthetised terminator template for cloning. We built genetic circuits
in two main template plasmids: pACYC184 for low copy plasmids and pUC19 for high
copy replicons (Figure 4.3). For pACYC184 circuits, we reduced the plasmid size by
kocking out the tetracycline resistance gene and replaced it by our terminators fusion.
For pUC19 (and pSB1AK3), we inserted terminators in the standard cloning site. We
used these plasmids as the basis for further genetic constructs assembly.
4.2.2.2 Choosing adequate ribosome binding sites
For the construction of a plasmid library and fair comparison of genetic constructs, we
chose to place all expressed proteins under the control of the same ribosome binding
site (RBS). We screened three different RBSs widely used in the synthetic biology com-
munity, which represented a set of high-, middle- and low-expression profiles (respec-
tively B34, B30 and B32)[20]. We studied these sites in the context of the expression of a
single, or two individual proteins as shown in Figure 4.4. We found that co-expressing
proteins usually lowered the fluorescence profile of genetic constructs, as opposed to
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FIGURE 4.2: Schematics of the V. fischeri Lux operon repurposing. Sender
and receiver units are created from subparts of the native operon, and
remotely controlled by the use of a specific inducer or by the detec-
tion/amplification of AHL. The feed-forward loop model includes LuxI
upstream the fluorescent reporter, providing more autoinducer to LuxR.
For the sender unit, TF denotes a transcription factor that represses or ac-
tivates the transcription of the autoinducer.
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FIGURE 4.3: Low copy (p15A replicon, pACYC184) and high copy number
(ColE1 replicon, pUC19) plasmids used as templates in this study.
the expression of the fluorophore only. The B34 and B32 RBSs are examples of regu-
latory units that are either too active or not active enough: these could not produce
similar expression levels between single or dual protein expression. However, B30 ap-
peared to sustain high levels of protein for both single or co-expression experiments
(e.g. closeness of B30-GFP and B30-luxI-B30-GFP curves in Figure 4.4). Therefore, we
chose B30 as our ribosome binding site of choice for protein expression.
4.2.2.3 Inducing quorum molecule production
We constructed two types of sender devices. Both drove the expression of LuxI, the
quorum inducer, but they were individually based on the PTET and PBAD systems
(Figure 4.5)[91]. The PTET promoter, in the absence of TetR, can be openly transcribed
by the RNAp. However, constitutive levels of this cofactor promote the negative reg-
ulation of the promoter. We tested constructs with a range of constitutive promoters
from Anderson’s library (Figure 4.1, promoters) to control different levels of TetR re-
pression. For minimal levels of PTET leakiness, we placed TetR under the control of
the J23119 strong constitutive promoter. In the PBAD system, we kept the inducible
promoter as it is in the pBAD33 template plasmid (AraC under the control of PC). For
the making of sender devices, we compared the production of target proteins either
via the repressible PTET or with the activable PBAD promoters.
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FIGURE 4.4: Ribosome binding sites characterisation: output fluorescence
(RFU) over time for constructs with BBaB0034 (B34), BBaB0030 (B30) and
BBaB0032 (B32) driving the expression of a single protein (GFP) or two
individual proteins simultaneously (GPF and LuxI). Error bars show stan-
dard deviation over three repeats of the assay.
FIGURE 4.5: Inducible promoters used in this study. PBAD is positively
regulated by AraC in the presence of arabinose. PTET is negatively reg-
ulated by its cognate protein TetR. Plus and minus symbols indicate the
state of transcription for each of the different promoter states. Adapted
from [223]
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TABLE 4.1: Fluorescent proteins used as genetic circuits reporter.
Fluorescence Multimer (λex/λem, nm) Monomer (λex/λem, nm)
Green eGFP (489/508) sfGFP (485/510)
Red mCherry (587/610) mCherry2 (587/610)
4.2.2.4 Detecting quorum molecules
The recognition of AHL is carried out by LuxR and triggers subsequent activation of
the PR−lux promoter. We created plasmids with different promoters for the expression
of LuxR in order to reduce the background signal observed in the native V. fischeri
genetic context. We first separated PL−lux and PR−lux units of the lux promoter by
a terminator to avoid PL−lux leakiness[145]. Then we replaced TetR PL−lux promoter
for promoters from Anderson’s library to fluctuate available amounts of cofactors to
trigger cellular response. In these different setups, we also tested the effect of removing
degradation tags from LuxR in translational regulation. Therefore, we screened for
combinations of adequate protein degradation time, promoter and RBS in order to
obtain levels of LuxR that can sustain robust induction of PR−lux.
In our circuits, activation of the PR−lux promoter leads to the production of an out-
put molecule (fluorescence). It proves that environmental AHL was detected at a per-
missive concentration and allowed binding of LuxR to PR−lux and recruitment of the
RNAp. We derived several options: circuits may simply be sensors, which provide a
yes/no answer to the detection of a molecule, or they may be amplifiers that reinforce
signal production[170]. We built both types of circuits and the latter was obtained by
placing LuxI under the control of a low strength RBS, upstream of the fluorescent re-
porter controlled by PR−lux (cf. Figure 4.2). As a final step for further characterisation
studies, we also included a modified version of the PR−lux promoter, where a cI protein
binding site interferes with LuxR binding (PRcI−lux promoter)[48]. In this scenario, a
sensor strain harbouring a plasmid driving the inducible expression of the cI protein
would be able to actively repress the activation of the PR−lux promoter. For the chain-
ing of sender and receiver strains, this would guarantee a perfect control over signal
production, detection and propagation (further details are given in Chapter 5).
4.2.2.5 Cotranscribed fluorophores
The construction of tunable genetic circuits in synthetic biology often involves the use
of fluorescent reporter proteins. In our genetic devices design, we placed genes encod-
ing reporter protein downstream of the LuxI coding sequence for sender plasmids and
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FIGURE 4.6: Genetic circuit variations in the use of fluorescent proteins.
FL denotes the location of the fluorescent protein. Both sender and
receiver circuits were propagated with monomeric fluorescent proteins
(sfGFP and mCherry2). On the left, sender circuits were assembled with
either wild-type (wt), ssrA-tagged sfGFP and ssrA-tagged mCherry2. On
the right panel, receiver devices were assembled with either ssrA-tagged
sfGFP or wild-type mCherry2. S1/S2/S3 and R1/R2 respectively repre-
sent different versions of the sender and receiver devices.
downstream of the PRcI−lux promoter in receiver devices. We compared a set of fluo-
rescent proteins to obtain minimal noise/maximum signal emission in genetic circuits.
Table 4.1 references the proteins we used for respective monomeric/multimeric fluo-
rophores. Individual strain characterisation was mostly followed by the production of
green fluorescence. Red light detection channels were characterised as an alternative
for more complex joint systems (mixed populations of sender and receiver devices).
Our optimised variations of fluorophores were based on the genetic circuits outlined
in Figure 4.6.
In this study, we developed series of genetic variants aimed at sending and detect-
ing/amplifying quorum signals. Optimisation of genetic circuit behaviour depends
over a set of factors. Unless high-throughput studies are endeavoured, considerations
should be taken to rationally restrict the number of combinatorial changes to be carried
out in a single device. This is because as this number of changes increase, the number
of controls required to study these changes goes up too, and this may add a significant
amount of labour to obtain results that may not be concordant with one another. In this
section, we have shown our model and variations of quorum devices. We assembled
these constructs in cloning strains (E. coliDH5α) and later expressed them in wild-type
or tailored strains (BW25113). The next section describes the results that were obtained
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for plasmids characterisation in in vivo studies.
4.3 Single cell and population scale in vivo characterisa-
tion
In this study, we built a series of quorum devices that were tailored to producing a quo-
rum signal, detecting this signal and amplifying it. Here, we describe the main results
that were observed from the construction of genetic circuits detailed in the previous
section.
4.3.1 Production of quorum compound
4.3.1.1 PTET and PBAD promoters
As aforementioned, we tested two genetic contructs for the production of AHL in E.
coli: the PTET and PBAD inducible systems[144]. Tailoring the expression of quorum
signal was coordinated with the emission of green or red fluorescent molecules. There-
fore, we optimised the inducible promoters expression for the highest production of
target molecules by the detection of fluorescence. For the PTET promoter, we tested
a range of promoter strengths and only strong expression of TetR would allow min-
imal levels of background fluorescence in the OFF state of the device. With PBAD,
the pBAD33 plasmid backbone provided by itself minimal leakiness of fluorescence
expression levels. Figure 4.7 shows different basal levels of background fluorescence
observed in the absence of inducer in bacterial cultures. Under the microscope, al-
though PBAD would occasionally show one bright cell, the vast majority of bacteria
kept a homogeneous and low level of background fluorescence. PTET , however, dis-
played a more heterogeneous response in fluorescence levels, varying from cells with
no fluorescence to cells with robust and significant signals. In genetic constructs with
weaker promoters driving the expression of TetR, more background fluorescence was
observed in all cells for the same heterogeneity within bacterial populations. Under
uninduced conditions, we thus report a better signal/noise ratio via the use of the
activable arabinose promoter.
To activate the production of quorum compound, cells were either provided anhydro-
tetracycline (aTc) or L-arabinose, respectively for PTET and PBAD systems. We tested
a range of inducer concentrations and compared bacterial strains in maximal levels of
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FIGURE 4.7: Fluorescence images of uninduced sender genetic circuits.
The Tet repressible promoter basal fluorescence levels for strong TetR ex-
pression are shown in the top panel. Bottom panel shows the arabinose
system behaviour in comparable conditions (absence of inducer) from the
pBAD33 plasmid backbone. Both circuits are shown for the emission of
green fluorescence with 300ms UV exposure.
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FIGURE 4.8: Fluorescence images of induced sender genetic circuits. The
PTET system is displayed at the top, while bottom panel shows the
arabinose-regulated genetic circuits. Both systems were screened for fluo-
rescence emission of the same green fluorophore with 300ms UV exposure.
fluorescence induction by microscopy. As shown in Figure 4.8, both promoters pro-
duced a homogeneous response to external induction. However, we constantly ob-
served the PBAD promoter to display higher fluorescence signals than maximal achiev-
able fluorescence observed with PTET . Therefore, to test whether these differences
wouldn’t be an imaging artefact, we explored higher level characterisation methods to
get a population scale summary of bacterial behaviour.
Analysis via fluorescence microscopy allowed us to perform single-cell resolution
imaging and to retrieve information about fluorescence levels fluctuation within cells.
We used flow cytometry as a complementary approach to represent fluorescence be-
haviour changes at the population scale. Figure 4.9 displays the fluorescence profiles
obtained in uninduced/induced conditions for both PTET and PBAD circuits. For a
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FIGURE 4.9: Sender genetic circuits were characterised via flow cytometry
in uninduced/induced conditions in comparable cell counts. Top panel
images display uninduced sample results, while bottom panel shows in-
duced conditions. PTET data is shown on the left and PBAD on the right.
In all graphs, the y-axis represents a number of cells screened per popula-
tion and the x-axis displays fluorescence fold changes (FL1, blue laser).
comparable amount of uninduced or induced cells and identical equipment parame-
ters, the PBAD promoter always outperformed PTET by producing a higher and more
homogeneous fluorescence intensity signal. All-in-all, with the combination of single
cell imaging and fluorescence cytometry, the arabinose inducible promoter appeared
to provide more robust cellular behaviour than the repressible Tet system, for both
minimising uninduced background noise and optimising fluorescence fold change in
induced conditions.
4.3.1.2 E. coli expression strains
For expression studies, we used E. coli MG1655 and BW25113. Both strains correspond
to common wild-type laboratory E. coli, but BW25113 was built from MG1655 and fea-
tures the knockout of inducible rhamnose and arabinose regulatory pathways (Rha−
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FIGURE 4.10: Flow cytometry results for induction of the sender quorum
circuit prapagated in two strains of E. coli: MG1655 (left) and BW25113
(right). Colored peaks represent the count of individual cells (y-axis) for
certain fluorescence levels (FL1, x-axis). Samples were analysed in the
absence of inducer (no arabinose, top panel) and in the presence of 1%
arabinose (bottom panel) in similar cell counts and in the same equipment
settings.
andAra−)[85]. We used BW25113 for the use of PBAD in sender genetic circuits in order
to reduce the amount of cellular resources using arabinose. Figure 4.10 shows variable
fluorescence responses that were observed for the same genetic circuits propagated
in MG1655 and BW25113. Using flow cytometry, we observed a more homogeneous
fluorescence (width of fluorescence peaks) for genetic constructs in BW25113. This is
concordant with this specific strain genotype, since the inducer molecule is only used
by the synthetic circuit, and not by any other cellular processes.
In a complementary assay, we tested an additional inducer concentration and ob-
served cells growing in exponential phase under a fluorescence microscope for both E.
coli MG1655 and BW25113. We took pictures, averaged data from 100 individual cells
and show differential induction profiles in respective strains in Figure 4.11. Constructs
propagated in E. coli MG1655 could reach slightly higher fluorescence levels but al-
ways showed bigger background fluorescence in uninduced conditions, thus showing
a smaller fluorescence fold change compared to BW25113. In E. coli BW25113, cells
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FIGURE 4.11: Single cell fluorescence intensities for different inducer con-
centrations in E. coli BW25113 and MG1655. Vector corresponds to an
empty pBAD33 plasmid in uninduced conditions. Light grey bars cor-
respond to BW25113 measurements and dark grey bars to MG1655. RFU
represents relative fluorescence units averaged from 100 cells imaged at
OD600nm = 0.4.
displayed a full OFF/ON fluorescence response for various inducer levels. This is con-
cordant with the availability of arabinose in wild-type vs. Ara− conditions. At 0.2%
arabinose in E. coli MG1655, cellular resources compete for inducer molecules: this is
visible by a lower average fluorescence (9, 991 RFU, 9x fold induction) compared to a
25x fold induction (14, 674 RFU) in BW25113 for identical conditions. In order to obtain
repeatable results in a range of conditions, we chose E. coli BW25113 as a model for the
study of sender devices in the PBAD context. This, in particular, was a better choice
to show transfer curves hysteresis in experimental modelling studies discussed in the
next section.
4.3.1.3 Continuous time-lapse of quorum circuit activation
The results described so far were focussed on discrete time points to analyse genetic
circuits by fluorescence. However, we performed an extensive continuous in vivo char-
acterisation of sender devices in automated plate readers (BMG Fluostar and Clariostar
plate readers). This allowed us to gather kinetic information over the state of bacterial
cells. In this setup, we studied cellular response as a function of variable fluorophores.
In all cases, monomeric proteins were preferred as fluorescent reporters rather than
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multimeric proteins. For the simple system of co-transcribing fluorophores with a tar-
get gene, monomeric proteins provide a more homogeneous fluorescent signal at sin-
gle cell resolutions. As a rule of thumb in synthetic biology, green fluorescent proteins
are often chosen instead of their red fluorescent homologues. In Figure 4.12 and 4.13,
we show individual fluorescence induction profiles and their mean/median values for
the emission of mCherry2 coupled with LuxI in panel A. Compared to measurements
obtained with green fluorescence (Figure 4.13), red fluorescence detection provided
much noisier data (Figure 4.12). Figures 4.12 and 4.13 show that AHL sender circuits
had an earlier onset of induction by arabinose when the sfGFP was used as reporter.
Fluorescence was generally detectable from 3h after induction for mCherry2 constructs
compared to 2h for sfGFP devices. This can be explained by different maturation times
of these fluorophores, which delay the onset of fluorescence for longer maturation time
proteins. In terms of stability, green fluorescence again outperformed mCherry expres-
sion because the signal/noise ratio in mCherry constructs significantly varied over
time. This was due to the harder calibration of plate readers for detection of red flu-
orescence, and explained by the kinetic properties of red fluorescent molecules and
sensitivity of the equipment. Although signal quality varied between green and red
fluorophores, synthetic circuits we created always displayed a quantifiable and signif-
icant OFF/ON behaviour for the activation of target molecules production. However,
due to better kinetics observed with green fluorescence, sfGFP was our fluorophore of
choice for further studies.
4.3.1.4 Testing for AHL production
We demonstrated in the previous sections how we could obtain a robust fluorescent
signal coupled to the production of AHL. However, we did not present direct evidence
for production of these chemical species. To verify functionality of sender circuits,
we used an E. coli strain harboring the pSB401 plasmid for detection of LuxI catalytic
activity. This plasmid encodes the native LuxR/LuxI operon from V. fischeri and is
thus an AHL sensor. We first tested for the functionality of this control sensor strain by
external AHL induction. As shown in Figure 4.14, in the absence of AHL, a 5 minute
exposure for detection of bioluminescence from plates did not show any signal for the
pSB401 plasmid alone, and a clear detectable luminescence in the presence of 1mM
AHL. This proved that pSB401 could be used as a control for specific production of
AHL.
In order to assess the capability of our sender genetic circuits to produce AHL, we
cultivated bacterial cultures in the presence of inducer and fed their supernatant to
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FIGURE 4.12: Plate reader assays results for the induction of sender ge-
netic circuits by arabinose over red channel luorescence. In all graphs, the
y-axis represents variation of fluorescence intensity in a range of inducer
concentrations over time (x-axis). On the left, different assays fluorescence
profiles are presented while their average are displayed on the right. The
top right corner graph displays the mean of all fluorescence measurements
while the bottom right corner graph shows median values.
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FIGURE 4.13: Plate reader assays results for the induction of sender ge-
netic circuits by arabinose over green channel luorescence. In all graphs,
the y-axis represents variation of fluorescence intensity in a range of in-
ducer concentrations over time (x-axis). On the left, different assays flu-
orescence profiles are presented while their average are displayed on the
right. The top right corner graph displays the mean of all fluorescence
measurements while the bottom right corner graph shows median values.
FIGURE 4.14: Plasmid pSB401 used as control for specific production of
AHL. No luminescence can be observed for the pSB401 sensor alone (left)
and a robust signal can be detected in the presence of 1mM AHL (right).
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FIGURE 4.15: Bioluminescence induction profiles of pSB401 AHL sensor
strains in the presence of variable levels of induced sender cells super-
natant. The pFU166 plasmid is used as a positive control for constitutive
luminescence expression. Luminescence values are plotted on the y-axis
over time (x-axis).
pSB401 sensor cells. With plate reader assays for the detection of bioluminescence, we
observed variable induction of sensor strains for different volumes of sender super-
natant (Figure 4.15). These results were always compared to basal light levels emitted
by the pFU166 plasmid constitutively expressing the LuxCDABEG operon[248]. For in-
stance, results displayed in Figure 4.15 show that a 1:4000 dilution of the supernatant
of an induced sender cells overnight culture (50µl) allowed to reach relatively high
levels of bioluminescence, thereby production of AHL. For the different sender genetic
circuits engineered in this study, we always verified AHL detection with pSB401 as a
control besides appropriate fluorescence emission.
Here, we described the results obtained for a few variants of a genetic circuit library:
sender devices. We demonstrated their ability to produce a target quorum molecule
(AHL), and optimised their design characteristics based on in vivo measurements. For
best signal emission towards sensor colonies, we used induction of LuxI via the PBAD
promoter coupled with emission of green fluorescence with sfGFP.
4.3.2 Quorum sensing response
As we engineered a sender genetic circuit, we also created receiver devices that de-
tected the presence of quorum sensing compounds. Starting from the native V. fischeri
LuxR/LuxI operon, we optimised the detection of AHL in E. coli using differential
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LuxR regulation and circuits that would only detect, or detect and amplify received
signals.
4.3.2.1 LuxR regulation
In V. fischeri, the PL−lux promoter of the lux operon provides weak LuxR constitutive ex-
pression. However, the binding of LuxR to lux boxes along the operon may reverse the
transcriptional state of this promoter, and it may exhibit leaky opposite direction activ-
ity. Since LuxR is expressed from the complementary DNA strand, we placed a double-
terminator directly downstream of its promoter sequence to reduce background noise
observed in genetic circuits. In continuous plate reader assays, we tested the induction
of the PR−lux promoter by detecting mCherry (replacing the native LuxICDABEG poly-
cistronic mRNA). In Figure 4.16, we observe a strong variation between induction pro-
files of individual experiments and AHL detection could only be reported for 100nM+
inducer concentrations. Although individual profiles showed variable reponse over
different assays, we demonstrated that we could detect environmental levels of AHL
in E. coli for this basic synthetic circuit using red fluorescence.
As we detailed for sender genetic circuits, different fluorophores were tested for
the induction of bacterial response. We have shown previously that a significant signal
was detected with red fluorescence, and attempted to improve this system by using
the sfGFP instead of mCherry. As shown in Figure 4.17, we detected a stronger flu-
orescent response when using sfGFP as a reporter. Besides showing brighter signal,
we also observed, for sfGFP constructs, a more homogeneous signal within bacterial
populations. In induced conditions, mCherry constructs produced an average 85x in-
duction varying from 50x - 500x, whereas sfGFP devices were very centered around
a 200x induction level. These results show that - based on discrete time points - the
sfGFP was brighter and provided a better signal robustness for the detection of AHL.
Reporter devices presented so far were based on the constitutive PL−lux promoter
to drive low expression of LuxR. To improve the AHL detection threshold we obtained
with previous constructs, we upregulated the expression of LuxR and controlled its
appropriate degradation via an ssrA-tag. We tested a range of promoters varying from
low to very high constitutive expression and obtained best fluorescence induction pro-
files for relatively high LuxR levels. Figure 4.18 displays the differential response that
was observed between the use of the native PL−lux and J23104 to drive LuxR expres-
sion. With higher levels of environmental LuxR proteins, we observed fluorescence
induction for a few nanomolars of AHL, making the system 100 times more sensitive
than with the use of the native V. fischeri promoter. The bacterial fluorescent response
108 Chapter 4. Genetic circuits engineering
FIGURE 4.16: Plate reader assays results for the induction of receiver ge-
netic circuits by AHL over red channel channel fluorescence. In all graphs,
the y-axis represents variation of fluorescence intensity in a range of in-
ducer concentrations over time (x-axis). On the left, fluorescence pro-
files of individual assays performed on different days are presented, while
their average are displayed on the right. The top right corner graph dis-
plays the mean of all fluorescence measurements while the bottom right
corner graph shows median values.
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FIGURE 4.17: Flow cytometry results for the induction of receiver quorum
circuits. Colored peaks represent the count of individual cells (y-axis) for
certain fluorescence levels (FL1, x-axis). Samples were analysed in the
absence of inducer (no AHL, top panel) and in the presence of 1mM AHL
(bottom panel) in similar cell counts and system settings.
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FIGURE 4.18: Effect of modifying LuxR regulation over receiver circuits
fluorescence induction. For different AHL concentrations, both graphs
show the induction of a green fluorescence signal (sfGFP, y-axis) over time
(x-axis). In (A) and (C), LuxR is regulated via V. fischeri PL−lux promoter
and in (B) via the strong E. coli J23104 promoter. In (C), LuxI was cotran-
scribed with the fluorophore.
was reduced for stronger constitutive promoters, probably due to a LuxR crowding
effect, where overnumerous LuxR molecules compete for AHL and binding to PR−lux.
For low synthetic LuxR expression, we also observed reduced signals due to a short-
age of LuxR proteins compared to the available inducer. Driven by the expression of
the J23104 promoter, we obtained robust and identical induction profiles for several
inducer dilutions. One induction rate in particular produced a better response than
all higher AHL concentrations, which is the closest to the theoretical PR−lux promoter
KD. Moreover, while it would take about 2h for cells to peak in fluorescence in the
native PL−lux context, J23104 regulation allowed a quasi instant peak of fluorescence
after starting time-lapse experiments. Here, we showed how adjusting cofactor pro-
moter strength provided a greater control over the inducible PR−lux in E. coli. Based
on the optimisation of the response fluorophore and LuxR regulatory mechanism, we
engineered receiver genetic circuits that coordinate a robust emission of fluorescence
when sensing environmental AHL.
In Figure 4.18, we can observe a reduction of the overall fluorescence profile in the
amplifier circuit (C) as opposed to the native V. fischeri context (A). One would natu-
rally expect the opposite situation, where a rise in fluorescence levels should be created
by an autoinduction loop. However, there are a few possible explanations: cells may be
undertaking a certain metabolic load that, over a certain induction threshold, becomes
toxic to bacteria, or the lux promoter may also display some properties such that higher
inducer concentrations become less active at starting transcription (not uncommon for
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FIGURE 4.19: AHL sensor induction by sender genetic devices super-
natant. On the left, receiver cultures were grown after plating 50µl of
uninduced sender circuit supernatant. On the right, the sensor was im-
aged after induction by 50µl of induced sender circuit supernatant.
inducible promoters, as exemplified in Figure 4.13). Finally, it is also worth keeping in
mind that the response detected via these experiments is solely based on fluorescence,
which is only a reporter for the activity of the promoter and an approximation of both
transcription and translation.
4.3.2.2 Induction via sender genetic circuits
As a control for the compatibility of our genetic constructs, we verified that AHL pro-
duced by sender devices could indeed induce fluorescence of sensor strains. In Figure
4.19, we detected the emission of fluorescence of receiver cells via a Typhoon scanner
set in fluorescence settings. Supernatant from uninduced/induced sender cells was
spread on plate over a high cellular density of sensor cells (necessary for the resolution
of this technique). A thin basal level of fluorescence was observed for uninduced sam-
ples, while induction via sender cells supernatant produced a clear saturated signal
over the bacterial lawn. This method had low resolution but allowed us to check the
state of fluorescent cells from plates fairly easily.
For further validation of sender and receiver cells activity, we grouped their cir-
cuits together within the same bacterial strain. For these means, we used different
fluorophores for each circuit (mCherry/sfGFP for sender/receiver cells respectively)
and observed whether induction of AHL production from sender circuits would allow
colocalised receiver plasmids to induce a subsequent response. As shown in Figure
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FIGURE 4.20: E. coli BW25113 was cotransformed with sender and receiver
circuits. Cells were induced by arabinose to produce a red fluorescent sig-
nal and AHL, subsequently used by receiver circuits to report their activity
by green fluorescence. Red channel fluorescence was imaged with 500ms
exposure and green fluorescence at 200ms exposure.
4.20, fluorescence microscopy results always colocalised the expression of green fluo-
rescence (functional receiver circuit) with cells expressing red fluorescence (activated
sender device). Relative variations in sender induction was also observed to differen-
tially induce receiver circuits activity within the same cell. Altogether, these controls
allowed us to match sender and receiver circuits, and to verify that both circuits were
behaving according to their expected behaviour.
4.3.2.3 Detector/amplifier circuits
For the building of receiver genetic devices, we undertook two approaches: (i) mak-
ing sensor-only strains that detect and signal the presence of AHL, and (ii) amplifying
any detected AHL signal. For the latter, we cotranscribed LuxI with the fluorescence
emission unit in order to actively maintain bacterial induction response. In Figure 4.18
A and C, we compared genetic circuits for the same regulation of LuxR (PL−lux ex-
pression) in both conditions. In these settings, coupling of LuxI downstream of the
PR−lux promoter mimics the regulatory situation as it happens in V. fischeri. With the
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FIGURE 4.21: Level of abstraction used to model genetic circuits. Ligands
(red circles) can bind a compound (blue square) on specific binding sites.
For modelling studies, we abstracted a Hill formalism by considering two
states of biological complexes: bound and unbound, dependent over con-
stants k1 and k2.
expression of this additional protein, genetic circuits generally showed a lower maxi-
mum induction level but identical or higher induction for smaller AHL concentration
samples. This is the logical effect created by setting up a feed-forward loop in AHL
sensor devices (cf. Figure 4.2). Therefore, we built two kinds of receiver circuits that
may be used in different biological contexts for intercellular communication between
bacteria. In the next section, we discuss modelling studies that helped us to draw these
conclusions.
4.4 Mathematical modelling
4.4.1 Non-linearity in biology
In cells, molecular interactions have a cooperative effect: the coordinated action of
representative chemical species over a substrate has a larger effect than the sum of
these species only. This process is called non-linearity[171]. In biology, enzymes can
have multiple sites where ligands can bind, and full enzymatic activity can only be
reached when all these allosteric centers are occupied. In theory, one could model ev-
ery individual binding state and characterise this systems intermediate behavioural
changes. However, we do not exert enough control over genetic devices to be able
to measure each condition precisely. Therefore, it is often easier to abstract biolog-
ical complexes as an all-in/all-out situation, as described in Figure 4.21. Here, we
adopted a Hill formalism and chose to group all "unknown" biochemical reactions (e.g.
transcription/translation intermediate steps) under non-linear terms of mathematical
equations.
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4.4.2 Modelling via the Hill equation
For the study of our genetic devices, we were interested in the production of specific
output molecules (fluorophores). We abstracted circuits transcriptional and transla-
tional regulation and derived quantities of signal (S) over time by the equation:
dS
dt
=
Kni
Kni + L
n
whereLn is a ligand concentration andKi the inhibition constant between the molecule
of interest and its ligand. In the Hill formalism, n represents the non-linearity term
that explains underlying molecular processes abstracted in the model. This equation
is often used to model the behaviour of promoters, where the RNAp competes with
additional factors to start transcription. In this kind of kinetic processes, we model
by the equation C + L ⇀↽ CL the coupling of a compound C (RNAp) to its binding
molecule L (ligand). Compounds thereby have two states: bound and unbound. At
any time, the amount of available compound is equal to the ratio between the unbound
compound and the overall number of chemical species it is involved with:
Cavailable =
C
C + CL
The amount of bound compound CL is suject to fluctuate over time, given different
ligand concentrations and its reversible state into individual subunits. It is thus com-
mon to use a dissociation constant that represents the rate at which CL complexes
break down into separate chemical complexes (as it happens in cells). Therefore, in a
steady-state system, we can transform the previous equation into the following:
C
C + CL
=
C
C + C∗L
KD
=
KD
KD + L
where KD is the dissociation constant between polymerase and inhibitor complexes
(AraC or TetR cofactors). The term KD
KD+L
is the simplest case of Hill equation with
n = 1 and Ki = KD. Here, only one molecule of ligand can bind to the polymerase and
affect its state at a given rate. However, as we described in previous sections, there are
several cofactors that affect the production of a target molecule in biological systems,
not a transcription rate only. This is represented by an added complexity for molecules
production with a Hill coefficient (or cooperativity) index n > 1. This allows us to
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revise a basic biochemical reaction description to:
nC + L ⇀↽ CLn
and implies changing the subsequent equation as:
C
C + CLn
=
C
C + C∗L
n
KD
=
KD
KD + Ln
To comply with dS
dt
=
Kni
Kni +L
n , the condition Ki = n
√
KD must be observed. Related to
the dissociation constant of a certain ligands,Ki is also referred to as the inhibition con-
stant that describes half of a target enzyme activity. Such Hill formalism is commonly
used for the modelling of biological species. Overall, it makes it easy to derive precise
chemical parameters and to observe any strong variations between experimental data
and simulated models.
4.4.3 Data normalisation
We generated time-continuous data with plate reader assays to follow the activation
of fluorescent molecules. As shown in the previous section, this resulted in sigmoid
curves representing the change in bacterial behaviour and fluorescence profiles (Fig-
ures 4.12, 4.13 and 4.16). For each analysed genetic construct, we gathered data from
at least 3 individual plate reader experiments, where bacteria were followed in tripli-
cates over a range from 8 to 11 inducer concentrations simultaneously. First, all sam-
ples were checked for normal growth profile, information provided by optical den-
sity measurements taken every 6 minutes. Any persistent growth defects over repli-
cation of the experiment would be sign of poor biological fitness due to the genetic
circuit. If all growth profiles appeared as standard curves (cf. Figure 3.11), fluores-
cence data was then normalised by substracting the blank medium fluorescence from
the observed signal (background noise) and normalised by uninduced samples to ob-
tain fold inductions. By applying this protocol over a set of biological replicates, we
averaged experimental data and used non-linear regression with our Hill model to
generate model fitting curves. These curves, by their proximity to experimental data,
defined the goodness of the model. Directly inferred from fitting curves, we extracted
residuals (closeness to experimental data) and plotted these over time to visually and
numerically assess a model goodness.
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4.4.4 Quorum sender devices modelling
When the model cannot be fit to experimental data, there are two potential solutions:
revising the theoretical model or the genetic device. The most common approach is
to modify genetic sequences, since theoretical models are meant to translate a "per-
fect" scenario of biological behaviour, thus the objective to reach. Within our library
of genetic devices, our first constructs provided bad fit of the model to experimental
data. This was shown in the development of the first version of our sender genetic
device in Figure 4.22 S2L. This circuit encoded LuxI and mCherry under the control
of the pBAD promoter on a low copy-number plasmid. As we demonstrated the opti-
misation of biological circuits with the use of alternative fluorophores and regulatory
mechanisms, modelling results significantly improved by reducing distance from the
theoretical model to experimental results to a minimum (low sum of residuals). As
seen in Figure 4.22, the difference between red and green fluorescence (S2/S3) pro-
vided an attractive target to improve signal quality. For red fluorescence studies with
mCherry, the signal:noise ratio was much higher than with green fluorescence pro-
teins. Therefore, this created constant variations in signal levels and made the mod-
elling process more challenging. Green fluorescent sfGFP exhibited very good kinetics
(up to 500x fold induction compared to 8x for mCherry) and thus provided a better fit
to the model. Expressing circuits from higher copy-number plasmids was also shown
to optimise the genetic models behaviour: providing higher expression levels allowed
reduction in the signal:noise ratio. Therefore, based on the knowledge gained from en-
gineering quorum sender units, we optimised sensor strains with sfGFP as a biological
reporter.
4.4.5 Sensor strains modelling
For the modelling of AHL sensor strains, two types of genetic circuits were developed:
basic AHL detectors and AHL amplifiers. Both were described by the same model and
are summarised in Figure 4.23. Four AHL receiver constructs were compared based on
two different regulatory mechanisms of LuxR: native (PL−lux controlled) or optimised
conditions (strong promoter/degradation tag). These are respectively displayed in Fig-
ure 4.23 left-/right-hand side panels. For all of these constructs, the model provided
a very good fit to the experimental data and allowed us to assess which versions per-
formed better than others. However, the same genetic devices set on low copy number
backbones provided much noisier signals. We thus decided to stick with higher copy
number plasmids as long as there was no cytotoxicity problems. In the next section,
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TABLE 4.2: Mathematical model fitting to individual sender and receiver
strains fluorescence induction profiles. Strain represents each individual
construct that was tested: S2L corresponds to the mCherry reporter pro-
tein on a low copy-number plasmid. All other constructs show relative
fluorescence units (RFU) over time for sfGFP reporters. S3L is the sender
device on a low copy-number plasmid while S3H has the same circuits
on a high-copy number plasmid backbone. R75 and R114 are basic re-
ceiver devices with weak or strong constitutive expression of LuxR. R104
and R120 respectively represent R75 and R114 with LuxI inserted on the
reporter mRNA, making it an AHL amplifier. Fluorescence fit (n) shows
how well a Hill model fits average induction by its inducer. Transfer (n)
is the cooperativity index of a Hill function that was used to characterise
genetic circuit transfer functions. Significance values were obtained from
nonlinear regression: ∗ = 10−01, ∗∗ < 10−02, ∗∗∗ < 10−03.
Strain Reporter Copy-number Fluo. fit (n)∗ Transfer (n)∗ KD
S2L PBAD-LuxI-mCherry Low 2.383∗∗∗ 14.419∗∗∗ 7.034× 10−4
S2H PBAD-LuxI-mCherry High 3.377∗∗∗ 15.296∗∗∗ 7.034× 10−4
S3L PBAD-LuxI-sfGFP Low 2.688∗∗∗ 7.819∗∗∗ 6.161× 10−5
S3H PBAD-LuxI-sfGFP High 3.498∗∗∗ 10.225∗∗∗ 7.369× 10−5
R75 PL-luxR/PR-sfGFP High 3.258∗∗∗ 12.765∗∗∗ 5.228× 10−7
R104 PL-luxR/PR-LuxI-sfGFP High 3.695∗∗∗ 12.067∗∗∗ 4.691× 10−7
R114 J23104-luxR/PR-sfGFP High 4.088∗∗∗ 16.780∗∗ 6.436× 10−9
R120 J23104-luxR/PR-LuxI-sfGFP High 3.820∗∗∗ 13.189∗∗∗ 1.093× 10−7
we provide an overview of the aforementioned genetic circuits, given modelling re-
sults that helped to optimise genetic designs.
4.4.6 Transfer function modelling
Given dose-response curves, it is possible to derive system transfer functions that char-
acterise their transition from inactive to active states (or the opposite). For the mod-
elling of biological complexes, we characterised transfer functions for the production
of AHL in sender genetic circuits, and for detection of quorum molecule in sensor de-
vices. Table 4.2 summarises modelling characteristics of the different genetic devices
presented thus far. The transfer function was based upon discrete induction points of
continuous experimental data (after 10h of culture), and was used to deduct respective
dissociation constants (KD). The same Hill function as the one used in previous subsec-
tions was employed to obtain transfer functions. For sender devices, the change from
red to green fluorescence protein improved the arabinose detection threshold 10 fold.
As for sensor circuits, strong expression/regulation of LuxR was shown to be the best
combination to obtain lower AHL detection thesholds. In Figures 4.24 and 4.25, we
show the transfer function curves that were obtained for a set of sender/receiver ge-
netic circuits respectively. A better fit was generally observed for higher copy number
4.4. Mathematical modelling 119
FI
G
U
R
E
4.
23
:
R
ec
ei
ve
r
ge
ne
ti
c
ci
rc
ui
ts
m
od
el
lin
g
re
su
lt
s.
R
75
an
d
R
10
4
st
an
d
fo
r
se
ns
or
de
vi
ce
s
un
de
r
th
e
co
nt
ro
l
of
th
e
lu
x
pr
om
ot
er
.
R
11
4
an
d
R
12
0
re
pr
es
en
t
th
e
sa
m
e
ci
rc
ui
ts
w
it
h
Lu
xR
un
de
r
th
e
co
nt
ro
l
of
th
e
st
ro
ng
J2
31
04
pr
om
ot
er
.
R
75
an
d
R
11
4
ar
e
A
H
L
se
ns
or
on
ly
st
ra
in
s,
w
hi
le
R
10
4
an
d
R
12
0
am
pl
if
y
de
te
ct
ed
si
gn
al
s
w
it
h
Lu
xI
.
To
p
ro
w
di
sp
la
ys
av
er
ag
ed
flu
or
es
ce
nc
e
da
ta
(y
-a
xi
s)
ov
er
ti
m
e
(x
-a
xi
s)
fo
r
th
e
fo
ur
di
ff
er
en
t
ci
rc
ui
ts
.
Fo
r
ea
ch
of
th
e
ge
ne
ti
c
ci
rc
ui
ts
,t
he
m
id
dl
e
ro
w
de
sc
ri
be
s
a
sp
ec
ifi
c
(m
ax
im
um
)
in
du
ct
io
n
pr
ofi
le
(b
la
ck
lin
e)
an
d
it
s
fit
to
th
e
m
at
he
m
at
ic
al
m
od
el
(r
ed
lin
e)
.
Bo
tt
om
ro
w
sh
ow
s
re
si
du
al
s
of
th
e
m
od
el
(d
is
ta
nc
e
be
tw
ee
n
m
od
el
an
d
da
ta
)
ov
er
ti
m
e.
Pe
rf
ec
tfi
ti
s
sh
ow
n
as
a
do
tt
ed
ho
ri
zo
nt
al
re
d
lin
e.
Er
ro
r
ba
rs
sh
ow
st
an
da
rd
de
vi
at
io
n
ac
ro
ss
sa
m
pl
es
.
120 Chapter 4. Genetic circuits engineering
plasmids and modelling fluorescence induction profiles allowed us to revise genetic
designs to gain control over expected and experimental behaviour.
4.4.7 Optimised bioengineered circuits
As shown in previous sections, we optimised the design of genetic circuits in order to
show a better fit to our theoretical model. For the different AHL sender/sensor strains,
we show the average fold induction they displayed in vivo under induced conditions
in Figure 4.26. In the sender devices, we demonstrated that sfGFP was a better re-
porter protein than mCherry (S2L/S2H vs. S3L/S3H). We also constantly observed
a better signal in high copy number settings for the same fluorophore (S2L/S2H and
S3L/S3H). As shown in Figure 4.22, there was a significant variation in induction pro-
files from experiment to experiment, and changing fluorophore appeared to be the
most straightforward solution to tackle this problem. The issue of getting poor sig-
nal/noise ratio with red fluorescence partly rises from the fact that the plate reader
equipment used in this thesis did not have great capabilities for handling red fluores-
cence emission/detection: this was performed over a spectrum that did not fully over-
lap with the one of the mCherry, thereby producing noisier output data. For sensor
circuits, amplification of AHL response always slightly decreased the observed signal,
likely due to the metabolic load applied by coexpressing LuxI along sfGFP. Lower copy
number versions of these circuits are not shown on this graph but averaged maximum
fold induction profiles of 10x, comparable to the mCherry sender model on low copy
plasmid. Overall, we showed for the optimised AHL sender/detector/amplifier cir-
cuits an average cellular response characterised by a≥ 100 fold induction of fluorescent
signals.
All-in-all, we constructed a series of genetic devices, characterised them in vivo and
simulated their fitness with the theoretical model. A cyclic process of optimisation
was carried out to improve the fit between model and experimental data, and our two
best circuit candidates for AHL production/detection were respectively summarised
in Figure 4.27. The most efficient AHL production device was based on the arabinose
inducible promoter with coexpression of LuxI and sfGFP, both with degradation tags.
This circuit displayed a dissociation constant of KD = 49nM arabinose. The best re-
ceiver plasmid was a simple detector (no amplification of AHL) with strong expression
of ssrA-tagged LuxR controlling sfGFP production upon binding of AHL. This device
allowed us to reach a detection threshold KD = 6.1nM AHL, about one or two orders
of magnitude below most receiver versions. In the final section of this chapter, we
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FIGURE 4.26: Fluorescence fold change in different genetic constructs:
AHL sensor (R75/R104/R114/R120) and sender (S2L/S2H/S3L/S3H)
strains. Data is normalised by uninduced samples and corrected for
growth medium background. The y-axis shows relative fluorescent units
(RFU) fold changes in fluorescence.
provide an overview of the setup of genetic circuits and their in vivo/in silico character-
isation methods.
4.5 Summary
Genetic engineering is a complex process that involves altering biological units to ob-
serve a physiological change in living organisms. Here, we describe the cyclic opti-
misation of genetic devices to obtain robust and well-characterised circuits. We con-
structed biological devices based on quorum communication: sender circuits were set
to produce a certain compound (AHL) remotelly detected or amplified by sensor units.
In this study, we built a documented library of genetic constructs and demonstrated
best model features by comparing experimental resources with modelling data. For the
development of our barcoding platform, these characterisation studies led to a thor-
ough documentation of biological circuits, and were the first parts of the Bac2code
biorepository. In the next chapter, we detail the fabrication of high-throughput mi-
crofluidics biochips for characterisation of genetic libraries. We further describe in
124 Chapter 4. Genetic circuits engineering
FIGURE 4.27: Optimised genetic circuits for production (top) and detec-
tion (bottom) of AHL. Top panel (A) describes the best sender circuit (pro-
duction of AHL under PBAD regulation) and bottom panel (B) the best
receiver device (LuxR under the control of J23104). First column displays
average experimental data, the second shows the fitting curve to maci-
mum induction profile and the third column represents the model residu-
als.
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Chapter 6 how the setup of a genetic library - together with a microfluidics platform -
may be integrated into a barcoding or screening platform.
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Chapter 5
The making of microfluidics devices for
bacterial screening
In this chapter, the work presented for the channel-type biochips was based on a silicon
wafer that was designed by Dr. Sunny Park.
5.1 Introduction to microfluidics studies
Modern technologies allow for the casting of specific microfeatures onto a range of
templates. Arguably, one of the most famous fabrication methods is 3D-printing[7,
36, 36, 119]. This kind of technique has been proved successful at creating microenvi-
ronments suitable for bacterial growth, but the resolution of current equipment rarely
goes under the 100µm order of magnitude. Since E. coli cells average a diameter of 1µm
and a length of 2−5µm, the study of specific bacterial communities needs a higher res-
olution, which is achievable by microfluidics. In fact, the production of microfluidics
is analogous to "reverse 3D-printing": instead of polymerising material, microfluidics
templates are often made by etching chemical layers over a silicon surface. Whilst 3D-
printing involves polymerising material onto a template, the process of photolithogra-
phy used to create microfluidics templates usually makes patterns in the opposite ori-
entation of the ones generated via 3D-printing. This provides several advantages based
on accuracy and reproducibility of higher resolution features. Also, silicon wafers used
for microfluidics design printing are routinely used in microelectronics, which makes
them well-studied and reliable materials. In this study, we designed and fabricated
PDMS microfluidics chips to exhibit series of micron-/submicron-size features suit-
able for bacterial growth. Here, we introduce specific notions that drove the design
process of polymer biochips.
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5.1.1 The use of microfluidics chips with bacteria
The use of microfluidics chips for the study of bacteria allows the programming of
dynamic functions, just as bacteria can be engineered with genetic devices. A system
of interconnected channels dictates fluid direction within a microcircuit in which bac-
teria multiply[223, 65]. Chambers exhibiting micron-scale features usually trap cells
and render time-lapse observations possible in a set of confined compartments. Mi-
crofluidics chips are connected to a wiring system ensuring continuous input of fresh
nutrients and output of waste products; in general, this manifold is linked to devices
that exert an external control over fluids flow (syringes and pumps). This external
control allows for the fine-tuning of environmental conditions in order to adjust phys-
ical forces and differential input effects over bacteria. Altogether, this well-controlled
environment makes the in vitro tracking of cells possible and provides a single-cell
resolution solution to the study of particular bacterial behaviour[72, 110]. In particu-
lar, biologically engineered cells can be tracked via an automated imaging system that
renders reconstitution of discrete cellular events over a continuous scale feasible, and
provides a better understanding of cellular physiology.
5.1.2 Small world effect
Due to tiny dimensions, microfluidics use very little medium and generate an equally
low volume of waste. For instance, compared to large scale chemostats that require
litres of sterile medium, microfluidics only use a few millilitres which is sufficient to
test one sample over several hours. Since the dimensions of chips are so small, it is easy
to engineer devices with combinatorial versions of a design and, therefore, to be able
to capture tens of different conditions at once[211]. In particular for biological studies,
the ability to reproduce experiments over a number of iterations is essential to draw
meaningful conclusions. Although microfluidics do not directly solve the problem of
replication of experiments, they tackle it by providing the possibility to set series of
design variations and repetitions, all observable at the same time in the same biolog-
ical context. This adds to the statistical significance of studies, where representative
data can be averaged from a large pool of samples. Thus, small dimensions in the
microfluidics world - even if they affect the laws of physics - should be considered as
an asset to ease technical and biological replication. However, even if microfluidics
experiments are cheap and repeatable, the process of making specific biochips may
sometimes involve considerable labour.
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5.1.3 PDMS substrates
For the setup of microfluidics chips, we chose to use PDMS as a substrate over agarose
in order to obtain higher resolution, more stable features[214]. PDMS has very advan-
tageous properties that make it a polymer of choice for replication of small template
features[142, 151]. It is a highly viscuous compound with good flexibility - that makes
it easy to work with - and exhibits unique physico-chemical properties (stable and bi-
ologically inert). At room temperature, PDMS is a gas-permeable transparent material
that provides a good support for microscopy studies involving fluorescence measure-
ments and direct observation of cells. While it prevents water-based solutions from
leaking due to its high hydrophobicity, PDMS is also a porous medium that gases can
easily permeate. In the context of fluorescence bacterial studies in particular, it is ben-
eficial to provide enough oxygen for efficient protein folding[190]. After fabrication,
PDMS substrates can be plasma activated and surface silicon groups bonded to oxygen
atoms[101]. By applying the same treatment to borosilicate glass coverslips, this pro-
vides the ability to form a strong chemical bridge between both substrates and results
in creating sterile microdevices ready for experimentation.
5.1.4 Scaling up bacterial screening
For the screening of bacterial libraries, microfluidics can adapt high-throughput de-
signs to allow combinatorial in vivo studies. In the context of fluorescence microscopy,
it is better to grow single layers of cells to obtain higher resolution over large fields
of view. In practice, this was accomplished by hindering E. coli within a 1µm height
surface area. By reducing the possibility of vertical stacking of cells, bacteria could
be studied in single cell or small community contexts and followed over time-course
experiments.
We have shown in Chapter 4 the possibility of wiring bacteria through certain
chemical inducers. We postulated that these may be characterised in high-throughput
microfluidics settings and fabricated polymer biochips to detect signal transduction
via intercellular communication[177]. As shown in Figure 5.1, small bacterial commu-
nities may be wired and respond to chemical stimuli[223]. For the physical setup of
bacteria in microfluidics, we engineered observation chambers that connect two po-
tentially interacting colonies over variable distances. For each design, we replicated a
range of conditions in which cells may show differential behaviour due to a change in
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FIGURE 5.1: Schematics of communicating microcolonies of bacteria. Each
colony carries a specific genetic circuit aimed at producing or sensing a
quorum molecule (AHL, small triangles between red cells from different
colonies) over a certain distance (d).
inducer concentration. Technically, over distances ranging from 1µm to 100µm, we fab-
ricated PDMS chips to study communication between microorganisms, allowing very
small size colonies (1− 200 cells) to be observed in continuous time.
5.2 Design of biochips
In the bacterial world, cell behaviour and timing of replication are often dictated by
the availability of fresh nutrients. Standard bacterial cultures are usually grown in
flasks and always reach a phase of saturation when left for a long enough time. How-
ever, chemostats can be used to sustain continuous bacterial growth with a constant
input/output flow. Microfluidics are a micro-alternative to chemostats: in fact, mi-
crofluidics chips developed for use in biology are chemostats. They simply follow the
same principles, but in a much more confined space[199, 65, 17, 199]. Due to the micro-
scopic size of microfluidics, this small space affects the laws of physics that rule fluid
dynamics behaviour. As shown in Figure 5.2, fluids in microfluidics behave more like
a river in which particles in water would not mix (with a low Reynolds number)[114].
The Reynolds number is defined as:
Re =
σUL
µ
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FIGURE 5.2: A reynolds number provides the ratio of inertial forces over
viscosity in fluids. Fluid dynamics change and become turbulent for high
reynolds numbers while low numbers are associated with an undisturbed
laminar flow.
with µ the molecular viscosity, σ the fluid density, U its velocity and L the length scale.
It corresponds to the ratio of inertial vs. viscuous forces, and as the scale L changes,
characteristic Reynolds numbers can jump by orders of magnitude. For instance, the
Reynolds number for water in standard microfluidics size channels is 10−2, which is
three orders of magnitude below the flow water would have in a river. This is due
to a higher impact of fluid viscosity over inertia, which results in making mixing in
microfluidics a tedious process[235]. Understanding the physics of microfluidics is
therefore important to ensure the successful creation of chips[196]. Although the rules
of fluid dynamics vary at the microscale, overall, they form an asset to predict the path
of particles in space and time.
5.2.1 Photolithography considerations
We fabricated microfluidics devices from silicon wafer templates produced via soft-
photolithography[151]. We casted negatively-printed circuits onto hard-PDMS and
transferred the pattern onto soft-PDMS, single-use biochips (cf. protocols in Append-
inx D). The circuits reproduced from silicon wafers in PDMS were first imprinted by
etching different resins on template materials. In photolithography, a resin is evenly
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FIGURE 5.3: Redundant mask alignment pattern for the construction of
multiple depths on silicon wafers. Each colour represents a specific depth
layer.
coated onto a substrate and different masks are aligned to etch microstructures in-
tended from the design. For each depth level of the design, an additional mask is
necessary to build specific features. The outlook of a specific wafer is always subject
to the photoprinting company manufacturing it. In our study, we delegated to two
Newcastle-based companies the production of 6 inch diameter silicon wafers with mi-
crofluidics imprints. In order to align the different masks and to produce the intended
structures, each wafer contained redundant features aimed at focusing a mask aligner
for photopolymerisation or etching. Such features are shown in Figure 5.3, where each
layer can be aligned via overlapping and unique features between depth levels. After
correct alignment, each depth level is created successively starting with the thinnest
and ending with the thicker layers. Altogether, this procedure resulted in the produc-
tion of three individual wafers including 33 biochips of interest to this study.
Microfluidics structures were imprinted in negative onto silicon wafers. In Figure
5.4, we review the main differences in the design of microfluidics chips for bacterial
intercellular communication. Since photolithography etches specific resins down to
different depths, there were two possibilities to offer a communication surface area
between distal bacterial colonies. This was achieved by either making a sub-micron
size channel (0.7µm width/depth) or a thin surface area (200nm depth) between com-
municating bacteria. In the following, we refer to these models of chips respectively
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FIGURE 5.4: Considerations for the design and fabrication of microfluidics
chips. (A) Top view of bacterial traps as circular or rectangular shapes in
respectively channel- and surface-type chips, (B) corresponding aperture
from traps to flow channels, (C) CAD design of microfeatures and (D)
photolithography process overview.
by channel and surface chips. Both models were produced on different silicon wafers
and compared based on cellular traps ease-of-access and their reliability for bacterial
culture. As shown in Figure 5.4 A and B, observation chambers were subject to two
distinct types of design that had a differential impact over input/output of cells from
bacterial traps. General biochip CAD designs are displayed in Figure 5.4C, while the
top chip masks/layers used for photopolymerisation/chemical etching of the silicon
wafer are streamlined in panel D. To create this particular chip, silicon (Si), silicon ox-
ide (SiO2) and silicon nitride (SiN4) resins were coated onto an SU-8 layer and etched
in multiple steps via three different masks. Since chemical etching was orthogonal be-
tween the three resin substrates, we could ensure relative dimensions intended in the
multilayer device would be respected. We compared the design methods of channel
and surface biochips for the setup of high-throughput bacterial screening in microflu-
idics, and we optimised PDMS chips fabrication protocols (cf. Appendix D) for ex-
tremely small features reproduction. In the next sections, we describe the fabrication
and main features of microfluidics devices that were created in this study.
5.2.2 Microfluidics chip compartments
Fabricating microfluidics chips is a multi-step process that allows the production of
cheap and reproducible microdevices. Micrometre scale features are printed on a pho-
toresist, which is in turn used to mould structures and shapes on a hard substance
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FIGURE 5.5: A master wafer is first manufactured by photolithography
and contains specific microfluidics patterns to be cast onto PDMS. In or-
der to obtain the same pattern orientation, we first generated an inter-
mediate mould made of hybrid hard-/soft-PDMS. This intermediate was
then used for the casting of final single-use biochips.
(usually agarose or polydimethylsiloxane (PDMS))[157, 92, 249]. The hard substance
covers the entirety of a given microfluidics design of channels and chambers, and seals
structures as a mirrored imprint. Depending on the negative or positive orientation of
features present on the first polymer, it is sometimes necessary to reproduce the design
on a second hard substance mould to obtain usable devices. As shown in Figure 5.5, in
this study, we built sub-micron scale features that needed to be first imprinted in neg-
ative due to size and precision limitations of their manufacturing process. Therefore,
a two-step process was necessary: first, a reusable intermediary mould was produced
which then was used as template for the making of single-use individual chips.
5.2.2.1 Physical considerations associated with PDMS structures
Very small structures are rendered best with PDMS[92]. While agarose chips are easier
to make, they degrade faster and are not particularly suitable for small design fea-
tures. PDMS is a hard polymer that can support high height:ceiling length ratios and
provides an improved rigidity necessary for small structures to hold[65]. Generally, if
the design for observation of bacterial cells is intended to comply with 1D-/2D-growth
(in a line or a plan, respectively), it is recommended to keep chambers between 1 and
1.5 times the diameter of bacteria. For work in E. coli, rod-shaped cells are usually
immobilised by a ceiling height of 1µm. Smaller ceiling heights may not be able to
trap cells while larger heights can allow for stacking of cells (3D-growth), and render
single-cell measurements more challenging.
5.2. Design of biochips 135
5.2.2.2 Observation chambers
In a microfluidics device, due to space restrictions and flow control, bacteria move
quickly. Since we aim to characterise single-cell or small population scale events, it is
necessary to provide windows in biochips, where cells can be fixed by a lower ceiling
height[65]. These observation chambers, or traps, immobilise bacteria and allow time-
lapse observation of their growth. Besides averaging a correct height for cellular immo-
bilisation, traps should also provide a suitable interface for bacterial growth[220]. This
implies that chambers should display a wide enough aperture to capture cells flowing
in high-speed channels and enough fresh medium, but also that this aperture should be
relatively small to limit bacteria from exiting the trap. When a chamber is full of cells,
the design should account for a way to discard cells and to keep the system growing
as a continuous culture. This is generally done via the same aperture as the one cells
use to enter the trap, which implies that nearby high-speed channels should provide a
waste removal possibility. While this approach suits best 1D-/2D-growth, 3D-growth
often requires bigger apertures (causing higher fluid velocity) that rise the need for al-
ternative chamber exits. One-dimensional growth consists of a growing line of cells.
However, two-dimensional growth aims to cultivate cells on a planar surface, and this
has to account for a specific geometry that complies with bacterial growth character-
istics[231]. As shown in Figure 5.6, E. coli cells show a self-organisation pattern when
reaching higher cellular densities in a 2D-growth space. This natural phenomenon
usually simplifies time-lapse tracking of bacteria and eases post-experimental image
processing. Altogether, a thoroughly planned and rational design of chambers should
allow the observation and tracking of single-cell resolution events on arrays of micro-
scopic chemostats.
5.2.2.3 Channels
In order to build a chemostat, any circuit needs to be closed and under constant pres-
sure to ensure stable continuous culture. This is achieved by connecting growth cham-
bers to higher-speed flow channels that: (i) provide an input/output interface to traps
and (ii) wire microfluidics chips to external flow control equipment (syringes, pumps,
waste)[65]. In general for E. coli studies, a good working depth is about 10µm. If
cells are to be studied in a two-dimension context, this exhibits a 10 : 1 ratio between
channel height and observation chambers, which fits the requirements of PDMS prod-
ucts[65]. The minimal achievable microfluidics circuit involves a single input/output
system, where two individual wires need to provide an input flow (first wire con-
nected to an input syringe), which is in turn propagated through the chip channels
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FIGURE 5.6: E. coli growth was observed from low to high cell densities at
three time points (after 60min, 90min and 138min of growth) and showed
robust cellular self-organisation. Adapted from [231]
and chambers, and exits the circuit via an outlet (second wire collecting used samples).
More complex wiring may be designed to allow the mixing of multiple input/output
systems, but these should be carefully planned and verified by fluid dynamics sim-
ulation to obtain parameters that would allow harmonious input/output flow rates.
In general, microfluidics channels are connected to external equipment by a physical
hole punched into the microfluidics chips before being bonded to a glass coverslip. Us-
ing a hypodermic needle of a slightly larger diameter than the one used to punch the
chip is a cheap alternative to seal biochips to input/output ports[154]. Microfluidics
channels are usually visible to the naked eye but the chamber system may be indistin-
guishable. Therefore, ports that connect the chip to external needle/tubing system are
normally designed as larger features (1− 3mm), with a recognisable pattern. Punching
holes in PDMS is thus streamlined by the presence of these specific structures. Once a
chip is bonded to a coverslip after plasma activation (necessary to bond two surfaces
together), connecting inlet/outlet tubing via needles to its ports starts the chemostat,
and then samples can be set for imaging.
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FIGURE 5.7: For a given chip design, (A) nodal analysis describes flow di-
rections and pressure drops, (B) finite element methods provide finer fluid
dynamics methodologies including (C) variable flow regimes in cross-
sections. Adapted from [65]
5.2.3 Fluid dynamics
For any microfluidics design, we recommend running at least one modelling tool to
predict the fluid dynamics of the circuit. This allows prediction of the behaviour of
fluids and the spotting of any design errors. Two approaches are used for modelling
this process: a simple node analysis or a more complex finite state elements method[65,
60]. Although the latter provides better visuals for flow simulation (Figure 5.7), it
requires a software license and specific modules to run. Alternatively, OpenFOAM is
a free software that can also solve fluid dynamic problems[243].
5.2.3.1 Node analysis
In fluid analysis, one method is to abstract segments of continuous channels as pipes,
and junctions between channels as pressure drops. By design and according to the
law of mass conservation, microfluidics circuits have an input/output system. For
whatever volume of fluid there is to enter the chip, the same volume of fluid needs to
be extracted from it by an outlet system[65, 18]. In node analysis, nodes (or junctions
between channels) are characterised as a system where the node can only handle a
certain amount of fluid at a given time.
The aim of this analysis is to check that design features are rational. Should they
not be, results from this analysis would indicate faulty junctions that fail to provide
viable input/output rates. Overall, node analysis is a straightforward method to ver-
ify microfluidics designs feasibility, and can be achieved relatively easily via a set of
free/commercial existing tools (R, Matlab or specialised apps).
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5.2.3.2 Finite element modelling
Methods of modelling exist to assess dynamic properties of microfluidics systems[261,
60]. However, these are a combination of complex algorithms and are mostly registered
with specialist companies. The most common one offering these methods with tailored
algorithms for microfuidics is Comsol. Even with the use of Comsol, for a better com-
patibility, microfluidics chip designs should always be exported as computer-aided
design files (.cad, or CAD files). Different encoding formats exist for the description of
design files but the CAD system is one of the few universally recognised. Specialised
software such as AutoCAD or L-Edit can be used to design and to export models for
such purposes.
In finite element modelling, a mesh is first created throughout the microfluidics cir-
cuit. Given determined input and output parameters, the software runs fluids through
the chip and their dynamics are simulated in order to predict any undesirable be-
haviour in the channelling system. As an additional feature, diffusion processes can
also be modelled and used to predict the behaviour of certain species of interest. In
bacterial signalling, it is essential to verify that metabolites used as signals go where
they should.
5.2.4 The making of biochips
Two types of polymer biochips were made in this study. Due to design restrictions
given photolithography techniques, microfluidics circuits were negatively printed on
SU-8 photoresists. It means that photoresists first needed to be mirrored into a positive
and hard-PDMS pattern (master template), that could then be used for production of
single-use soft-PDMS chips in series (cf. Figure 5.5). The photoresist manufacturing
process was delegated to specialised companies: either INEX in Newcastle (UK) for the
surface-type biochips, or a company based in Belgium for the channel-type biochips
(name undisclosed). The subsequent steps of making chips were carried out by myself,
and protocols on how to proceed can be found in Appendix D. In the next sections, we
characterise the two main types of biochips and discuss their use with bacteria.
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5.3 Channel-type chips
5.3.1 Design
The first type of microfluidics biochips we tested was developed by Dr Sunny Park.
From a silicon wafer carrying specific design features, we replicated the circuit into
PDMS substrates and used these in a cellular context. This design contained features
that are represented and simplified in Figure 5.8. Two bacterial strains may be stud-
ied in proximity from one another by feeding individual flow channels with respec-
tive bacteria. Cells were trapped in circular observation chambers and communicated
via a 0.7µm diameter channel that allowed diffusion of cellular compounds between
colonies such as inducers. The distance that separated microcolonies was invariant,
but the number of colonies placed either side of the diffusion channel could fluctuate
(cf. Figure 5.8).
5.3.1.1 Cellular flow
Under steady-state conditions, as per design, cells should grow in a single plan and
achieve intercellular communication via diffusion channels. As we demonstrated in
Chapter 4, the activation of genetic circuits can trigger physiological changes, observ-
able at a single-cell level via fluorescence microscopy. In order to analyse differential
communication behaviour in cells, we studied microcolonies of variable size undergo-
ing the same physiological changes simultaneously. As shown in Figure 5.8, colony
sizes may vary from a single cell (1µm width channel, similar to a mother machine
device[233]) up to tens of bacteria (40µm diameter circular trap). In these settings,
variable activation of a second distal bacterial colony could be compared in high-
throughput settings.
5.3.1.2 Unique identifiers
The identifiers used for channel-type biochips were designed by Dr. Sunny Park.
Combinatorial studies provide a strong advantage to analyse quantities of biological
replicates in parallel. However, the data obtained from such experiments needs to be
thoroughly documented in order to provide meaningful information. In microfluidics,
structures usually cannot be recognised by the naked eye, and they need specific la-
belling distinguishable by microscopy for correct identification. For the construction
of channel-type biochips, two individual identifiers were appended to the pair of com-
municating bacterial colonies within each feature (cf. Figure 5.10C). On the one hand,
140 Chapter 5. The making of microfluidics devices for bacterial screening
FIGURE 5.8: Simplified schematics of channel-type microfluidics biochips.
Bacterial strains can be observed simultaneously in variable size microre-
actors connected by a thin diffusion channel. Inducers can be added to
flow channels directly or propagated in diffusion channels.
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each combination displayed a human-readable code to help the experimenter to locate
and understand microfluidics features while setting up the experiment. On the other
hand, this identifier was complemented by a machine-readable code. This code con-
sisted of a pattern with unique description features (similar to a barcode) that image-
processing pipelines may recognise for automated processing of microscopy images.
Thus, the combination of interconnected bacterial strains together with specific iden-
tifiers allowed an easier mapping of high-throughput data to the theoretical design
features.
5.3.2 Fabrication of PDMS devices
Channel-type microfluidics chips were produced from silicon wafers in a two-step pro-
cess detailed in Appendix D. General microfluidics protocols should be adapted to
different designs. For the setup of micron- and submicron-size features, one must en-
sure that all surfaces are well covered and conditioned for an easy separation between
template mould and replicated PDMS circuit. For instance, silanisation of templates
is generally performed overnight in a closed container but needed to be carried out
in high-pressure vacuum chambers for our microfluidics devices, in order to provide
a uniform coating of silanising agent on all surfaces. This step was very important
as small features may tear whilst separating the template from newly creating PDMS
chips, rendering both substrates unusable. Moreover, the use of harder PDMS sub-
stances for circuit replication was also crucial but trickier to cast into tiny dimensions.
Again, under vacuum conditions, we used a high-speed spin coater to overcome this
issue and to reproduce microfeatures with high accuracy. In the following, we provide
an overview of the channel-type PDMS microfluidics chips examination.
5.3.2.1 SEM screening
As it was described above, we optimised PDMS chips fabrication protocols in order
to obtain circuits that accurately reproduced the intended microfeatures. To verify
the integrity of intermediate PDMS chips (hard-/soft-PDMS hybrid) features, we used
scanning electron microscopy (SEM) to observe samples with a great level of detail (cf.
Figure 5.9)[150, 179]. An overview of channel-type biochips is provided in Figure 5.10.
PDMS chips were first cut with scalpels into small samples fitting SEM observation
chambers, then coated with a thin layer of gold (5nm) and finally mounted onto the
microscope. SEM equipment relies on blasting a high-power electron beam onto dif-
ferent specimens. Object surfaces and shapes are then computationally reconstructed
142 Chapter 5. The making of microfluidics devices for bacterial screening
FIGURE 5.9: Overview of a scanning electron microscope. On the left, we
show a picture of the microscope setup, with an incubation chamber for
specimen visualisation, an electron beam apparatus and a computerised
platform for dynamic treatment of data. On the right, we display the view
from the interior of the specimen observation chamber. A central platform
features up to 7 specimens that should be gold-coated before imaging.
based on the differential impact of electrons over focal zones. Coating samples with
a conductive metal layer (5nm gold in our case) allowed to limit undesirable effects
such as sample degradation whilst imaging. Although it is usually not necessary to
use a clean room for the construction of microfluidics devices, we report that doing so
greatly increases cleanliness of small features, as observed by SEM. Throughout this
chapter, we aimed at keeping the microfluidics chips fabrication process as clean as
possible in order to provide a better chance to get functional designs in in vivo condi-
tions.
Figure 5.10 displays an overview of the features reproduced in PDMS from the
channel-type silicon wafer. In panel A, we show a large view of five potential cellu-
lar combinations, where a cellular compartment varying in a 1µm, 10µm, 20µm, 30µm,
40µm size range communicates via a thinner diffusion channel with three individual
complementary mother machine devices[233]. In these mother machine features, a single
mother cell is blocked at the end of an observation channel, and its daughter cells are
extracted by pushing each other through the aperture of the trap. For each of these
combinations, a negative control is included on the other side of the flow channel of
sensor bacteria. In these settings, higher flow in deeper channels avoids any signal to
be detected by cells placed on the opposite side of a specific experimental condition. In
Figure 5.10B, we provide a zoomed-in picture of diffusion channels: while cell cham-
bers show a size of approximately 1µm, diffusion channels are designed to be thinner
in order to block the passage of cells and eventual biological contamination. Identifiers
that were discussed in the previous section are visible in panel C. This specific example
reads out as the combination number 35, where 4 cells (3 test samples and 1 negative
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control) are set in proximity of a 1µm trap. Alphanumerical indices refer to wafer-
specific abbreviations providing information about design location and chip version.
Overall, with the use of SEM technology, we ensured that PDMS chips accurately repli-
cated wafer design features and that a correct behaviour should be observed following
the input of cells in coverslip-bonded microfluidics chips.
5.3.2.2 Adequate flow verification
Before injecting a flow of cells for direct and time-lapse observation in microfluidics
chips, it is recommended to verify the functionality of the biochip flow system. This
was done by using a food colourant visible to the naked eye as a red dye. Besides pro-
viding a direct visual verification over the directionality of flow channels, it also helped
with visualising smaller features on a fluorescent microscope setup. Since the dye
used to input flow in the microfluidics chip was coloured, red-channel fluorescence
provided strong evidence for locating immersed regions of cellular traps. In Figure
5.11, four individual combinations of cellular chambers are shown over the fluores-
cence channel. At the bottom of the different images, small pillars may be observed in
bigger cellular compartments: these were set on purpose in order to strengthen the ob-
servation chambers. For all channel-type microfluidics chips that we verified through
this characterisation method, we always observed a correct distribution of medium
over microfeatures and obtained correct flow directionality. Here, we demonstrated
the concordance between theoretical design and in vitro characteristics of PDMS mi-
crofluidics chips. In the following section, we expand our model to in vivo conditions
with the input of cells to channel-type biochips.
5.3.3 In vivo studies
For the study of bacterial communication in these chips, we used two genetic circuits
that were engineered in Chapter 4 and thoroughly characterised via a range of tech-
niques in discrete and continuous time series experiments. These corresponded to the
optimised sender and receiver devices presented in Figure 4.27.
5.3.3.1 Cell size control
Our study relied on trapping cells in specific microfluidics chambers. However, with
the design features of channel-type microfluidics chips, observation channels/chambers
were inaccessible to E. coli under normal size conditions. The standard protocol to load
E. coli into microfluidics chips involves growing bacteria from a fresh colony, refreshing
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FIGURE 5.11: Fluorescence images of channel-type microfluidics features
immersed in a red dye. Features visible over a black background corre-
spond to cellular traps and diffusion channels. (A), (B), (C) and (D) re-
spectively represent bottom traps widths of 10µm, 20µm, 30µm and 40µm.
Top cellular channels have a width of 1µm and diffusion channels 0.7µm
on average.
saturated cultures and providing exponential phase cells to the input system. Given
the facilities provided by the Centre for Bacterial Cell Biology, we may have been able
to load cells via an optical tweezer[182], but this method would have implied to move
the microfluidics apparatus after cellular loading to a fluorescence microscope for live
imaging. Since E. coli cells undergo physiological changes as they grow in different
phases, we rather tested inputting cells extracted from higher cellular density condi-
tions - thus smaller cells - into microfluidics chips[126, 136]. Although this step did not
help the efficient loading of cells into biochips, we overcame this issue by exploring
poorer growth media alternatives prior to live cell imaging. We tested a range of min-
imal media, derivative of M9 salts, and managed to reduce E. coli size by an average
of 3-4x fold compared to cultures that were grown in richer media (LB-based). This
poor growth medium consisted of 1x M9 supplemented with 0.02% casamino acids
and 0.5% glycerol. By growing cells to exponential phase in this poorer medium, we
significantly improved cellular loading in microfluidics chips, from ≤ 1 cell per trap to
several cells per observation feature (cf. Figure 5.12A).
Microfeatures aimed at maintaining cells in observation chambers were initially
designed to accommodate standard E. coli cells grown in rich medium. Therefore, we
could not keep mini-cells obtained from starvation in poor medium in bacterial traps.
These were too tiny and could move in small compartments supposed to hinder cells.
We thus needed to swap medium after loading of smaller cells for a richer, standard
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FIGURE 5.12: E. coli cells in channel diffusion microfluidics chips. (A)
and (B) show the same location within the biochip at two different time
points: after cell starvation (small cells, A) and after reverted physiological
change in LB (bigger cells, B). (C) displays the fluorescence levels observed
in two bacterial communities respectively sending (bottom) and sensing
(top) AHL after 2h of sender culture induction.
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LB growth medium supplemented with eventual inducer. Cells started recovering nor-
mal size within half an hour after providing richer medium. In general, we allowed
a 2-3h recovery time for cells to grow back to normal size, and afterwards performed
a final medium change to induce cultures. The physiological change from small cells
(just loaded) to recovering cells after 1h culture at 37◦C is shown in Figure 5.12A and
B. After the obtention of normal size E. coli that would fill bacterial traps, cultures
were induced and followed by fluorescence over time. Figure 5.12C displays a fluo-
rescence snapshot of two sender and receiver communicating colonies in channel-type
microfluidics chips. Here, sender devices were located at the bottom of the image in
the large cellular compartment, while sensor cells were growing above these. Over
≥ 10 experiments, we consistantly started to detect AHL sensing by the activation of
sfGFP signal in receiver colonies after 2h of sender cultures induction. Overall, we
managed to successfully load bioengineered cells into channel-type biochips, and we
observed significant signal for intercellular communication between microcolonies of
bacteria separated by 50µm within 120 minutes.
5.3.3.2 Limiting design factors
We have previously demonstrated how channel-type microfluidics chips may be engi-
neered and adapted for in vivo studies of E. coli. However, after fabricating channel-
type PDMS chips and visualising their features, it became quickly obvious that trap-
ping cells in 1µm wide aperture channels would become challenging (cf. Figure 5.12).
Although the process of cellular loading could be optimised for our purpose as de-
tailed in the previous paragraph, we ran into major challenges when reaching high
cellular densities in bacterial traps. The design of 0.7µm diffusion channels appeared
to be fine to block the passage of cells over the first couple of hours, but subsequent cel-
lular divisions ended up squeezing cells within diffusion planes. Individual bacterial
colonies would then join and contaminate each other, rendering the screening of bac-
terial behaviour impossible in extended time-course assays. Figure 5.13A and B show
the same bacterial trap at 6h of interval during which cells gradually overfilled the ob-
servation chamber. At the top of the circular trap, we observe in panel A a single cell
starting to enter the diffusion channel getting progressively filled over a few hours, as
shown in panel B. Besides the stacking of cells within observation chambers rendering
fluorescence measurements less precise (e.g. cells growing in 3D), we also noticed a
big deterioration in E. coli physiology. As shown in Figure 5.13C, cells under observa-
tion eventually acquired mutations and developed significant phenotypical changes.
The cell shown here and other occurences displayed atypical lengths of ≥ 50µm. The
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FIGURE 5.13: E. coli cells in channel diffusion microfluidics chips after
extended culture. (A) and (B) show the same location within the biochip
at two different time points: at cell induction (A) and after 6h of culture
(B). (C) shows a bacterial trap where a mutant cell is hanging in deeper
flow channels after an overnight culture.
development of such abnormalities could be due to the trigger of a SOS response that
ends up affecting the cellular division machinery in subsequent biological pathways. It
decreases cellular fitness and is proof that cellular observation chambers were not op-
timal for bacterial growth. This could be reasonably well explained by an aperture for
input/output of fresh medium/cells too small to accommodate larger colonies. Over-
all, channel-type biochips were poorly adapted for bacterial growth. This stresses out
the need for a correct balance between ideal design and compromises for bacterial fit-
ness to achieve a certain function when using microfluidics chips. Therefore, based on
the knowledge gained from experimenting with these biochips, we engineered other
types of microfluidics chips aimed at screening for intercellular communication, and
present these in the next section.
5.4 Surface-type chips
We engineered a second type of microfluidics chips and drove their design to optimise
the limiting factors that were observed with the use of channel-type biochips. While we
designed microfluidics patterns and fabricated all PDMS products, the manufacturing
of the silicon wafer was outsourced to the INEX company, based in Newcastle-Upon-
Tyne (UK). We developed these microfluidics chips to improve channel-type biochip
properties observed in in vivo conditions. As they featured smaller channels than the
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channel-type chips previously described, the casting process of PDMS needed to be op-
timised for a better replication of microfeatures. This optimisation process was based
on the making of PDMS chips under different conditions, to then test for the adequate
pattern replication via microscopy. In this section, we provide an overview of the de-
sign, validation studies and in vivo assays that were undertaken for the characterisation
of surface-type microfluidics chips.
5.4.1 Design features
5.4.1.1 Improving biological fitness
In order to obtain a functional genetic circuit in in vivo conditions, two properties
should be observed: (i) the genetic device should be characterised and provide robust
behaviour, and (ii) cells should grow in near-optimal conditions. We have described in
Chapter 4 how to optimise the design of genetic circuits and demonstrated their func-
tionality in E. coli. However, the structure of observation chambers in microfluidics
may impact on cellular growth conditions. The design of microbial culture chambers
is subject to a number of limiting factors, inherent from the dimensions of the cells
and their requirements to proliferate. To improve cells fitness and to avoid the kind of
scenario described in Figure 5.13, we changed the shape of cellular traps from circular
to rectangular and we expanded the aperture opening towards flow channels (Figure
5.4A-B). First, as we described earlier in this chapter (Figure 5.6), E. coli can adapt to an
organised planar growth in straight shape channels. Therefore, we based all observa-
tion chambers design around rectangular shapes. This approach needed to provide a
larger opening from flow channels to observation chambers, so we adjusted the aper-
ture of bacterial traps to the size of their relative width. Although this approach would
provide higher chances for cells to escape traps due to stronger lateral flow, it better ac-
commodated higher cellular densities that were found to be a problem in channel-type
biochips.
5.4.1.2 Creating thinner diffusion features
In the characterisation of channel-type microfluidics chips, we demonstrated that cells
started entering diffusion channels shortly after the beginning of time course assays.
In that design, the dimensions of diffusion features were adapted from the tiniest fea-
tures achievable via soft-photolithography on a same alignment mask. Standard sizes
achievable by common soft-photolithography techniques resolve around 1µm. There-
fore, the design of submicron size features can only be approximated when other
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features (e.g. cell traps) are placed on the same dimension. To overcome this is-
sue, we based the diffusion process between distal bacterial colonies in surface-type
biochips on another photolithography mask (additional vertical dimension). At INEX,
the smallest separation between silicon layers on wafers was of 200nm for the equip-
ment that we used. So, we designed diffusion planes of a 200nm depth to separate
distal observation chambers. For the most uniform propagation of inducer, we also
adjusted the width of these surfaces to the bacterial traps.
In Figure 5.14, we provide an overview of one of the few types of surface biochips
we developed in this study. Shown in the bottom frame of this figure, the feature un-
derneath the 515 index displays two bacterial traps of 20µm × 50µm separated by a
1µm diffusion plane. For surface biochips, we engineered 5 individual types of bac-
terial traps to study variable cell numbers in simultaneous conditions. These were
labelled based on their size from 1 to 5 (1 being the smallest single-cell size trap, 5 the
biggest trap suitable for up to 200 cells) and a similar scale was set for diffusion dis-
tances (from 1µm up to 100µm). In the example given in Figure 5.14, the code 515 is
read out as a first size 5 bacterial trap connected via a small diffusion distance (size 1,
1µm) to a second large bacterial trap. On each side of these features are flow channels
that bring cells, fresh nutrients and collect waste materials from observation cham-
bers. Bacterial communication features are located at U-turns of deeper flow channels.
These are split into a main channel that takes a sharper turn, while a smaller lateral
subchannel brings cells in the proximity of traps. This subchannel reduces width as it
approaches the observation trap, creating a higher flow and making cells pushing each
other into the target 1µm depth area. As per design, the higher flow hereby created
should also ensure that cells are correctly extracted from bacterial traps and receive
enough nutrients to sustain robust growth.
5.4.1.3 Correcting design by fluid dynamics
In microfluidics, flow channels are the main effectors to input cells and to provide con-
tinuous fresh medium for optimal bacterial growth. Since several variations may be
designed from a basic microfluidics pattern, we screened for best combination of fea-
tures in order to obtain predictable and adequate flow behaviour near bacterial traps.
First, we optimised the design of entire microfluidics chips by replicating the same
conditions twice per chip. As shown in Figure 5.14 in the top right corner, if an input
flow is provided in position S or R, then it is equally split over top and bottom parts
of the chip biological replicas (towards S1/S2 or R1/R2). We simulated this behaviour
by fluid dynamics with Comsol (analysis software) and showed the division of input
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FIGURE 5.14: Overview of surface type microfluidics chips design. Top
left panel represents the location of different chip designs as they should
be printed on silicon wafers. The zoom-in frame in the top right corner dis-
plays the bigger features of biochips, while the bottom frame corresponds
to the L-edit design an observation area[131]. In this feature, 2×200 bacte-
ria from different colonies are separated by a 1µm diffusion plane. Along a
single microfluidics chip, there is an array of 30 individual communication
features as the one shown in the bottom panel, where sender and receiver
colonies may be observed in different numbers at a variable distance.
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FIGURE 5.15: Comsol fluid dynamics simulation results in surface
biochips deep flow channels. Near input channel ports, a junction equally
splits the main channel into top and bottom flow feeding individual bio-
logical replicas.
medium in Figure 5.15. As well as correct directional fluid flow, we designed deep
channels to form a pattern similar to a spring in order to provide good mixing of the
input flow and waste products. Subsequent U-turns are a simple method to mix liq-
uids in microfluidics, and this would ensure that waste products from cells higher up
in flow channels would stay separated from further bacterial traps. In these settings,
we could ensure that continuous fresh medium could populate microfluidics chips and
behave according to theory in larger-scale features (10− 60µm).
In a second optimisation process, we investigated the differential impact of flow
speed near bacterial traps. As it was described earlier, a small subchannel from the
main input flow is diverted towards micron size features at deep channel U-turns.
Here, we designed different features to restrict subchannel dimensions near observa-
tion chambers. We present the design and flow simulation of a basic microfluidics
communication feature in Figure 5.16. In this instance, we ensured that deep flow
channel speed would be slightly accelerated near bacterial traps, and that eventual
waste products (medium or surplus of cells) could be easily evacuated from growing
cells regions. Based on this microfluidics template, we generated series of microvaria-
tions in which we included PDMS features that physically pushed bacteria for cellular
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loading of microfluidics chips.
With the restricted ability to load large E. coli cells observed in channel-type biochips,
we simulated the behaviour of 5 different PDMS devices for an easier loading of bacte-
ria. The best model that we found is presented in Figure 5.17 besides the basic system
introduced in Figure 5.16. In this device, we show that the theoretical loading of a sin-
gle cell can be improved by reducing the distance between cell traps and the back of
flow channel PDMS features. For a 1µm depth level, we can observe a much higher
flow near bacterial traps after reducing this distance to 3µm, which implies that cells
are more likely to be squeezed in observation chambers near these features. However,
we had to consider that this higher flow and reduced distance may also have an im-
pact over clogging of microchannels. In microfluidics, as we showed earlier for the
example of channel-type biochips, one should always make compromises during the
design phase to obtain an optimal function in-vivo. Therefore, we selected two sets of
biochip designs for manufacture of silicon wafers, and we created analogous circuits
to the basic and higher flow surface chips presented in Figure 5.17.
5.4.2 Characterisation of PDMS devices
Two surface chips silicon wafers were manufactured by INEX and corresponded to
respective designs of basic and high flow near bacterial traps biochips. On each 6
inch wafer, we printed 15 individual chip circuits and replicated their design in hard
and soft PDMS, as described in Appendix D. To inspect correct reproduction of micro-
features from wafer to PDMS, we characterised PDMS samples by scanning electron
microscopy by the same method as described in Figure 5.9 for channel-type biochips.
5.4.2.1 SEM screening
In the previous section, we demonstrated the adaptation and optimisation of PDMS
device fabrication for the construction of channel-type biochips. Using the same opti-
mised protocols, we generated series of intermediate (h-/s-PDMS) and single use chips
(s-PDMS), and we examined the accuracy of the microfeature reproduction process. In
Figure 5.18, we display two views of PDMS chips coated with 5nm gold and mounted
onto a SEM observation platform. In these assays, we managed to obtain an entire
single microfluidics chip per SEM sample. This allowed us to fully characterise the
accuracy of the molding process, with biological replicas located on top and bottom
halves of individual biochips. In all SEM experiments with surface-type microfluidics
chips, we also report that PDMS devices that were prepared in a clean room showed
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FIGURE 5.17: Models of flow acceleration towards bacterial traps in sur-
face biochips. The three top simulation panels describe the basic flows that
occur, from left to right, at 5µm, 1µm and 0.2µm depths levels in basic sur-
face chip design. Bottom frames correspond to the same simulation results
for a chip that displays higher flow near bacterial traps. The left-hand side
legend displays colour-coded differential flow velocities.
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FIGURE 5.18: View of gold-coated surface biochips from the SEM internal
camera. On the left, we display a overview of the 7 gold-coated specimens
to observe on the rotary central platform. On the right, we show a low
magnification of the entirety of a microfluidics chips at a 55◦ angle (chip
CWqs21).
more accurate microstructures. For chips that were prepared in traditional lab condi-
tions, we could observe the presence of multiple dust particles that may impair micron
size structures (cf. Figure 5.10A on the right side). Therefore, we constructed all mi-
crofluidics chips under fume hood or vacuum conditions.
In the screening of a large set of microfluidics chips, it is inevitable to detect ab-
normal microstructures. In Figure 5.19, we show the reproduction of a teared flow
channel rendering both intermediate and soft PDMS substrates unusable for a specific
feature. The aim of optimising PDMS fabrication protocols was to minimise this error
in order to generate functional circuits. In Figure 5.20, we provide an overview of a sin-
gle surface-type biochip and display its associated microfeatures for half of the design
replicas. This chip shows the smallest distance two bacterial colonies may be sepa-
rated by in an in vivo context (1µm). In a general case, all hybrid PDMS chips (positive
mould from silicon wafer) as the one presented in Figure 5.20 reproduced the intended
design submicron size features with great accuracy. By this step of the PDMS devices
fabrication pipeline, we could thereby ensure that intermediate moulds replicated all
microfluidics features with good fidelity.
Following the production of hybrid PDMS chips, we generated single-use, soft
PDMS chips from the intermediate templates, and examined microfeatures correct
replication from mould to sample. In Figure 5.21A and B, we show the same part of a
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FIGURE 5.19: Potential defects in the reproduction of PDMS microstruc-
tures from silicon wafers. Left panel displays the intermediate mould that
tore a microfeature, likely during separation from template. The red rect-
angle is placed around the diffusion channel that, despite flow channel
collapse, was accurately reproduced. Right panel shows reproduction of
the same defect onto soft PDMS chips.
microfluidics chip resulting from the separation of hybrid template from s-PDMS prod-
ucts. Features that were observed so far for intermediate PDMS devices were printed
positively on hard PDMS, and panels A and B display the evidence for a consistent
good replication of microfluidics features from hard to soft PDMS. In Figure 5.21C,
we focussed on the observation of the smallest biological feature of all surface-type
biochips. Progressive magnifications show the localisation of two observation cham-
bers that consist of individual mother-cell devices, while a 200nm plane separates these
by 1µm. In a biological context, this could allow the study of intercellular communica-
tion between two single cells directly facing each other. Altogether, we demonstrated
by SEM imaging that nearly all PDMS microfluidics chips could replicate exact submi-
cron size features, proof that surface-type biochips may be used in an in vivo context.
5.4.2.2 Liquid flow check
As it was described for channel-type microfluidics chips, we performed the same sim-
ple colorimetric test to verify the functional flow of surface biochips. We injected a
158 Chapter 5. The making of microfluidics devices for bacterial screening
F
IG
U
R
E
5.20:M
icrofluidics
chip
C
W
qs21
SEM
overview
.This
chip
displays
the
sm
allestdiffusion
distance
betw
een
tw
o
separate
bacterialcolonies
(1µ
m
).
5.4. Surface-type chips 159
FIGURE 5.21: Overview of surface biochip microfeatures by SEM. In (A)
and (B), each column compares features reproduction on hard PDMS (in-
termediate mould, h-PDMS) and soft PDMS (single use chips, s-PDMS).
The largest diffusion distance separating potential bacterial colonies
(100µm) is presented in (A) while a 5µm diffusion plane is shown in panel
(B). In (C), we display different magnifications of the smallest microfea-
ture present in any chip: 2 single cells communicating via a 1µm diffusion
channel.
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FIGURE 5.22: Flow dynamics test of a surface-type biochip with a
coloured compound. Input flow from a syringe plugged into the top mid-
dle port splits symmetrically into left-/right-hand part of the microfluidics
design (biological replicas). The flow is contained within the top half of
the chip and separated from bottom replicas by a narrow diffusion surface.
diluted red food dye into input ports of surface chips and observed the expected be-
haviour of the liquid dynamics. As it is displayed in Figure 5.22, theoretical simula-
tions were supported by the colouring of only half of the biochip. The other half, that
corresponded to a potential separate bacterial strain, was well isolated by a small dif-
fusion surface that did not allow the flow from the opposite side to leak. Together with
this final verification step and PDMS chips imaging by SEM, we proved that we could
replicate submicron size microfluidics features accurately and obtained identical flow
behaviour as simulated in silico. In the next section, we reveal in vivo characteristics of
surface-type microfluidics chips.
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FIGURE 5.23: Microfeatures of surface biochips immersed in LB medium
under an inverted microscope. Soft PDMS was bonded to a coverslip,
plugged at input/output ports and observed in microscopy before apply-
ing a flow of cells.
5.4.3 In vivo cellular fitness
5.4.3.1 Cellular loading
After a similar plasma bonding protocol as the one used for channel-type chips, we
fixed microfluidics chips to thin borosilicate glass coverslips and mounted the result-
ing microfluidics apparatus onto fluorescence microscopes. According to the standard
microfluidics cellular loading technique, we grew cultures overnight, refreshed them
in the morning and injected cells extracted from exponential phase into surface-type
biochips. Before loading cells, we immersed PDMS devices into culture medium in
order to reduce the formation of eventual air bubbles within the circuit. Figure 5.23
provides an overview of the bacterial traps present in a single microfluidics chips. In
standard Nikon-Ti inverted fluorescence microscopes, we could not always obtain a
precise focus of diffusion surfaces by vertical alignment. However, strong unequal
flow from either part of the microfluidics input ports always showed medium leakage
into the opposite side patterns. This meant that diffusion planes may not have been
visible under fluorescence microscopes, but were still present in the final, single use
chips. After correct immersion of all microstructures, which may take up to 5 minutes
without an external pump, we simply swapped culture medium reservoirs for specific
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FIGURE 5.24: Surface biochips bilateral cellular loading. Two E. coli cel-
lular reservoirs were plugged to a surface diffusion microfluidics chip
and let to flow in circuit channels without external pressure. (A), (B) and
(C) represent top views of different intercellular communication features,
where colonies are separated by a distance of 50µm. (A) displays the com-
bination of a small and a large colony tested together, (B) two small and
(C) two large bacterial colonies. Diffusion surface is visible in (B) as a
channel connecting the two growth chambers.
E. coli strains. With this method, contrary to the channel-type biochips, we consis-
tently obtained robust cellular loading in terms of number of cells naturally trapped
in observation chambers. Here, we mean that cells would directly enter observation
chambers without any external stimuli or change in the syringe input/output system.
This showed some contrast with the loading of channel-type biochips, where cells first
needed to be starved to reduce their size before loading, after what the input medium
would have to be changed to allow for the recovery of standard-size E. coli. Notice-
ably, surface biochips that displayed a model of higher flow near bacterial traps were
very efficient at hindering cells within observation chambers. As shown in Figure 5.24,
bacterial traps of different sizes were easily filled by cells. This setup allowed us to
start time-lapse experiments in a favourable context, where a good starter amount of
cells could be symmetrically provided to all observation chambers. Overall, these re-
sults supported the correctness of our theoretical model and proved the adequacy of
surface diffusion microfluidics chips for bilateral cellular loading. We deemed cellu-
lar loading sufficient to persue time-lapse experiments when cells would be hindered
within the 1µm observation chambers and would multiply over 3 successive divisions,
whilst remaining stuck in the bacterial trap.
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5.4.3.2 Bacterial growth stability over time
From the setup performed by a robust cellular loading process, we grew cells hin-
dered in observation chambers over 12h periods in continuous culture at 37◦C. Over
the first 2h of the assays, we observed small observation chambers gradually empty-
ing themselves. This was likely due to the high pressure of the nearby flow channel
that displaced cells under observation. However, in microcolonies growing in cham-
bers of 10µm × 20µm or larger, we could follow the growth of bacterial species over
time. As shown in Figure 5.25, three different situations generally emerged after fol-
lowing continuous growth of bacteria in surface-type biochips: (i) reasonable bacterial
growth filling bacterial traps as expected from the design (Figure 5.25A), (ii) abnor-
malities in design features developed around higher cell density regions (Figure 5.25B)
and (iii) clogging effect caused by PDMS impurities and cellular aggregates (Figure
5.25C). In a suitable setup for bacterial growth, discrete final time-points revealed the
correct activation of the bacterial genetic circuits tested in this study. However, the
most recurrent situation was the emergence of PDMS feature failure, starting by dif-
fusion channels colonisation by bacteria. Although we demonstrated the correct di-
mensions of surface-type microfluidics earlier in this chapter, wild-type laboratory E.
coli appears to be able to significantly shrink its size to enter 200nm deep surfaces with
the help of PDMS flexibility. Since PDMS is an elastic polymer, we cannot exclude that
it may have bent under cellular pressure, eventually allowing cells to create an addi-
tional and undesirable growth layer. However, it is difficult to quantify this effect at a
sub-micron scale. In all instances of diffusion surfaces overtaken by bacterial invasion,
which would take place after 2-3h of culture, we observed the detachment of PDMS
from the glass-coverslip over a variable size area. This abnormality could have differ-
ential impact over the microfluidics features and - in isolated cases - may create a break
between respective flow channels, thus cross-contaminating samples. Nevertheless, in
most cases, only the specific feature was affected and rendered unusable for experi-
mental measurements. Also, as displayed in Figure 5.25C, PDMS residues sometimes
ended near bacterial traps and triggered clogging of high-speed biochips (with only
3µm of flow channel width). Therefore, due to these different detrimental effects, it
was difficult to follow continuous growth over long periods of time.
Altogether, the model of surface biochips we developed in this study was successful
in short-time assays, but inadequate for longer time course experiments due to design
mechanical constraints. As we describe in the following section, these constraints were
partly inherent from the photolithography resolution that was used for the construc-
tion of microfluidics devices.
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FIGURE 5.25: Potential situations following continuous bacterial growth
in surface-type biochips. (A) describes an adequate bacterial growth, (B)
colonisation of the diffusion surface by cells and (C) a clogging effect (top
left) due to residual organic matter stuck in a flow channel.
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5.5 Intercellular communication in microfluidics
Microfluidics provide a platform for the setup of biological high-throughput assays.
In this chapter, we presented the set of microfluidics chips that were developed in this
thesis. Designing microfluidics chips is relatively straightforward but should always
be bespoke to the requirements of the specific application. Engineering the right mi-
crofluidics circuit is a cyclic process where biochips are in turn designed, simulated,
created and modified to improve their fit to application-specific needs. In this study,
we engineered microfluidics biochips to study combinatorial events taking place in mi-
croscopic bacterial windows. Here, we discuss the limiting factors that were observed
for the study of microscale intercellular communication via genetic devices engineered
in Chapter 4, and further circuits that may be developed as expansions of the current
microfluidics design.
5.5.1 Microscale reaction-diffusion systems
5.5.1.1 PDMS device fabrication
We built microfluidics devices to study individual communicating colonies of bacteria
at the microscale. For these means, we designed observation chambers to trap bioengi-
neered cells at distal locations, connected by diffusion areas. For the study of E. coli,
microscopic dimensions of these circuits first required the optimisation of the PDMS
device fabrication process (see Appendix D). If microfluidics chips are tailored to the
observation of single cells and display hollow features, a clean and robust replication
of the microfluidics wafer patterns is essential to obtain usable devices. Although there
is usually no need to perform PDMS chips fabrication in a clean room, this appeared to
be critical step to limit the amount of microscopic dust that could block chip compart-
ments after bonding to glass coverslip. Due to the size of features on SU8-photoresists,
we also had to make a thick hard-PDMS layer to enable the intermediary wafer to accu-
rately replicate features into soft-PDMS chips. In consequence, detaching PDMS from
master wafer became more challenging after a simple silanisation step[65]. We thus
needed to optimise the incubation of the master wafer by sealing it in a vacuum cham-
ber under high pressure (27psi) in the presence of the silanisation agent. We screened
appropriate replication of PDMS features onto intermediate and final single-use chips
by SEM, and provided a thorough explanation of the PDMS chips molding process
(Appendix D). With these protocols, we demonstrated very accurate reproduction of
submicron-size microfluidics features, and could ensure that a specific design was cor-
rectly imprinted before use in biological assays.
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5.5.1.2 E. coli growth in observation chambers
Microfluidics allow the characterisation of genetic circuits in bacteria via two main
functions. First, cells are immobilised in specific compartments where they can be fol-
lowed over time. Then, a dynamic control can be applied over fluid flow to provide
appropriate growth conditions for the studied cells[65]. In practice, this is achieved
by creating multiple channel depths over a uniform PDMS surface, and by plugging
external devices such as input syringes and waste outline into a microfluidics chip.
Altogether, the wiring of such device results in a well-controlled environment for bac-
terial proliferation and the study of specific physiological behaviour. However, there
are multiple factors that can impact cellular behaviour in microfluidics settings, and
we provide in the following an overview of the key elements that we observed during
continuous growth of E. coli genetic circuits.
We presented above two types of biochips: channel and surface diffusion devices.
As their name suggest, they differed in the process of diffusion for intercellular com-
munication. First, we tested channel-type biochips that had been developed by Dr
Sunny Park and connected individual bacterial strains by 0.7µm size channels. Later,
we manufactured and reproduced a variant design of channel biochips with thinner
diffusion surfaces (200nm depth) instead of channels between microcolonies of bacte-
ria. These two designs of microfluidics chips, as described in Figure 5.4 and produced
via the protocols listed in Appendix D, were tested in vivo and showed a much eas-
ier cellular loading for the second type of surface biochips. One of the main design
differences between these chips was the way cells flowed near bacterial traps. While
channel-type chips featured straight flow channels, we optimised the amount of cells
naturally trapped in observation chambers by altering these and actively pushing bac-
teria into 1µm depth compartments. Nevertheless, the latter caused clogging issues to
arise in a couple of instances[50]. In nature, cells tend to adhere to surfaces and to pro-
duce different chemicals that help the setup and development of microcolonies. For
instance, this is what happens during the creation of biofilms[175]. In microfluidics, a
single cell adhering to a PDMS wall can replicate every 25min and manage to attract
and attach itself to further flowing cells. Over a few hours of experiment, this effect
can be multiplied and completely block some parts of the flow channels. In Chapter 5,
we presented two types of surface diffusion biochips where cells were loaded by either
a 3µm or a 10µm wide flow channel. In practice, we observed that a narrower distance
(3µm) performed better at loading cells in bacterial traps, whilst this made chips also
more likely to develop clogging of cells combined with PDMS residue (cf. Figure 5.25).
On the contrary, 10µm features never displayed cellular clogging but only loaded half
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FIGURE 5.26: Surface diffusion microfluidics chips limitations with E. coli
cultures. In all panels, deep flow channels are shown in dark grey, obser-
vation chambers in blue and diffusion area in light grey. Individual yellow
rods represent bacteria in different settings. (A) shows the possibility of
clogging in two type of biochips. Top and bottom panels shows different
distances of flow channels reduction nearby bacterial traps and eventual
clogging effect via PDMS residue (red star). (B) displays colonisation of a
surface diffusion area (X = 200nm) by individual cells over gowth.
the amount of cells attainable with the alternative design. This process is outlined in
Figure 5.26A with clogging of the 3µm wide channel. Altogether, the design of each
microfluidics chip should be considered for the optimisation of multiple factors, and
allowing for model variations greatly helps troubleshooting specific issues during in
vivo studies.
In surface diffusion microfluidics design variations, we included the modification
of observation chamber aperture size. In channel-type chips, we overcame poor cel-
lular loading issues by growing E. coli cells in minimal medium, and swapping back
to a richer medium after biochip loading. However, as a consequence of the design,
this model of bacterial traps did not display a good fitness for growing microcolonies
of bacteria. In these settings, observation chambers did not allow for easy removal
of the excess cells[65, 50]. Besides a stacking effect observed in a theoretically two-
dimensional environment, E. coli cells also regularly developed mutations that signif-
icantly affected their morphology and underlying physiological processes. Therefore,
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as suggested by the literature and as we observed in surface-type biochips[65], we
report that providing a larger aperture to observation chambers is a strong determi-
nant in bacterial growth fitness over time. In general, multiple design considerations
should be accounted for in the optimisation of microfluidics circuits, and these should
be carefully reviewed for potential implications with the culture of bacterial cells.
5.5.1.3 Diffusion system limitations
We have previously demonstrated how the setup of surface-type microfluidics chips
helped the cellular loading and culture of E. coli cells. In the biological context of this
study, we investigated diffusion of quorum signals between specific bioengineered
strains presented in Chapter 4. Although computational and wet lab studies have char-
acterised the wiring of bacteria by quorum compounds at macroscopic distances, there
is little known about microscopic interactions and how autoinducers act at a smaller
scale[223, 47, 152, 206]. In our microfluidics chips, we designed the thinnest achievable
features by soft-photolithography to represent planar diffusion surfaces between two
individual strains. While cells were anchored for growth in a 1µm depth surface area,
excess bacteria were extracted from observation chambers via flow channels. Since
channel-type biochips revealed that 0.7µm were insufficient to retain E. coli from enter-
ing diffusion surfaces, we designed these planes as 200nm to minimise bacterial entry
into theoretically cell-free compartments. Whilst this approach appeared to accom-
modate low to medium cellular densities, the elasticity of PDMS and the increase in
pressure exerted by higher cell density allowed colonisation of 200nm diffusion areas
after a few hours of experiment (cf. Figure 5.26B). At the current time, the develop-
ment of micro-/nanoengineering techniques accelerates the study of biological sam-
ples in large scale screening assays. However, soft-photolithography did not provide a
suitable platform for the study of bacterial communication endeavoured in this study.
For the development of further microscale intercellular communication devices, we
would likely consider photolitography alternatives such as E-beam lithography that
can achieve nanometer-scale features[5, 62]. This manufacturing process increases the
resolution obtained compared to standard photolithography but nevertheless multi-
plies the costs of wafer production.
5.5.2 Wiring and controlling bacterial communication
Quorum sensing systems are a landmark for the study of bacterial intercellular com-
munication[155, 225]. They perfectly mimic the process of reaction-diffusion observed
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in systems we studied in Chapters 4, and we generated synthetic constructs that al-
lowed the specialisation of certain strains to either produce, sense or amplify environ-
mental quorum molecules. So far, we have described the microfluidics results obtained
for a simple sender-receiver system, and demonstrated the production and sensing of
quorum signal in E. coli. However, the propagation of chemical waves within or be-
tween bacterial colonies naturally follows rules that can be distinguishable at a higher
scale[227]. In the following subsections, we describe potential microfluidics applica-
tions that may use more complex genetic circuits that were presented in Chapter 4.
5.5.2.1 Quorum signal repression
In nature, quorum sensing is a mean of synchronisation across bacterial species. Quorum-
controlled behaviour is usually observed at high cell densities and depends on local
concentrations of an autoinducer. A positive feedback loop normally amplifies the
production of quorum compounds, and cells undergo different subsequent physiolog-
ical changes. In this study, we used a promoter fusion between the activable PR−lux
promoter and the cI repressible binding site known as PRcI−lux[48]. A cI binding site
was placed between lux operators, preventing luxR to dimerise and activate the tran-
scription of PR−lux in the presence of AHL and the cI protein at the same time. In this
context, environmental cI protein is considered as an inhibitor of the quorum circuit.
This means that, regardless of the presence of a quorum signal, one could reset the
state of a sensor strain. For the study of computation with bacterial cells, this sort
of feature allows one to obtain spatiotemporal control over growing cells, and to ob-
serve dynamic physiological behaviour in time-lapse experiments[56, 15, 220, 164, 193,
137]. Together with a repressor system, one may use the quorum strains engineered
in Chapter 4 and attempt to adapt the ON/OFF quorum response of sensor devices to
oscillatory circuits.
5.5.2.2 Pulse generator devices
Pulse generators are molecular devices that express a signal molecule to trigger cyclic
or unidirectional regulation of complementary compounds. In both regulatory pro-
cesses, the iterative activation and repression of biological units can transduce an in-
put signal and be identified via the formation of a specific pattern over macroscopic
distances[16, 46, 4]. In Figure 5.27A, we simulated the behaviour of a quorum circuit
split between individual bacterial strains that, in turn, produced, sensed, amplified
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FIGURE 5.27: Simbiotics simulation results of a pulse generator device.
In both models, cells are represented as individual coloured circular en-
tities growing in the grey cage outline. (A) displays three different time
points after inducer production (blue) in microfluidics settings (e.g. two-
dimensional growth). Pink cells are inactive and green cells amplify quo-
rum signal. (B) presents cells producing a quorum molecule (red) or sens-
ing this signal (blue and green) in a three-dimensional space allowing
stacking effect. Blue cells are repressed and inactive while green cells are
activated for quorum production.
and repressed signalling molecule detection. This snapshot represents the physiolog-
ical state of different colonies after bacterial growth in static conditions, and is con-
cordant with other in vivo models that have been explored for quorum devices in the
literature[16, 15, 203]. To simulate growth from separate bacterial species, we used
a three-dimensional simulation platform developed by Jonathan Naylor called Sim-
biotics (http://simbiotics.org)[169]. Using the same approach, we also simulated the
behaviour of these circuits in microfluidics-like conditions, where single layers of cells
should be placed and grown in relative proximity from one another (cf. Figure 5.27B).
While the real complexity for the study of intercellular communication in microfluidics
relies on maintaining bacterial cells controlled in in vivo conditions, this type of in silico
work greatly helps the setup and design of potential circuits.
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5.6 Summary
In this chapter, we described the theoretical design and fabrication process of mi-
crofluidics chips for high-throughput characterisation of intercellular communication.
Firstly, we optimised PDMS devices making for micron or submicron size features
replication. Then, we developed different microfluidics circuits to improve cellular
growth in these settings. Based on the genetic devices engineered in Chapter 4, we ob-
served signal transduction (e.g. production/sensing of quorum molecule) between mi-
crocolonies of bacteria distal of 20µm to 100µm, but it was impossible to gather signif-
icant experimental data from small cellular compartments due to limitations of PDMS
devices themselves (cf. Figures 5.13 and 5.25). In the fabrication of silicon wafers, soft-
photolithography allows the setup of small structures but has a resolution limited to a
few hundred nanometres. Therefore, physical constraints are imposed on the design
of specific circuits and while we demonstrated correct features replications in PDMS,
in vivo conditions may differentially affect microfeatures through pressure drops and
high cellular densities. Here, we tested the smallest achievable features that could be
printed by standard soft photolithography, and we showed that these were inefficient
at keeping well-controlled growth conditions intact over long-term continuous culture.
The development of high-throughput approaches in microfluidics was shown to help
the screening and understanding process of cellular behaviour. Although the tiniest
features were unstable, it would remain interesting to detect bacterial communication
events at the single-cell level. For instance, this could provide some valuable insights
into how bacteria may differently communicate when they are alone or surrounded by
other cells. In the next chapter, we integrate the results and discuss the data that were
presented in Chapters 3, 4 and 5.
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Chapter 6
Integrating bioengineering approaches
in synthetic biology
In this thesis, we have reviewed and explored a few of the basic elements of bioengi-
neering in synthetic biology. In this respect, we presented the setup of a DNA encoding
method to identify and track bacteria via DNA barcodes. Our work focussed on build-
ing the abiological sequences and in their integration in living organisms. Chapter 3
provides details about barcode stability in vivo. We engineered and characterised a
library of genetic circuits that could be used as model for barcoded strain documen-
tation profiles (Chapter 4). In Chapter 5, we show the potential for microfluidics to
scale up and optimise genetic circuits single-cell characterisation. At the submission
time of this thesis, we are in the process of developing a spin-off platform about DNA
barcoding with the help of Newcastle University. Here, we discuss some key aspects
of the barcoding platform, and how they link the different parts of this study.
6.1 Bac2code online barcoding platform
Synthetic biology relies on using specific biological devices to perform some given
action in an in vitro or in vivo context. For both types of work, the construction of
tailored genetic circuits and their associated wet lab documentation is essential[29].
In order to facilitate interdisciplinary approaches complementing wet lab resources
with in silico studies, we created and presented in Chapter 3 a barcoding platform
called Bac2code. In this study, we designed DNA barcodes for the development of a
strain repository that would allow the browsing of bacterial strain profiles and their
associated in vitro/vivo and in silico documentation. Dr. Jurek Kozyra, who encoded
the hexadecimal to DNA conversion algorithm, is developing this online repository.
The following explains the prototype of such online barcoding platform.
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6.1.1 Possible actions on the Bac2code website
First, possible actions on the online barcoding platform are defined by the type of user.
The Bac2code system targets three main type of users with specific needs, as sum-
marised in Figure 6.1. At the write-up time of this thesis, the main type of users of the
system would be categorised as "Expert users", since the barcoding platform started
as an empty repository with no strain to browse. These users are mostly interested in
populating new barcoded strain profiles with specific documentation. This can be per-
formed in a similar manner as the creation of wiki pages[109], or by simple document
upload as outlined by Figure 6.2. Usually, users have a working and documented strain
that needs barcoding (e.g. commit changes to a strain repository), and the Bac2code
website provides a unique DNA barcode to track this strain. After following the bar-
coding procedure outlined in Appendix C, users can insert a new barcode or update a
strain already barcoded with the newly generated DNA identifier. The experimental
procedure to barcode a new strain or to update a barcode is identical. Although users
may barcode all their strains, we envision that only "milestone strains" (e.g. final ver-
sions of working and documented strains) will be recorded in the Bac2code system.
Finally, users publish their strain documentation on the Bac2code website and choose
to make this strain profile public, private or protected by access restricted to a limited
set of users.
A main feature of the Bac2code website, once populated with a community of users
and a large number of barcoded strains, is to provide an easy way for retrieval of
barcoded strain profiles. As shown in Figure 6.3, users are offered the possibility
to retrieve specific barcoded strain content. This can be done either via direct DNA
sequence input or by the upload of a sequencing read file targeted by the universal
primer. The Bac2code website then finds a barcode in our database that matches the
user input, and directs this user towards the specific strain profile.
Finally, our barcoding platform also offers the possibility to pre-order a batch of
DNA barcodes for further strain development. The case explained in Figure 6.4 shows
that users could order several DNA barcodes at once, possibly for strains that are yet to
be constructed and documented. The Bac2code system thereby allows for the creation
of blank barcode pages that can be edited to prepare the development of genetic circuits
in research projects. As detailed above, this may be done privately or in collaboration
with other users (mainly academic colleagues) that could view and/or edit specific
strain profiles. To this extent, we aim to develop the Bac2code system as a version
control and tracking tool for barcoded strains.
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FIGURE 6.1: The Bac2code platform targets three types of users (left panel)
that often perform a similar type of action on the website. New users
generally browse only, and explore "dark zones", or specific details, that
may be associated with specific strains. Expert and supervisory users have
others needs that need to be accounted for in the possible actions they can
perform.
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FIGURE 6.2: Barcoding with Bac2code: users can upload a set of documen-
tation to fill in a blank barcoded strain profile that is linked to a specific
DNA barcode. This barcode is automatically generated by the online plat-
form and provided to users, who can then barcode strains using protocols
listed in Appendix C.
FIGURE 6.3: Retrieval of barcoded strain profile on Bac2code. Users can
retrieve any barcoded strain profile given a sequencing read used to iden-
tify a specific barcode sequence via a universal primer.
6.1. Bac2code online barcoding platform 177
FIGURE 6.4: Possibility to order and reserve DNA barcodes prior to the
construction bacterial strains. Here, strains 1, 2 and 3 are respectively
meant to be associated with barcodes B_ 001, B_ 002 and B_ 003.
6.1.2 Integration of in silico resources
In synthetic biology, large consortia of scientists have adopted the use of standards
for bacterial strain engineering and documentation[149, 73, 123, 29]. By creating the
Bac2code platform, we do not endeavour to simply create an additional standard. In-
stead, we aim at grouping large amounts of in silico data based on individual platforms
onto a single hub, and to integrate computational studies that help genetic device char-
acterisation. In particular for the setup of genetic libraries, such a platform would
facilitate the handling of computational models, gather available information from ex-
ternal resources and create strain variants automatically, which currently is a tedious
process for most large scale studies. With in vitro/in vivo data users should provide
for each barcoded strain, the integration of the Bac2code platform with other online
resources is key to building a system that may truly bring together experimental and
computational biological studies.
6.1.3 Integration of barcoded strain specifications
We described above what we intend the Bac2code platform to be, and this includes
a collection of experimental data to consult when browsing strain specifications. The
data we first gathered to populate the Bac2code server was extracted from biologi-
cal studies documented in Chapter 4. These were focussed on the construction and
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characterisation of a library of genetic circuits. For the characterisation of these de-
vices in vivo, we followed bioengineered bacteria over time, built mathematical mod-
els based on the Hill function and simulated fluorescence behaviour for individual
constructs[46]. We tested slightly more complex models with additional factors af-
fecting the Hill function such as molecule production and degradation rates, but did
not observe any significant improvement in fitness between experimental data and
computational model. Compared to the genetic devices initially developed, optimised
constructs showed an improved fitness with Hill predictions, suggesting that simple
models were good at explaining reaction-diffusion systems (cf. Figure 4.27). For the
assessment of best synthetic constructs, the matching between the theoretical model
and experimental measurements was a main factor of comparison. Altogether, the ex-
perimental data gathered from these studies represented a great starting point to be
uploaded onto Bac2code strain profiles, where complete datasets may then be further
explored to develop circuit derivatives. By building such repository of strains, we can
exemplify the progression of a research project, here by the optimisation of genetic
construct behaviour in response to quorum sensing signals.
The Bac2code platform is being developed to ease the transfer of information and to
improve communication between researchers. We propose a system where all experi-
mental and computational data related to a bacterial strain may be gathered in a single
place. Since the amount of information provided when exchanging strains between
laboratories is often very little, this would facilitate and favour the exchange of ge-
netic parts and data in the research community. Here, we demonstrated the setup of
cloning methods for the barcoding and update of E. coli and B. subtilis DNA barcodes,
but our method is being developed to accommodate barcoding of a larger number of
species. Although we presented barcodes encoded on the bacterial chromosome, the
Bac2code online platform may be adapted to barcode plasmid systems. In this instance,
barcodes could be specifically assigned to background strain or genetic construct (bar-
code located on plasmid directly), and a barcoded strain profile may be associated with
a combination of barcodes. However, such work is beyond the scope of this thesis, and
these next challenges are being undertaken by Jonathan Tellechea.
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6.2 Barcoding in microfluidics
In Chapters 4 and 5, we have discussed the different methods and results obtained for
the characterisation of genetic circuits, and the application of microfluidics to reaction-
diffusion systems that were built. As detailed in the previous section, data obtained
from these experiments can be used to document barcoded strain profiles on the Bac2code
server. Here, we propose how barcoding may be taken to the next step in terms of in-
dustry, e.g. how to perform it in high-throughput settings. This strategy is based on
the use of microfluidics for large scale processing of individual barcoded species.
In this thesis, we have demonstrated the perfect stability of barcode sequences
over hundreds of bacterial generations in different experimental conditions. For these
means, we used high-throughput methods that consumed relatively large amounts of
culture medium, and needed external methods to extract DNA and to sequence bar-
code fragments. Towards the automation of bacterial strain handling, we are work-
ing on the development of a microfluidics platform that could operate two types of
functions: (i) the barcoding of new bacterial strain and (ii) DNA barcode retrieval.
Currently, there are three steps to barcoding cells: the assembly of recombinant DNA,
bacterial transformation and the selection cassette loopout. In practice, biological tech-
niques used to perform these actions are mainly based on temperature cycling and
growth of bacterial strains. A number of applications have been developed to auto-
mate molecular cloning in microfluidics, and the type of operations that are required
to barcode cells could also be adapted to the microscale[89, 88, 211, 255]. In fact, this
may be achieved via a microfluidics platform that would allow region-specific temper-
ature control for the assembly of recombinant DNA/culture of bacterial cells, and pro-
grammable methods for on chip transformation. Likewise, a system for barcode DNA
retrieval may also be developed and tailored to grow cells, extract gDNA and perform
PCR on barcode target regions. Parallelisation of processes can be easily achieved in
microfluidics and, therefore, such platforms would provide autonomous equipment
that would be suitable for cellular library barcoding and large scale identification of
bacterial species.
Automated digital technologies are a hallmark for the development of biological appli-
cations. Synthetic biology uses these by making the fusion between wet laboratory and
computational investigations. Nevertheless, the overall progress of multidisciplinary
studies can only be achieved by an easy access to relevant in vitro/vivo and in silico data.
Yet to be physically connected, here, we solve this problem with the Bac2code system
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and endeavour to use DNA barcodes on integrated platforms that could handle multi-
ple series of bacterial species at one time. Besides helping the screen of genetic libraries,
the Bac2code platform is also being built to allow the tracking of individual strain lin-
eage and thus, to display the capabilities of a biological version control software. As
was shown for the field of computer science[247, 63], shared repositories are the solu-
tion to a smooth orchestration of multiple project strands. With Bac2code, we aim to
facilitate strain referencing with an online system, and we aspire to assist collaborative
work and the progress of state-of-the-art bacterial studies.
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Chapter 7
Concluding remarks and further
prospects
In this doctoral thesis, we developed a physical link between bacteria and their asso-
ciated documentation. We propose a unified platform for the authentication and the
tracking of bacterial strains. Using standard bioengineering methods, we constructed
a genetic library and used it as a template to demonstrate our system’s capabilities. Fi-
nally, we showed the optimisation of microfluidics for the study of bacterial cells, and
discuss further considerations of this research area, directed towards the development
of automated high-throughput barcoding approaches.
Synthetic biology is about optimising the design and function of novel synthetic
circuits. In Chapters 2, 3 and 4, we reviewed the methods that were developed to engi-
neer synthetic circuits in this study. In particular, we provided in Chapter 3 a thorough
walkthrough of the design process of DNA barcodes, their in vitro assembly and in vivo
integration in two model bacterial species. We then explained the retrieval process of
DNA barcode information, and provided evidence for the in vivo stability of these ar-
tificial sequences. Altogether, we showed the setup of a universal cloning method that
uses analogous mechanisms for different bacterial strains, how to engineer bioorthog-
onal barcodes, and most importantly, how to retrieve barcode information, which pro-
vides access to a unified computational and experimental resource platform. Based
on this, we postulated in Chapter 6 about further developments in order to adapt mi-
crodevices to the automation of parallel barcoding (insertion of barcode) and serial
strain identification (retrieval of barcode). At the submission time of this thesis, we are
preparing a patent application for our barcoding platform, and consequently aim to
expand to a startup company, with the help of Newcastle University.
Adequately documenting scientific work is of upmost importance to ensure the re-
producibility of results. In the development of genetic circuits, novel synthetic devices
should be associated with a thorough explanation of their characterisation process, in
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order to provide meaningful information. In Chapter 4, we explored the growth and
fluorescence profile of a series of bioengineered E. coli strains. For the optimisation
of specific device behaviour, we used various experimental and computational meth-
ods, and demonstrated their usefulness to obtain robust physiological changes over
a range of different conditions. In the context of microfluidics, we studied the previ-
ously obtained optimised strains at the microscale, and for these means had to improve
standard PDMS fabrication protocols for the accurate replication of micron and submi-
cron size features. However, in in vivo conditions, we reached the technological limit
imposed by microfluidics printing technologies; we observed biochip failure at submi-
cron size domains due to the forces bacterial cells exert in order to proliferate. Yet, this
provides hints for the development of further microfluidics circuits, and helps us to
understand the need for specialised equipment for the progress of scientific research.
As a final note, although we demonstrated how to bridge the gap between experi-
mental and computational biology via the Bac2code platform, our technology remains
at an early stage. In the plethora of available synthetic biology tools, it remains difficult
to provide a new unified solution, sometimes overriding others. Therefore, our plat-
form may, one day, be used as a standard laboratory notebook, or it may as well end
up as a bacterial strain identifier test in hospitals. At the present time, both scenarios
are unlikely to happen; however, we hope that the work in this thesis will eventually
help the development of further applications to solve real world problems.
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Appendix A
Biological protocols
Synthetic biology aims at the assembly of modular genetic circuits in order to control
specific functions. Here, we provide an overview of the experimental methods and
the equipment that were used for the assembly and characterisation of the synthetic
devices presented in Chapters 2 and 4.
Bacterial culture medium We investigated the growth of bacterial cultures with a
range of culture media, including rich and poorer growth alternatives to obtain differ-
ent growth of E. coli and B. subtilis species. In general, we mainly used the Luria Bertani
rich medium (LB), and favoured Super Optimal Broth (SOB) or Super Optimal broth
with Catabolite repression (SOC) richer equivalents of LB for cellular recovery after E.
coli transformation. For the use of the Agilent in vitro mutagenesis kit, we performed
transformation recovery in NZY medium (an auto-induction LB medium). For cellular
culture in poorer, or more controlled growth media, we used M9 salts derivatives for
E. coli, in which we varied the carbon sources (glucose vs. glycerol) and casamino acid
concentrations. For B. subtilis, we used growth media based on the Spizizen minimal
medium salts (SMM), and adapted these to minimal growth, or starvation conditions.
Autoclaving Samples that needed sterilisation were autoclaved in Sanyo MLS 3751L
autoclaves.
Polymerase chain reaction DNA is a very small molecule. Although we only need
small amounts of DNA for cloning, the construction of synthetic devices starts by the
amplification of individual fragments aimed to be assembled. This is possible by Poly-
merase Chain Reaction (PCR), where a template DNA is added to a mix of deoxyri-
bonucleotides and DNA polymerase enzyme, which amplifies fragments flanked by
primer sequences through specific temperature cycling. For the correct amplification
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of DNA, primers should be oppositely directed, and anneal to the template at a per-
missive temperature before polymerisation extension. We generally used the NEB Q5,
Phusion or Taq polymerases (NEB M0491, M0530 and M0273) for PCR amplification
of DNA fragments. Following manufacturer instructions relevant to each polymerase,
we performed PCRs in Sensoquest Labcycler gradient and Jena Biometra trio/analytic
thermocyclers.
Gel electrophoresis In order to identify different DNA, RNA and protein mixtures, a
simple method is to analyse biological samples based on their relative size. Samples are
migrated through a gel immersed in a conductor environment, and voltage is applied
from one end to separate biological species based on their molecular weight. Individ-
ual molecular species travel at a speed inversely related to their length, which makes
possible their accurate identification by comparison to an appropriate ladder. A lad-
der is the gel reference that contains different biological fragments of known sizes[76].
Therefore, we can verify biological sample size, and thereby decide to continue or to
repeat a given cloning process.
In this thesis, we used agarose-based electrophoresis techniques for DNA migra-
tion. We varied agarose concentrations (Sigma A9539) from 0.5% to 2% according to
the expected fragment size. In general, we used lower agarose concentrations to sep-
arate low molecular weight species, whilst we increased the agarose concentration to
separate larger samples. We mixed the agarose to either Tris-borate EDTA (TBE, Ther-
moFisher AM9863) or Tris-acetate EDTA (TAE, ThermoFisher AM9869). The buffer
that was used to immerse the gel in a tank (ThermoFisher EH15) had to be the same as
the one used to make the agarose gel. While TAE was adequate for most gels, it has a
tendency to overheat and requires gel tank cleaning more regularly than its TBE equiv-
alent. TBE was thus preferred for longer runs (≥ 30min), since it does not produce such
heat. The physical migration of samples was led by a voltage (70-140V) applied from
a negative electrode towards the opposite pole, placed on the other side of the gel con-
taining samples. After migration and staining, for which we used Ethidium bromide
(EtBr, ThermoFisher 15585011), we proceeded to UV exposure on a transilluminator
(Syngene bioimaging gel doc used with GeneSnap) to reveal relative biologal sample
sizes. This result could further be followed by appropriate cloning steps.
Centrifugation A widely used technique in microbiology is to centrifuge samples
in order to separate different molecules. For the centrifugation of samples at room
temperature or at 4°C, we used Eppendorf 5430R and Hettish 320 centrifuges.
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Gel extraction In order to purify biological samples, one method is to load them onto
a gel electrophoresis apparatus, and to extract the fragment of interest by cutting a
small piece of the gel after sample migration. This is usually done with a scalpel blade,
and should be performed with appropriate Personal Protective Equipment (PPE) to
be protected from both UV and staining agent. Commercial kits such as the Qiaquick
(Qiagen 28706) or Monarch (NEB T1020S) gel extraction kits were generally used to
purify specific DNA fragments. Both protocols are based on a membrane purifica-
tion method, wherein agarose-embedded DNA is first dissolved in a binding buffer at
50°C and then loaded/bound to a column through centrifugation. An ethanol-based
washing buffer is then applied to clean DNA fragments, later eluted in MilliQ water
or elution buffer (10mM Tris-Cl, pH 8.5).
PCR purification As a general use after PCR amplification, Qiaquick PCR purifica-
tion kits (Qiagen 28106) were used to elute primers and contimants from the amplified
DNA fragments. Similarly to the Qiaquick gel extraction kit, purification is carried out
by mixing samples with a binding buffer that sticks DNA to a membrane, secondly
washed with an ethanol based solvent before eluting in MilliQ water or the elution
buffer.
Drop dialysis For DNA purification after ligation, we dialysed samples on mixed-
cellulose membranes (Millipore VSWP, 0.025µm pores), floating on MilliQ water in a
petri dish. Thirty minutes of incubation were used to purify DNA from contaminants,
and samples were then aspirated from the top of the membrane to be used for bacterial
transformation.
DNA ligation DNA self-ligation can be promoted by the use of DNA ligase. A com-
mercial kit (NEB M0202S) offers the T4 DNA ligase that allows formation of a phos-
phodiester bond at complementary DNA ends, ligating individual fragments to one
another based on a specific cloning strategy. In general, the mixture of DNA frag-
ments to be assembled contains various molecular species ratios, from equimolar up
to 7:1 excess in one species. These ratios depend on the relative size of individual
fragments to be ligated. We usually preferred higher insert to vector ratios for the as-
sembly of low molecular weight species. Otherwise, we would generally perform a 3:1
excess in insert DNA to promote the correct assembly with a given DNA backbone. For
cohesive-end ligations, reaction mixtures were left for incubation for one hour at room
temperature (20-25°C), while blunt-end fragments were rather incubated overnight in
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a thermocycler, repeating 30 seconds oscillating periods between temperatures of 10°C
and 30°C for four hours, before stabilising at 16°C overnight.
DNA digestion via endonucleases Restriction enzymes are endonucleases that cut
DNA at specific sequence they can recognise. For molecular cloning, individual en-
zymes were purchased from New England Biolabs (NEB), and digestion was carried
out for either one hour or overnight at the enzymes optimal temperature in appropriate
buffer conditions (Cutsmart buffer or NEBuffer derivatives).
Gibson-type DNA assembly By the design of overlaping arms between individual
DNA fragments to be assembled, samples can be fused via a mixture of enzymes that
exhibit 3’-5’ exonuclease, DNA polymerase and DNA ligase activities. We used a com-
mercial tool provided by NEB in order to perform Gibson assembly (NEB HiFi), in
conjunction with their online platform to help the primer design for specific amplica-
tion of individual DNA fragments (NEBuilder HiFi DNA assembly tool).
In-vitro mutagenesis In order to perform small changes on existing plasmids, we
performed in vitro mutagenesis with the amplification of template DNA from muta-
genic primers. To do this, we either used the Agilent Quickchange XL II kit or an in-
house method, which only involves a 35-cycles PCR amplification and dpnI digestion
before bacterial transformation by heat shock.
Ethanol precipitation In order to concentrate DNA, a simple method is to precipi-
tate it, to separate it from its solution and to elute it in a smaller volume. In practice,
we achieved ethanol precipitation by adding three volumes of 100% ethanol to half a
volume of 5M ammonium acetate, and added this solution to the samples at a 1:1 ratio
before incubating one hour at -80°C. Samples were then centrifugated at 14000rpm for
30 minutes, the supernatant was removed and residual ethanol left to evaporate for
30 minutes. DNA was then rediluted in an appropriate volume of MilliQ water and
incubated for 10min at 65°C.
Plasmid DNA extraction After bacterial growth with appropriate antibiotic selec-
tion, plasmid DNA can be extracted from lysed cells, and subsequently used for fur-
ther cloning steps. For high-copy number plasmids, 1.5ml of E. coli overnight culture
was centrifuged for 30 seconds at 14000rpm, whist 5 to 10ml of culture were used for
low-copy number vectors. In order to purify plasmids from bacterial contaminants, we
used commercial Qiaprep kits (Qiagen 27106). This method is based on cell lysis, RNA
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degradation and protein precipitation. These contaminants are spun down as a pellet,
whilst plasmid DNA remains in the supernatant. Via a similar column as the ones used
in other Qiagen kits, DNA is then bound and washed on a membrane, before elution
in MilliQ water or elution buffer.
Genomic DNA extraction In order to extract genomic DNA, we grew B. subtilis strains
in rich medium up to late-exponential phase, harvested 2ml of culture and lysed the
cells for DNA purification. This allowed us to avoid the purification of DNA from
spores, which are much more difficult to break and represent a biological contaminant.
For E. coli species, we harvested 1.5ml of an overnight culture before cell lysis. Bacteria
were spun down for 1min at high settings and resuspended in 100µl 50mM Tris-EDTA
(TE) supplemented with 0.5mg/ml lysozyme and 0.5mg/ml RNase A. Gram negative
species were incubated 15min at 37°C while Gram-positives were left for a one hour
incubation period. Samples were then processed via nuclei lysis (75mM NaCl, 24mM
EDTA for 5min at 80°C), protein precipitation (Promega A7951) and spun down for
10min at 14000rpm. DNA was then extracted from the supernatant by isopropanol
precipitation, washed with 70% ethanol and eluted in MilliQ water for 10min at 65°C
after individual centrifugation steps.
Bacterial transformation In order to propagate plasmid DNA in E. coli, we used elec-
troporation and heat-shock as the main transformation methods. Electroporation con-
sists of applying an electric field through a bacterial sample mixed wth DNA, which
forces the entry of assembled DNA products through the cell wall. We used a Biorad
Gene Pulser II (25µF ) with a Pulse Controller II (200Ω) to electroporate 100µl samples
in 1mm cuvettes. As an alternative, we also used heat-shock as a mean to transform
DNA into bacterial cells. We based our method on the Hannahan high-transformation
efficiency protocol, available in the Sambrook and Green manual[83].
Optical density reading In order to measure bacterial growth, optical density (OD)
readings provide an approximation of the number of cells in a sample. We followed
specific bacterial growth via OD measurements at a 600nm wavelength (OD600) using
Biochrom Libra S35 or WPA biowave CO8000 spectrophotometers. Optical density
readings may also be used in order analyse DNA molecules, and provide an accurate
approximation of a species concentration and purity in a certain volume. In order to
verify DNA concentration after sample purification, we used a Nanodrop 1000 spec-
trophotometer (Thermo Fisher Scientific 79482).
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Bioluminescence and fluorescence plate scanning During the development of ge-
netic circuits, we used chemoluminescence as a control of adequate biological be-
haviour. To image this, we used an EM-CCD camera at -25°C in an ImageQuant
LAS4000 mini platform. For plate scanning, a 1min illumination period was sufficient
to provide a qualitative answer about biological results in different conditions. By sim-
ilar means but for fluorescence imaging, a GE Healthcare Typhoon trio variable mode
imager was used with ImageQuant in order to analyse green fluorescence from plates.
Flow cytometry Flow cytometers provide a technology that allows the analysis of
single cells at a population scale level. In this thesis, we used two models of flow cy-
tometer: a Partec CyFlow space and a Fortessa x20. At specific time points, bacterial
cultures were diluted and loaded onto the equipment in polypropylene tubes (Sarsedt
55.484.005), and individual cells were analysed via laser refraction, providing infor-
mation about cell size and fluorescence profiles. An integrated analysis software was
used for the gathering of experimental data (FloMax), and individual plots were then
adequately collated for sample comparison.
Fluorescence microscopy We described in Chapter 4 a series of genetic devices that
used fluorescence as a reporter system. For the imaging of individual cells, we used
M200 and Nikon Ti (Ti-E/Ti-U) inverted microscopes. These microscopes were com-
bined with a live imaging system, and mostly used in oil immersion for phase contrast
and fluorescence measurements.
Fluorescence plate readers For the characterisation of kinetic changes in fluorescence
over time, we used automated plate readers that performed simultaneously OD and
fluorescence measurements. Used with 96-well plates (Greiner Bio-one, black and flat-
bottom, 655090), we performed experiments in BMG labtech Fluostar optima and Clar-
iostar plate readers.
189
Appendix B
Recombining barcode DNA in B.
subtilis and E. coli
In Chapter 3, we explained the assembly of barcode recombinant products for the
cloning of two model bacterial species. Here, we provide the experimental protocols
required to clone these assembled fragments into B. subtilis and E. coli strains. We
developed and optimised these methods in order to obtain a maximum number of
true-positive colonies after transformation. These protocols were also proof-tested by
three additional scientists (Jonathan Tellechea, Dr. Nunzia Lopiccolo and Dr. Wendy
Smith).
B.1 Transformation in B. subtilis
In B. subtilis, we used an antibiotic marker (zeocin) to propagate recombinant barcodes
within the genome. This was made according to the following protocol:
1. Inoculate a single colony of the strain to be made competent (ready to receive
recombinant DNA) in minimal medium (MM: 10ml SMM basic salts, 125µl 40%
(w/v) glucose, 100µl 2% (w/v) tryptophan, 60µl 1M Mg2SO4.7H2O, 10µl 20%
(w/v) casaminoacids, 5µl 2.2mg/ml ferric ammonium citrate) and grow overnight
at 37◦C
2. Dilute saturated medium 1/100 in fresh MM and grow for 3h at 37◦C
3. Prewarm a solution of starvation medium (SM: 10ml SMM basic salts, 125µl 40%
(w/v) glucose, 60µl 1M Mg2SO4.7H2O) and dilute the refreshed culture 1:1 in
SM and set for a further 2h incubation at 37◦C
4. Aliquot 400µl cells, add about 1µg recombinant DNA and shake in a 2ml eppen-
dorf for 1h at 37◦C
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5. Plate dilutions on nutrient agar (NA) plates supplement with the appropriate
antibiotic (zeocin at 20µg/ml) and incubate overnight at 37◦C
Coupled to an inducible mazF toxin[258, 162, 260], successful transformant colonies
(PCR screening and sequencing) were isolated and induced to express a toxin favouris-
ing excision of the selection/counter-selection cassette according to the following pro-
cedure:
1. Pick a positive colony and inoculate a LB culture supplemented with 0.4% (w/v)
glucose/20µg/ml zeocin, grow overnight at 37◦C
2. Dilute the overnight culture to OD600 = 0.1 in LB with 0.4% (w/v) glucose only
and grow to OD600 = 0.3
3. Add 1% (w/v) xylose to the culture and incubate for 8h at 37◦C
4. Spot 30µl of culture on a NA/1% (w/v) xylose plate, streak to obtain single
colonies and grow overnight at 37◦C
5. Restreak individual colonies onto NA/1% (w/v) xylose and NA/20µg/ml zeocin
plates and screen for zeocin sensitivity (loss of the selection cassette)
B.2 Transformation in E. coli
E. coli MG1655 and many other substrains do not encode recombinase enzymes that
are required for homologous recombination. Therefore, we first propagated a helper
plasmid in barcode recipient strains (via electroporation). This plasmid contained the
PBAD inducible promoter to drive the expression of three essential proteins that allow
chromosomal insertion of recombinant DNA. It also contained a temperature-sensitive
replicon, and bacteria should thus grow at 30◦C to avoid plasmid loss. Bacteria har-
boring the helper plasmid were made electrocompetent and transformed with recom-
binant DNA according to the following protocol:
1. Pick a single colony to inoculate an overnight culture of LB medium supple-
mented with helper plasmid antibiotic (ampicillin 100µg/ml for the pKD46 helper
plasmid) at 30◦C
2. Refresh the culture 1/100 and grow to OD600 = 0.1 at 30◦C
3. Add arabinose to 0.7% and grow cultures for a further 90min at 30◦C. This step
provides time for the recombination enzymes to be synthetised.
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4. Prepare electrocompetent cells by aliquoting 1.4ml culture and spinning/resuspending
in ice-cold glycerol at 4◦C twice (10min at 3000rpm centrifuge settings). Spin cells
again and resuspend in 50µl of residual glycerol.
5. Electroporate cells with 500ng recombinant DNA and grow cells for 3h at 37◦C,
which allows recovery of transformed cells
6. Plate culture dilutions on NA/34µg/ml chloramphenicol and grow for 24h at
37◦C
Positive colonies were identified by restreaking on NA/ampicillin plates (sensitive
with plasmid loss), PCR and sequencing.
Selection cassette removal in E. coli was performed using a flipase, an enzyme
recognising and cleaving at pairs of 34bp Frt sites[103]. A positive barcoded colony
was picked and transformed with a helper plasmid (pCP20)[32]. Similarly to the pre-
vious helper plasmid, this one’s replicon was temperature-sensitive and should not
replicate at temperatures higher than 30◦C. Colonies harboring the helper plasmid
were then induced to lose the selection cassette by following these steps:
1. Inoculate in LB supplemented with helper plasmid antibiotics a barcoded colony
and grow at 30◦C overnight
2. Dilute cells 1/100 and grow to OD600 = 0.1 at 30◦C
3. Swap the cultures from 30◦C incubation to a 42◦C shaking water bath and grow
cultures to OD600 = 0.9
4. Spot 30µl of culture on a NA plate, streak to obtain single colonies and grow
overnight at 37◦C
5. Restreak single colonies on NA, NA/ampicillin and NA/chloramphenicol plates.
Positive colonies have lost the helper plasmid (ampicillin sensitivity) and the bar-
code selection cassette (chloramphenicol)
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DNA barcoding kit
The following protocol provides the experimental procedures, written as for a kit, to
undertake barcoding studies and to retrieve the barcode sequence of any barcoded
strain.
How to barcode bacteria? Cloning E. coli or B. subtilis with barcodes works in a two-
steps process: (i) the assembly of recombinant DNA and (ii) a species-specific transfor-
mation protocol. Using the reagents supplied with the Bac2code cloning kit, follow the
protocol "Assembling recombinant barcode DNA" to assemble ready-to-clone barcode
DNA. According to the species you are working with, follow either the "Transform-
ing E. coli with recombinant barcodes" or "Transforming B. subtilis with recombinant
barcodes" protocol to barcode bacteria.
How to retrieve Bac2code documentation from an unknown barcoded strain? Us-
ing the cloning kit universal primer and the "Retrieving DNA barcodes" protocol, you
can amplify barcode sequences from genomic DNA and sequence them to gain access
to the relevant online Bac2code profile.
What comes in the Bac2code cloning kit?
• Barcode sequences (B fragments)
• Recombinant DNA fragments (L1, R1 and S1 for E. coli vs. L2, R2 and S2 for B.
subtilis)
• PCR verification primers (pF1 forward and pR1 reverse primers for E. coli vs. pF2
forward and pR2 reverse primers for B. subtilis)
• Universal sequencing primer (pU1)
• E. coli helper plasmids (H1, H2 and H3, respectively pKD46, pIJ790 and pCP20)
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• 40% glucose supplement (G, Sigma G8270)
• Nuclei lysis solution (N, Promega A7941)
• Protein precipitation solution (P, Promega A7953)
C.1 Assembling recombinant barcode DNA
Aim Prior to cloning, barcodes need to be fused to homology regions and selection
cassette to promote the occurrence of double-recombination events in E. coli and B.
subtilis.
Species-specific information (supplied with the Bac2code cloning kit)
• in E. coli: use L1 (left homology), R1 (right homology) and S1 (chloramphenicol
antibiotic resistance) fragments with primer pair pF1/pR1.
• in B. subtilis: use L2 (left homology), R2 (right homology) and S2 (zeocin antibi-
otic resistance) fragments with primer pair pF2/pR2.
Reagents needed
• Polymerase chain reactions (PCR) should be carried out using a high-fidelity
DNA polymerase. Examples are given for the NEB Q5 DNA polymerase (M0491).
• Step 3 gel extraction should be carried out using a commercial kit (NEB T1020 or
Qiagen 28704).
C.1.1 Primer-free PCR assembly
Prepare a 25µl PCR reaction as follows: mix 5µl Q5 buffer, 0.5µl 10mM dNTPs, 2µl of L-
and R-fragments, 1µl of B- and S-fragments, 5µl Q5 GC enhancer, 8.25µl MilliQ water
and 0.25µl Q5 polymerase. Run the reaction in a thermocycler for 12 cycles with a low
annealing temperature (TA=55°C) and a 2.5kb extension time (1min40sec) using your
PCR reagents recommendations.
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C.1.2 Recombinant DNA amplification
Prepare a 200µl PCR reaction as follows and split into 50µl aliquots: mix 40µl Q5 buffer,
4µl 10mM dNTPs, 10µl of pF and pR primers, 12µl of PCR products from the primer-
free PCR, 40µl Q5 GC enhancer, 82µl MilliQ water and 2µl Q5 polymerase. Run the
reaction in a thermocycler for 25 cycles with a high annealing temperature (TA=64°C)
and a 2.5kb extension time (1min40sec) using your PCR reagents recommendations.
C.1.3 Purification
Mix recombinant DNA obtained from the previous step to a DNA loading dye for gel
extraction, and run the whole sample on a 1.2% agarose gel electrophoresis. Using a
recommended gel extraction kit, elute the correct gel size band in 30µl MilliQ water:
• for E. coli, cut and purify the 1875bp band.
• for B. subtilis, cut and purify the 2123bp band.
This aliquot is the recombinant barcode DNA, ready-to-use for bacterial transforma-
tion.
C.2 Transforming B. subtilis with recombinant barcodes
Aim Recombinant barcode DNA is naturally taken up by B. subtilis and selection
cassette excision is based on the MazF toxin.
Reagents needed
• Luria-Bertani (LB) growth medium: for a 1L preparation, mix 10g peptone, 5g
yeast extract, 10g sodium chloride with 800ml MilliQ water. Adjust the volume
to 1L and autoclave 35min on sensitive cycle
• sterile 40% glucose (solution G supplied with the Bac2code cloning kit)
• minimal medium (MM): 10ml SMM basic salts, 125µl 40% (w/v) glucose, 100µl
2% (w/v) tryptophan, 60µl 1M Mg2SO4.7H2O, 10µl 20% (w/v) casaminoacids,
5µl 2.2mg/ml ferric ammonium citrate
• starvation medium (SM): 10ml SMM basic salts, 125µl 40% (w/v) glucose, 60µl
1M Mg2SO4.7H2O
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• nutrient agar (NA) plates: for a 1L preparation, mix 3g beef extract, 5g peptone,
15g agar with MilliQ water. Autoclave on sensitive cycle, add antibiotics at 50°C,
pour into petri dishes and keep at 4°C for further use (max 2 weeks for plates
supplemented with antibiotics)
• working antibiotics/supplements concentrations: 20µg/ml for zeocin, 1% xylose
C.2.1 Barcoding cells
Inoculate a single colony from the target strain in 10mL MM and shake at 37◦C overnight.
In the morning, refresh the culture 1/100 in 10mL MM, prepare 10mL sterile SM to
prewarm and incubate at 37°C for 3h. Add the warm SM to the cells and carry on
incubation for 3h. Aliquot 400µl cells in a 2ml eppendorf tube, mix with 1µg recombi-
nant barcode DNA, and shake for 1h at 37◦C (barcode integration now occurs). Spread
100µl cells onto a NA/Zeocin plate and incubate overnight at 37◦C. Restreak a sin-
gle colony on NA/Zeocin plates, incubate overnight at 37◦C and screen for positive
transformants by PCR using the pF2/pR2 primer pair at 62◦C for a 2123bp band.
C.2.2 Removing the selection marker
Inoculate a single colony from Step 2 in 10mL LB/zeocin and grow the cells at 37◦C
overnight. In the morning, dilute cells 1/100 in 10mL fresh LB without antibiotics and
grow up to OD=0.4. Add 1% xylose to the culture and grow the cells for 10h. Streak
a 30µl cells spot from the edge of a NA/xylose plate and incubate overnight at 37◦C.
Restreak single colonies on NA (positive colony) and NA/Zeocin (selection cassette
excision control); incubate overnight at 37◦C.
Single colonies from the NA plate that do not grow on NA/Zeocin are barcoded
strains. A PCR using the pF2/pR2 primer pair at 62◦C should lead to a 1170bp band.
C.3 Transforming E. coli with recombinant barcodes
Aim Prior to barcode DNA transformation, the target E. coli strain needs to be prop-
agated with a helper plasmid remotely expressing essential proteins for chromosomal
recombination. Induction of recombinase proteins by arabinose allows the integration
of recombinant barcode DNA into the bacterial genome.
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Helper plasmids information (supplied with the Bac2code cloning kit) The H1
helper plasmid contains an ampicillin resistance cassette for selection. If this is in-
compatible with the target strain design, use the alternative H2 plasmid conferring
resistance to chloramphenicol.
Reagents needed
• Luria-Bertani (LB) growth medium: for a 1L preparation, mix 10g peptone, 5g
yeast extract, 10g sodium chloride with 800ml MilliQ water. Adjust the volume
to 1L and autoclave 35min at 123◦C.
• sterile 40% glucose (solution G supplied with the Bac2code cloning kit).
• sterile 10% glycerol: for a 1L preparation, mix 100ml glycerol with 700ml MilliQ
water and mix. Adjust the volume to 1L and autoclave 35min at 123◦C. Cool
down and keep the bottle sterile at 4◦C.
• Nutrient agar (NA) plates: for a 1L preparation, mix 3g beef extract, 5g peptone,
15g agar with MilliQ water. Autoclave 35min at 123◦C, add antibiotics at 50◦C,
pour into petri dishes and keep at 4◦C for further use (max 2 weeks for plates
supplemented with antibiotics).
• Working antibiotics/supplements concentrations: 100µg/ml for ampicillin, 34µg/ml
for chloramphenicol and 0.7% arabinose.
C.3.1 Propagate the helper plasmid
Inoculate a fresh colony of the target strain in 25ml LB and shake the culture overnight
at 37◦C. In the morning, dilute cells 1/100 in 25ml fresh LB medium supplemented
with 0.4% glucose (250µl solution G) and incubate at 37◦C. At OD600 ∼ 0.4−0.5, freeze
the culture on ice for 15min and turn a cold centrifuge on. Further steps should be
carried out at 4◦C. Spin cells at 5000rpm for 10min, discard supernatant and resus-
pend the bacterial pellet in the same volume of ice-cold 10% glycerol. Repeat this step
twice; discard the final supernant and aliquot 50µl concentrated cells from the residual
glycerol. Add 1µl helper plasmid (H1 solution), mix and transfer to a chilled 1mm
electroporation cuvette. Place the cuvette in a gene pulser (25µF , 200Ω at 1.8kV) and
electroporate cells. A time constant close to 5ms is expected. Immediately add 950µl
LB to the cuvette, pipette up/down six times, transfer to a 12ml round-bottom falcon
tube and shake for 1h at 30◦C. Spread 50µl cells onto a NA plate supplemented with
ampicillin (or chloramphenicol if H2 used). Incubate the plate overnight at 30◦C.
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C.3.2 Barcoding cells
Inoculate a single colony from Step 1 transformants in 25ml LB/ampicillin and shake
at 30◦C overnight. In the morning, refresh the culture 1/100 in 25ml LB/ampicillin
and grow the cells at 30◦C to OD600 ∼ 0.2− 0.3. Add arabinose to a final concentration
of 0.7% and grow for 1h at 37◦C, this gives time for recombination proteins to be ex-
pressed. Further steps should be carried out at 4◦C. Spin cells at 5000rpm for 10min,
discard supernatant and resuspend the bacterial pellet in the same volume of ice-cold
10% glycerol. Repeat this step twice; discard the final supernatant and aliquot 50µl
concentrated cells from the residual glycerol. Add 400ng recombinant barcode DNA,
mix and transfer to a chilled 1mm electroporation cuvette. Place the cuvette in a gene
pulser (25µF , 200Ω at 1.8kV) and electroporate cells. A time constant close to 4ms is
expected. Immediately add 950µl LB to the cuvette, pipette up/down 6 times, trans-
fer to a 12ml round-bottom falcon tube and shake for 3h at 37◦C (recombination now
occurs). Spread 100µl cells onto a NA plate supplemented with chloramphenicol and
incubate overnight at 37◦C. Restreak single colonies on NA/chloramphenicol plates,
incubate overnight at 37◦C and screen for positive transformants from genomic DNA
by PCR using the pF1/pR1 primer pair at 64◦C for a 1875bp band.
C.3.3 Removing the selection marker
Site-specific recombination Starting from a positive colony obtained in Step 2, reit-
erate Step 1 with the H3 helper plasmid that promotes excision of the selection cas-
sette. After electroporation, carry out all incubation steps at 30◦C as H3 contains a
temperature-sensitive replicon; adjust antibiotics concentrations to 100µg/ml ampi-
cillin and 17µg/ml chloramphenicol.
Excision of the selection cassette Inoculate a single colony from previous step in
25ml LB/ampicillin/chloramphenicol and grow the cells at 30◦C overnight. In the
morning, dilute cells 1/100 in 25ml fresh LB without antibiotics and grow at 30◦C up
to OD600 = 0.1. Swap cells to a 42◦C shaking water bath and carry on bacterial growth
up to OD600 = 0.9. Streak out from a 30µl cells spot a NA plate and incubate overnight
at 37◦C. Restreak a single colony on NA (positive colony), NA/ampicillin (helper plas-
mid loss control) and NA/chloramphenicol (selection cassette excision control); incu-
bate overnight at 37◦C.
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Single colonies from the NA plate (not growing on the antibiotics plates) are bar-
coded strains. A PCR from genomic DNA using the pF1/pR1 primer pair at 64°C
should reveal a band at 1068bp.
C.4 Retrieving DNA barcodes
Aim For any barcoded strain, a straightforward process consisting of amplifying ge-
nomic DNA containing the barcode allows its sequencing via universal primers, and
to retrieve strain information from the Bac2code server.
Species-specific information (supplied with the Bac2code cloning kit)
• in E. coli: use the pF1/pR1 primer pair at an annealing temperature TA = 64◦C.
• in B. subtilis: use the pF2/pR2 primer pair at an annealing temperature TA =
62◦C.
Reagents needed
• Polymerase chain reactions (PCR) should be carried out using a high-fidelity
DNA polymerase. Examples are given for the NEB Q5 DNA polymerase (M0491)
• PCR purifications should be carried out using a commercial kit (Qiagen 28104)
• Luria-Bertani (LB) growth medium: for a 1L preparation, mix 10g peptone, 5g
yeast extract, 10g NaCl with 800ml MilliQ water. Adjust the volume to 1L and
autoclave 35min at 123◦C
• sterile 40% glucose (solution G supplied with the Bac2code cloning kit)
• TE buffer: 10mM Tris-HCl, 1mM EDTA in distilled water
• RNase A (10mg/ml, store at 4◦C – Sigma R6513) and lysozyme (10mg/ml, store
at −20◦C – Sigma L3790)
• 100% isopropanol and 70% ethanol
• Protein precipitation and nuclei lysis buffers are supplied with the Bac2code
cloning kit (respectively solutions P and N – Promega A7953 A7941)
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C.4.1 Harvest bacterial genomic DNA
Inoculate 2.5ml of fresh LB/0.4% glucose with the strain to identify and shake at 37◦C
up to OD600 ∼ 0.5− 0.6. Spin spin cells down for 3min in a high-speed centrifuge and
resuspend the pellet in 100µl TE and add 5µl RNase A and 5µl lysozyme, incubate at
37◦C for 30-45min. Add 600µl solution N and heat for 5min at 80◦C. Cool down to
room temperature, add 200µl solution P, vortex thoroughly and place on ice for 10min.
Spin down 10min at 14000rpm and add 600µl supernatant to a clean 1.5ml eppendorf
containing 600µl room temperature 100% isopropanol. Invert the tube about 10-15
times, until DNA precipitation becomes visible, and spin for 10min at 14000rpm. Tip
the supernatant out, add 600µl 70% ethanol and spin for 5min at 14000 rpm. Carefully
aspirate the supernatant and let the tube opened to dry out in a clean place for 15min.
Add 30µl MilliQ water and let DNA dissolve for 10min at 65◦C. This provides the
eluted genomic DNA for a specific barcoded strain.
C.4.2 Barcode DNA amplification
Prepare a 25µl PCR reaction as follows: mix 5µl Q5 buffer, 0.5µl 10mM dNTPs, 1.25µl
of pF and pR primers, 1µl of barcoded strain genomic DNA, 5µl Q5 GC enhancer,
10.75µl MilliQ water and 0.25µl Q5 polymerase. Run the reaction in a thermocycler
for 35 cycles at the species-specific recommended annealing temperature with a 1.2kb
extension time (1min30sec).
C.4.3 Purification and barcode retrieval
After checking 4µl PCR products on gel electrophoresis for the presence of a 1170bp (B.
subtilis) or 1068bp band (E. coli), purify DNA using a commercial PCR purification kit
and perform the final elution step in 30µl MilliQ water after a 10min incubation period
with the washing buffer. Send this purified PCR fragment to sequencing using the
pU1 primer and input sequencing results onto the Bac2code server to retrieve bacterial
strain information.
C.5 Troubleshooting
• A tip to detect barcode positive clones? In general, after barcode DNA transfor-
mation, smaller colonies on plates reveal the right chromosome insertion.
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• What if I get low recombinant barcode DNA concentration? This procedure
should lead to a final DNA concentration ≥ 30ng/µl. If DNA products concen-
tration is ≤ 20ng/µl, it is recommended to rehearse Step 23 from leftover Step 1
PCR products.
• What if I get low genomic DNA concentration? This procedure should lead to
a final DNA concentration ≥ 100ng/µl. If DNA products concentration is within
the range 20− 50ng/µl, it is recommended to add more template DNA for PCRs
(∼ 100ng). If DNA concentration is ≤ 20ng/µl, it is recommended to repeat the
genomic DNA extraction while being extra-careful not to aspirate DNA after the
ethanol wash. Optionally, you can leave the bottom 50µl from the supernatant
and dry samples overnight in a clean cabinet before eluting in water.
• What if the right band does not show up on gel? Always verify that you use
the right primer pair for the sample organism (pF1/pR1 for E. coli vs. pF2/pR2
for B. subtilis). Always verify that you use the right annealing temperature in
PCR reactions. Always verify that PCRs elongation time can cover an up to 2kb
product. Typically, 1min40 for the Q5 polymerase should always be suitable.
• What if I get low B. subtilis cloning efficiency? Always prewarm the starva-
tion medium (SM) well in advance and add it without removing cultures from
the 37◦C incubator. Always compare your PCR results to a negative control: B.
subtilis non-barcoded strains show a 1002bp fragment with pF2/pR2 primers.
• What if I get low E. coli cloning efficiency? If the electroporation time-constant
for plasmids or barcode DNA propagation is very different from the standard
(respectively 5ms and 4ms), make sure your cells are fully resuspended during
the glycerol wash for competent cells preparation. Always compare your PCR
results to a negative control: E. coli non-barcoded strains show a 903bp fragment
with pF1/pR1 primers.
• What if I do not get any sequencing read? Make sure PCR fragments are always
very clean before sending sequencing reactions. In standard purification proto-
cols, a longer incubation period with the cleaning buffer (usually ethanol-based)
improves a lot samples purity. Additionally, you may want to try using pR1 or
pR2 primers to identify barcodes from the reverse DNA strand. E. coli strains
should provide a read with pR1, while pR2 should be used in B. subtilis.
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Appendix D
Making PDMS microfluidics chips
The following protocols provide details of the experimental procedures required to
produce intermediate hard-/soft PDMS or single-use soft PDMS biochips.
D.1 Intermediate-PDMS template
This protocol was designed to produce PDMS-based microfluidics intermediates. A
thin layer of hard PDMS (h-PDMS) is deposited onto a SU-8 photoresist featuring mi-
crofluidics patterns to reproduce. This surface layer is backed with a thicker layer of
soft PDMS (s-PDMS) and serves as master for the molding of further s-PDMS chips.
For this protocol, lab coat, nitrile gloves and goggles should be worn at all times.
Silanising the wafer, in this one and further protocols, is used to guarantee better sep-
aration between template and PDMS after cross-linking.
1. Preparing the wafer:
• Wash the wafer with (i) 100% isopropanol, (ii) 100% acetone and (iii) 100%
isopropanol
• Blow dry the wafer with pressurised air
• Silanise the wafer in a vacuum chamber: (i) center and stick the wafer to
a 50ml falcon tube inverted cap using blue tak or equivalent, (ii) under a
fume hood, pipette 40µl 1H,1H,2H,2H perfluorooctyl tricholosilane onto a
piece of whatman paper and place it in the vacuum chamber (leave pipette
tip inside, perfluorooctyl tricholosilane is toxic), (iii) apply vacuum to 27psi
and incubate for 30min, and (iv) slowly reintroduce air into the vacuum
chamber
2. Creating the h-PDMS layer:
• Prepare the h-PDMS mixture:
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– In a 50ml falcon tube, mix 27.2g Vinylmethylsiloxane-dimethylsiloxane
copolymer (pour directly from container) and 144µl Platinum divinylte-
tramethyldisiloxane complex (with a 200µl tip)
– Add 0.8g 1,3,5,7-Tetravinyl tetramethylcyclotetrasiloxane (disposable pipette)
and mix
– Add 8g Methylhydrosiloxane- dimethylsiloxane copolymer (disposable
pipette) and mix
– Add 4g hexane with a disposable pipette and mix: careful to eventual
vapors
• Degas the polymer mixture in a vacuum chamber at 27psi for 15min: in-
crease/decrease pressure at first to avoid PDMS bubbles splashing in the
vacuum chamber
• Preheat a hot plate to 65◦C
• Set the clean wafer (photoresist) at the centre of a spin coater on the central
spin chuck
• Activate vacuum and verify that the wafer is well centered
• Spin at 100rpm for 1 min and pour degassed h-PDMS at the centre of the
spinning wafer, slowly move towards wafer edges as PDMS spreads from
the centre
• Place the wafer onto a clean towel in the vacuum cleaner and degas all bub-
bles that may have been formed after spinning (5-10min at 27psi)
• Place the wafer back on the spin coater and run it for 5sec at 500rpm, then
40sec at 1000rpm
• Place the wafer in a large petri dish and bake for 1h on the 65◦C hot plate
3. Creating the s-PDMS layer:
• Mix 70g Sylgard 184 base and 7g Sylgard 184 curing agent using a serological
pipette in a 200ml beaker
• Degas the mixture at 27psi in a vacuum chamber for 30min
• Fold a holder for the master wafer that is coated with h-PDMS: (i) place the
wafer at the center of a piece of strong tin foil, dull side up and (ii) fold
the aluminium at the edges of the wafer to build walls that will contain the
s-PDMS from pouring out of the h-PDMS layer
• Gently pour degassed s-PDMS at the centre of the wafer
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• Degas at 27psi in a vacuum chamber to remove any residual PDMS bubbles
for 10min
• Place on a hot plate at 65◦C and bake overnight (16-18h)
4. Removing PDMS from the wafer:
• Remove the wafer from the hot plate and let it cool down to room tempera-
ture
• Remove any residual PDMS that may have leaked at the bottom of the wafer
• Gently detach the tin foil from the coated wafer
• With a scalpel n11, very precisely separate PDMS from the silicon wafer by
sliding the blade all around its edges
• Delicately pull the polymer layer from the wafer and trim the polymer edges
as wanted for further use
D.2 Cleaning microfluidics wafers
Sometimes, removing a wafer from a photoresist can leave residual polymer behind.
For a better conservation of SU-8 photoresists, wafers are best kept clean and any
residue should be removed. The recommended cleaning method is to successively
use isopropanol and acetone washes. Pressurised air is very good at detaching tiny
pieces of polymer that may be stuck in small microfluidics features. However, if none
of these methods manage to clean the wafer, one last procedure remains possible: a
piranha solution wash to dissolve any organic matter on the SU-8 layer. For this proto-
col, besides ordinary personal protective equipment (PPE, lab coat and goggles), wear
a face shield and trionic gloves at all times. Pyrex glassware should be used at all
times. In a class 2+ fume hood, prepare the piranha solution: in a beaker, pour 60ml
sulfuric acid and add 20ml hydrogen peroxyde millilitre by millilitre. Carefully mix
the mixture and be aware of hydrogen fumes. This chemical reaction produces a lot of
heat, do not touch the glassware without gloves. Pour the piranha solution in a large
petri dish and tilt the wafer upside down in the solution. Gently tilt the petri dish
back and forth to immerse the entire wafer and incubate overnight in the fume hood
on high fan settings. In the morning, wash the wafer with deionised water for 1h and
blow it dry with pressurised air before storing it in a clean wafer box. Neutralise the
piranha solution with 99% NaOH: in a fume hood, (i) add NaOH millilitre by millilitre
and stir the mixture, being aware of splashes generated by the exergonic reaction, and
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(ii) when the pH reaches a value between 4 and 10, dispose of the solution via a drain
under running tap water.
D.3 Single-use soft-PDMS
This protocol was designed to produce single-use soft PDMS microfluidics chips. A
thick layer of s-PDMS is deposited onto a master intermediate mould to reproduce the
features of the initial SU-8 photoresist.
For this protocol, a lab coat, nitrile gloves and goggles should be worn at all times.
1. Prepare the wafer the same way as detailed for intermediate chips with a 45min
silanisation incubation period.
2. Create the s-PDMS layer the same way as detailed for intermediate chips but
proceed to a 2h bake at 80◦C instead
3. Separate the s-PDMS layer from the intermediate mould the same way interme-
diate PDMS is removed from SU-8 photoresists. Separate polymers very slowly
as soft PDMS is more likely to break at small microfluidics features
4. Trim the s-PDMS layer to make individual s-PDMS chips according to design
(keep track of chip identifiers)
5. Bonding chips to coverslips:
• Features side up, delicately create holes in s-PDMS chips by using a 0.75mm
biopsy punch at the tubing inlet/outlet ports
• Turn on a pressurised plasma cleaner and prepare 3 individual s-PDMS
chips to bond (3 polymer chips and 3 glass coverslips)
• Close the plasma cleaner door and adjust the internal pressure to 500-1000mTor
• Turn the plasma on “high” setting for 45sec and turn it off before reintro-
ducing air into the chamber
• Within a minute, invert s-PDMS chips onto glass coverslips and apply a
gentle pressure on top of each chip. Verify that the polymer is well bonded
to the glass and that no air bubbles remain.
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